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Abstract 
 
The chirality of biological systems can be probed using highly emissive lanthanide 
complexes with the aid of circularly polarised luminescence and emission spectroscopy. 
Such chirality probes can be synthesised through the incorporation of a remote chiral 
centre within the ligand framework, which can preferentially stabilise a particular 
stereoisomer giving an enantiopure complex of well-defined helicity. Alternatively, 
lanthanide chirality probes can be derived from achiral or dynamically racemic ligands, 
where the selective induction of a CPL signal can be monitored as a function of the nature 
and concentration of a selected chiral analyte. 
A series of chiral lanthanide complexes has been synthesised. Each complex is based on 
an amide substituted 1,4,7-triazacyclononane system derived from either R-(+) or S-(-)-
α-methylbenzyl amine. The stereochemistry of the amide moiety controls the helicity of 
the complex, and one major diastereoisomer is formed for each lanthanide metal. The 
absolute stereochemistry of the major diastereoisomer was determined by X-ray 
crystallography (S-Δ-λλλ and R-Λ-δδδ). Inclusion of an aryl-alkynyl chromophore 
generated complexes that exhibited large extinction coefficients (up to 55,000 M-1 cm-1) 
and high quantum yields (up to 37%) in water. 
A second set of bright Eu (III) complexes has been prepared based on an achiral 
heptadentate ligand system, which vary in the nature of the pyridyl donor (phosphinate, 
carboxylate and amide). The binding of a number of chiral acids including lactate, 
mandelate and cyclohexylhydroxyacetate was monitored by a change in the emission 
spectrum and the induction of strong CPL. Empirical analysis of the ΔJ = 4 region of each 
of the Eu (III) complexes allows an assignment of the complex-anion adducts as R-Δ and 
S-Λ. Furthermore, variations in the sign and magnitude of CPL allow the enantiomeric 
purity of samples with unknown enantiomeric composition to be assessed. 
Finally, several dynamically racemic lanthanide chirality probes have been synthesised 
and characterised. Induced CPL has been assessed, which arises as a result of the change 
in complex constitution upon binding to important chiral biomolecules such as, sialic 
acid, O-phosphono-amino acids and peptides and oleoyl-L-lysophosphatidic acid (LPA). 
This work presents the first example of induced CPL in the detection of cancer 
biomarkers, sialic acid and LPA, and demonstrates the utility of this class of dynamically 
racemic Eu (III) complexes as chirality probes. 
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CHAPTER ONE 
INTRODUCTION 
 
CHAPTER ONE - INTRODUCTION 
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1.1. Overview 
 
Molecular chirality is a description applied to molecules that are non-superimposable on their 
mirror images through translation and/or rotation. The word chirality is derived from the Greek 
word for hand (cheir) as it is a mathematical approach to the ‘handedness’ of a molecule. 
Although enantiomers (molecules related to each other as mutual mirror images) have identical 
chemical properties, their three-dimensional structure profoundly alters their interaction with 
the surroundings. This property is of particular relevance in the pharmaceutical industry, where 
it is imperative to accurately determine the enantiomeric purity of a drug molecule. The 
molecular recognition of a guest molecule can also provide an in-depth understanding of a 
variety of chemical and biological processes, including structure-function relationships. There 
is a wide range of chiral biomolecules of interest, and development of accurate and informative 
chiral recognition studies is of considerable importance. 
Europium and terbium luminescence occurs on a millisecond timescale and has been used as 
an analytical tool for many years, with a wide range of applications in material1 and biological 
sciences.2–4 In particular, the signalling and sensing of reversible anion binding to a lanthanide 
centre has been studied using emission and luminescence lifetime measurements.5  However, 
to date, there is relatively little consideration given to the three-dimensional structure, or 
chirality, of the chosen analyte. Circularly polarised luminescence (CPL) spectroscopy exists 
as a tool that in conjunction with a highly luminescent probe, allows for detailed investigation 
of the chiral environment of the molecule or system of interest. 
This chapter begins with a comprehensive discussion of CPL spectroscopy, including the key 
equations that underpin the theory, and the methods and instrumentation that are used to record 
CPL spectra. A review of the types of system that exhibit this phenomenon is discussed, 
ranging from small organic molecules through to transition metal and lanthanide complexes. 
In the context of this thesis, particular emphasis will be placed on the design of chiral lanthanide 
complexes that exhibit strong CPL. The final section  reviews examples of lanthanide 
complexes as chiral probes that exhibit modulation or induction of their CPL output, following 
a change in their environment.  
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1.2. Circularly polarised luminescence 
Since the 1940s and Samoilov’s first observation of the phenomenon of circularly polarised 
luminescence (CPL) from a sodium uranyl acetate crystal,6 the measurement of CPL or CPL 
spectroscopy has become a well-developed technique and has been applied in the study and 
structural determination of optically active chiral molecules.7–9  
1.2.1. CPL spectroscopy: background theory and equations 
Before we begin analysing the theoretical principles surrounding the phenomenon of CPL, 
consider first the classical description of polarised light. Electromagnetic waves (light) are 
made up of two vectors which are the electric and magnetic fields. The light’s polarisation 
direction is by convention, along the direction of the electric field. The electric field vector 
itself can be split into two components that are perpendicular to one another and oscillate with 
identical frequency. In the case of circularly polarised light, these two components have the 
same amplitude, but are phase shifted by exactly one quarter of the wavelength (Figure 1). This 
results in one component being at a maximum or minimum value, while the other component 
is at zero. Therefore, circular polarisation confers helical chirality to a beam of light depending 
upon the propagation mode. Circularly polarised light can be generated by passing linearly 
polarised light through a quarter-wave plate at an angle of 45º to the optic axis or by the 
interaction of light (linear or unpolarised) with a chiral molecule. 
 
Figure 1 – Left and right circularly polarised light (from the point of source). The two perpendicular components of the 
electric field vector are depicted in blue and green. 
 
By definition, CPL spectroscopy measures the differential spontaneous emission of left versus 
right circularly polarised light from a luminescent system, ΔI.2,10,11 
 ∆𝐼(𝜆) = 𝐼𝐿(𝜆) − 𝐼𝑅(𝜆) (1.1) 
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As it is difficult to measure absolute values of emission intensity, the degree of CPL at a 
particular wavelength is reported in terms of the emission dissymmetry factor, gem, as defined 
in equation 1.2. 
 
𝑔𝑒𝑚(𝜆) =
2∆𝐼(𝜆)
𝐼𝐿(𝜆) + 𝐼𝑅(𝜆)
 
(1.2) 
 
In their pioneering studies into the observation of CPL from chiral molecules in solution, Emeis 
and Oosterhof were able to demonstrate that in the limit when the orientational distribution of 
emitting molecules is isotropic, an analogy can be drawn between the CPL observables and the 
molecular properties of the system.12 Within this limit, the degree of CPL can be linked to a 
single fundamental molecular property – the rotatory strength parameter, equation 1.3. 
 𝑅𝑖𝑗 = 𝐼𝑚(⟨𝑗|𝝁|𝑖⟩⟨𝑖|𝒎|𝑗⟩) (1.3) 
 
In this equation the rotatory strength of the electronic transition|𝑗⟩ → |𝑖⟩, is defined as the scalar 
product of the electric, µ, and magnetic, m, transition dipole vectors. Orientational averaging 
of the system yields a second equation, in which the emission dissymmetry value can be 
defined in terms of this molecular parameter, equation 1.4. 
𝑔𝑒𝑚 =
4𝑅𝑗𝑖
𝐷𝑗𝑖
 (1.4) 𝐷𝑗𝑖 = |𝑚|
2 + |𝜇|2 (1.5) 
 
Here, Dji is the dipole strength of the transition, also defined in terms of the magnetic and 
electric transition dipole moments, and is influential in determining the intensity of the total 
emission, equation 1.5. If we assume that the magnetic transition dipole moment is much 
smaller than its electric counterpart, as is typically the case, equation 1.4 can be scaled and 
consequently gem can be expressed by equation 1.6, 
 
𝑔𝑒𝑚 =
4|𝑚|
|𝜇|
𝑐𝑜𝑠𝜏 (1.6) 
where τ is the mutual orientation angle between the magnetic and electric transition dipole 
moments and is dependent on the geometry of the system. It should be noted that a value of 
zero for gem corresponds to no circular polarisation in the emission output; the maximum value 
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is ± 2. An important piece of information to acknowledge from these equations is that, generally 
speaking, transitions that are magnetic dipole allowed and electric dipole forbidden will exhibit 
large gem values. 
 
1.2.2. Advantages and limitations of CPL 
The chiral character of a beam of light is the basis of chiral photonics or chiroptics. Circular 
dichroism (CD) is the more widely recognised spectroscopic technique in this area and is based 
on the differential absorption of left and right circularly polarised light. CPL is the emission 
equivalent of CD and therefore gives us information about the chiral properties of a molecule 
in its excited state.  The two techniques exist as complementary tools, allowing information 
about geometry differences in the ground and excited state to be elucidated. There are, 
however, a few advantages to take into account when employing an emission based chiroptical 
technique such as CPL.7 CPL is inherently more sensitive than CD and it is often possible to 
observe weak CD transitions, i.e. transitions from excited states that are only weakly accessible 
via absorption processes. Also, interpretation of spectra in CPL is often simpler and only 
selected transitions are observed particularly in systems containing many chromophores, as 
only select luminophores will respond at a specific excitation wavelength.  
The measurement of CPL also has some inherent limitations, the most severe being that the 
system under investigation must contain a luminescent chromophore with a reasonable 
quantum yield. This drawback can be addressed by intelligent probe design and will be 
discussed in greater detail in subsequent sections (Sections 1.3 to 1.5). 
 
1.2.3. Measurement techniques and instrumentation 
The technique of measuring CPL from chiral molecules in solution dates back to the 1970s in 
the laboratories of Professors Oosterhof,12 Richardson13 and Dekkers.14 Yet despite this, the 
first commercial CPL spectrometer has only recently become available (JASCO CPL-200). As 
a result, the majority of CPL studies in the literature have been performed using ‘in-house’ 
built spectrometers which share many common features in their setup. The technique has been 
developed to a point where detection of CPL for moderately luminescent chiral systems can be 
performed with a high degree of reliability and sensitivity (~1 part in 104-105). 
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In a typical experiment, the incident light used to excite the sample is linearly polarised or 
unpolarised. The sample is excited at 90º to the direction of emission detection and the emitted 
light is collimated and selectively modulated by a photoelastic modulator (PEM). The PEM is 
made of an isotropic clear optical material, such as quartz, that becomes anisotropic on 
application of periodic stress. The PEM can be driven by an AC signal at a frequency of ~50 
kHz, thereby acting as an oscillating quarter-wave plate. On alternate cycles, the PEM retards 
or accelerates the wavelength of emitted light, which results in the right and left components 
of the circularly polarised light being converted to the appropriate linear polarisation. The 
monochromated light is then selected by a linear polariser orientated at 45º and passed on to a 
photomultiplier tube (PMT).   A typical detection system may comprise of a lock-in amplifier 
(LIA) which detects the difference signal (AC) and the total intensity (DC) and converts them 
to the CPL and total luminescence (TL) respectively after background correction (Scheme 
1).15,16,17 An alternative detection method may utilise photon counting. This method has been 
shown to be more reliable than the analogous lock-in detection and less influenced by 
electronic problems such as ground loops.18  
 
 
Scheme 1 - Schematic diagram showing a typical instrumentation set-up for the measurement of CPL based on a lock-in 
detection system.15 
 
It is not difficult to imagine that small changes to the conventional spectrometer set-up allows 
for alternative CPL experiments to be devised. One example of this is the induction of CPL 
from a racemic mixture of molecules by employing circularly polarised light as the excitation 
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source. This technique has been used in the determination of optical purity of partially resolved 
systems by achieving preferential excitation of one enantiomer.19,20 Another method of 
inducing and measuring CPL from an achiral, optically inactive system is via the application 
of a static magnetic field along the direction of emission detection. This technique is termed 
magnetic circularly polarised luminescence (MCPL) and is particularly useful in eliciting 
electronic structural information.21 Despite the utility of these techniques, the remainder of this 
review will focus primarily on zero-field CPL where a linearly polarised or unpolarised 
excitation source is used to elucidate key stereochemical information from naturally optically 
active systems.  
 
1.2.4. Calibration standards for CPL  
It is important to be able to measure accurately the sign and magnitude of CPL signals and 
emission dissymmetry values. Therefore, it is imperative to ensure effective spectrometer 
calibration with the use of a reliable standard to certify that recorded data is transferable and 
comparable between other ‘home-built’ and commercial spectrometers. 
The commercially available NMR shift reagent tris(3-trifluoroacetyl-(+)-
camphorato)europium (III) (Eu((+)-facam)3) in DMSO is the most commonly used CPL 
calibration standard.22 However, there are some drawbacks associated with this lanthanide 
complex that limit its use as an effective calibrating agent. Of these, the most notable is the 
relative sensitivity of Eu((+)-facam)3 to water in DMSO. This drawback severely limits the 
reliability of this complex as a CPL standard as gem values can vary depending on the water 
content of the solution.  
 
Scheme 2 - Chemical structure of facam (left) and N,N'-bis(1-phenylethyl)-2,6-pyridine carboxamide L1 (right).22,23 
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More recently, an alternative europium complex has been proposed in an attempt to improve 
accurate routine CPL calibration tests. The CPL standard is based on chiral N,N’-bis(1-
phenylethyl)-2,6-pyridine carboxamide ligands, L1, in a 1:3 (Eu: ligand) ratio (Scheme 2).23 
Ligand 1 can be prepared in a simple one-step synthesis in high yield (90%). The most 
prominent advantage of this standard over the traditional Eu((+)-facam)3 calibration agent is 
the solution stability. For instance, no change to gem values were found between fresh and 
several month old solutions of the complex. The standard was also found to be stable to 
photobleaching under continuous UV irradiation over several days. This complex may present 
an attractive alternative to the traditionally used (Eu((+)-facam)3 standard. However, the 
reliability of the speciation of the complex is worth considering. The authors claim that by 
mixing Eu3+ and the ligand in a 1:5 ratio, only the [Eu.(L1)3]
3+ species is formed, yet provide 
limited evidence that this is in fact the species that is being observed. It may be time for the 
development of a better defined complex for use in the calibration and routine tests of CPL 
spectrometers, to allow for more comparable results across the literature. 
 
1.3. Systems that exhibit CPL 
 
There is a wide variety of systems documented in the literature that exhibit the phenomenon of 
CPL, including simple organic molecules, transition metal complexes and lanthanide-based 
structures. This section aims to review the literature surrounding the intense development of 
each class of CPL-active system and discuss potential applications, advantages and draw-backs 
of each approach. 
 
1.3.1. CPL from simple organic molecules 
CPL from simple organic molecules (SOMs) dates back to the emergence of CPL spectroscopy 
and the study of bicyclic chiral ketones in the laboratories of Emeis and Oosterhof in 1967.24 
There lies a great challenge in the development of small, non-aggregated organic molecules 
that are able to emit circularly polarised light efficiently due to the lack of magnetic dipole 
character present in most of the considered transitions (e.g. π-π*). The attractive properties of 
SOMs, such as their small size and organic solubility, means that they are very amenable for 
application in display devices,25 optical storage devices26 and in asymmetric photochemical 
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synthesis.27  This has led to considerable effort focussed on improving the CPL properties of 
this class of molecules, which will be reviewed in this section.9 
 
1.3.1.1. Simple carbonyl compounds and extended π-conjugated systems 
Original efforts were focused upon simple organic ketones and the n-π* electronic transition, 
which is not inherently chiral in itself, but is chirally perturbed within the structure in which it 
is embedded.14,28,29 This work was further advanced by Dekkers in the study of the excited state 
of dynamically coupled chirally-perturbed carbonyl chromophores of polycyclic β,γ-enones.30 
It provided one of the first examples of using CPL as a tool to elucidate chiral structural 
information of a molecule in the excited state. The study found that the bonding interaction in 
the excited state differs dramatically from that of the ground state. The authors hypothesised 
that as the carbonyl bond becomes stretched upon excitation, the geometry around carbon 
switches from planar to pyramidal resulting in an increased bonding interaction with the β,γ-
olefinic bond. The asymmetric distortion causes the molecule to become chiral and exhibit CPL 
activity. 
The very poor fluorescence efficiencies of simple carbonyl compounds has led to the 
development of extended π-conjugated systems and CPL from π-π* transitions in polymers and 
simple organic molecules.31 One of the most commonly employed chromophores in these 
systems is the achiral BODIPY moiety.32A recent example of this type of CPL-SOM has been 
developed by de la Moya, SOM-1, in which a set of C2 symmetric chiral enantiomers is used 
to chirally perturb an achiral BODIPY chromophore resulting in the emission of  CPL (Figure 
2).33 Small gem values were calculated of the order of 10
-3, which is typical for an organic 
chromophore (CPL ˂0.1%). However, the system did exhibit a high fluorescence quantum 
yield (46%).  
 
Figure 2 – Chemical structure of spiro-BODIPY enantiomers (SOM-1) exhibiting equal and opposite CPL upon radiation at 
529 nm in CHCl3. Axially chiral 1,1-binapthyl unit (blue), achiral BODIPY chromophore (red).33 
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1.3.1.2. Helicenes 
 
 
Figure 3 – Stereochemical description and chemical structure of right (P or Δ) and left (M or Λ) handed carbohelicenes.34 
 
Based upon the attractive emission properties associated with π-conjugated systems (section 
1.3.1.1), attention turned to improving the CPL properties of this class of SOMs. This approach 
led to the development of simple organic molecules consisting of n-ortho-fused aromatic rings 
with inherent helical chirality, governed by a conformational distortion of the π-system 
imposed by the high steric strain (Figure 3). The molecules are termed ‘helicenes’ and 
demonstrate good chiroptical activity; the direction of which depends upon the handedness of 
the helical twist.  
To ensure that good emission and CPL properties are obtained, it is important to avoid 
aggregation of the molecules and thereby circumvent associated problems such as excited state 
quenching and linear polarisation complications.35 A nice example of a non-aggregating 
helicene was published by Venkataraman and co-workers which included bulky functional 
groups along the helicene backbone.36 Each enantiomer of the triarylamine helicene exhibited 
oppositely signed CPL when irradiated at 434 nm in CHCl3 with a gem value of 0.001 at 442 
nm. It should be noted that despite the increased helical overlap provided by the additional 
aromatic ring in Δ-3 compared with Λ-2, there is still only a small net circular polarisation in 
the emission, suggesting that net chirality of the observed transitions is not just a function of 
molecular geometry (Figure 4). 
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Figure 4 – Structures of triarylamine helicenes.36 
 
Often the preparation of enantiopure helicenes poses significant synthetic issues, most notably 
in the separation of the resulting enantiomers. Separation of enantiomeric helicenes can be 
achieved by chiral resolution in conjunction with a resolving agent but typically results in a 
low yield.37 A more attractive alternative is to employ an enantioselective synthesis strategy.34 
An example of such an approach was adopted by Tanaka in the synthesis of S-shaped double 
aza-helicenes that showed good CPL activity (gem(492 nm) = 0.0028 in CHCl3).
38 The double-
helicenes were synthesised in >99% ee via Au-catalysed sequential intramolecular 
hydroarylation of alkynes. 
 
1.3.1.3. Simple organic molecules as responsive probes 
One of the first examples of an anion responsive SOM-CPL probe was based on an extended 
π-conjugated design, (section 1.3.1.1). Introduction of a BINOL-boron moiety coordinated to 
a dipyrrolyldiketone ligand results in the formation of a symmetrical environment that is broken 
upon anion binding.39 When the probe, 4, interacts with an anion such as chloride or acetate, a 
CPL signal was obtained from the previously CPL-silent system. The induced CPL was 
attributed to a key conformational change of the π-planes, resulting from a flipping of the two 
pyrrole rings as a result of anion binding (Figure 5). This example demonstrates the first 
example of a chemical-stimuli responsive CPL probe based on an organic framework. 
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Figure 5 - Left: fluorescence (bottom) and CPL (top) spectral change for 4 in the absence (black) and presence of 200 equiv. 
chloride ion (red) – insets show solution change of 4 upon anion binding. Right: anion binding mode of 4 showing key 
conformational change on anion binding.39 
 
Maeda later reported a set of probes based on a similar design to 4 that were able to produce 
CPL signals on forming diastereomeric pairs with chiral cations40 and also direct binding to 
chiral analytes, more specifically, amino acids.41 The second set of responsive probes were 
based upon dimers of a π-conjugated system, connected by a terphenyl spacer group to ensure 
a large enough binding cavity for the chiral analyte, 5 (Figure 6). The geometry of the acute 
angled terphenyl spacer group was either meta-meta-meta or para-ortho-para. The authors 
found that the point chirality of the amino acid (S-phenylalanine) could induce opposite helical 
chirality in probe 5, depending on the geometry of the spacer, resulting in the induction of CPL 
(Figure 6). This study demonstrates the use of SOMs as CPL probes in an example where a 
very low concentration (µM) of chiral auxiliary can induce a chiral response. The biggest draw-
back to systems based on this class of probes is the very low gem values that are measured. 
Experiments were carried out at -50 ºC, as it was hypothesised that the low temperature would 
increase the conformational rigidity of the helices and also alter the distribution of Λ and Δ 
diastereoisomers. However, even within this restraint, the gem values were measured at 10
-4.  
Potentially, the most useful application that could be envisaged would not be in biological 
recognition but in material applications, such as multifunctional molecular devices. 
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Figure 6 – Probe 5 design based on a π-conjugated dimer linked by a terphenyl spacer unit. Point chirality of the amino acid 
induces opposite helical conformation (Λ or Δ) depending on the geometry of the spacer group.41 
 
1.3.2. CPL from transition metal coordination complexes  
 
1.3.2.1. Metallohelicenes 
The impressive chiroptical properties exhibited by inherently chiral helicenes were discussed 
earlier (Section 1.3.1.2). An important challenge in further expanding the potential of these 
molecules is in the design of a variety of helical frameworks that allow for tuneable chiroptical 
properties, with a focus on application as OLEDs and in chiral displays. Recent advances have 
seen the incorporation of transition metal ions, such as Re,42 Os,43 and Pt,44–46 into the backbone 
of the helical ligand. The presence of a heavy metal ion improves the π-conjugation of the 
system, exhibits close electronic interaction with the helicoidal ligand system and as a result, 
phosphorescent CPL-active systems can be investigated.  
Metallohelicenes incorporating platinum ions tend to exhibit the best chiroptical activities. 
These types of systems exhibit the largest gem values compared to other transition metal 
helicenes, and are phosphorescent, due to spin-orbit coupling. Although platinum is not a 
stereogenic centre, the enhanced properties can be attributed to the platinum 5d orbitals being 
the most conjugated with the π-system of the helical ligand. One of the first examples in the 
literature describes a mono-(platinahelicene) with interesting photophysical and chiroptical 
properties that can be fine-tuned by chemical oxidation of the metal centre. However, the 
measured gem value was no greater than that of the simple organo-helicene.
44 A more recent 
example has demonstrated an enantiopure mono-(platinahelicene), Pt-[6]helicene, with a gem 
value of the order of 10-2, an order of magnitude greater than the non-platinated system and the 
CHAPTER ONE - INTRODUCTION 
13 
 
biggest value recorded for molecular helicenes.46 The large emission dissymmetry values, and 
interesting tuneable photophysical properties of Pt-[6]helicene are promising for future 
development into its use in chiral optical displays. 
 
1.3.2.2. Platinum and iridium chiral complexes 
A very good illustration of the potential utility of transition metal CPL-active complexes in 
chiral displays such as chiral memory, chiral switching devices and also as biosensors has been 
developed by You et al.47 The design is based on a Pt (II) complex, probe 6, that is able to 
aggregate in aqueous solution via π-π and hydrophobic-hydrophobic interactions resulting in a 
novel helical structure which is CPL active. However, the CPL activity can be reversibly 
‘switched’ by an external stimulus, in this case temperature. Upon heating to 353 K, the CPL 
activity becomes zero, most likely due to deaggregation or decomposition of the Pt (II) 
complexes at higher temperatures (Figure 7). 
 
 
 
Figure 7 – Structure of chiral cyclometalated platinum (II) complex, probe 6, and process of reversible ‘CPL switching’ in 
aqueous solution upon changing the temperature.47 
 
The final example of a CPL active transition metal complex that will be discussed is based 
upon neutral Δ and Λ bidentate iridium (III) complexes. Iridium complexes are readily colour 
tuned through systematic modification of the ligand system, possess high phosphorescent 
quantum yields and are therefore readily employed in optical devices. Enantiomeric resolution 
of a racemic mixture of Δ and Λ iridium complexes, 7,  was achieved using chiral supercritical 
fluid chromatography and the resulting enantiomers displayed net circular polarisation in their 
emission.48 A gem value of 0.002
 at 495 nm was measured for the C3 symmetric complex (Figure 
8) which is significantly larger than the value for related C2 complexes. This is an important 
observation, showing the need for high symmetry and strong conformational rigidity in a 
system in order to obtain large gem values and observe strong CPL activity. The authors were 
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also able to employ a novel TD-DFT approach to predict the magnitude of the emission 
dissymmetry value of a number of Ir (III) complexes and also Ru (II) and Zn (II) hemicages; 
calculated values correlated well with experimental determinations. 
 
Figure 8 – Structure of homoleptic C3 symmetric Ir(III) complex, 7.48 
 
1.3.3. CPL from emissive lanthanide complexes 
Organic and transition metal based CPL-active systems, including their attractive properties 
for specific applications, have been considered in detail, most markedly in smart chiral 
materials and in biosensing (Sections 1.3.1 and 1.3.2).  However, it is apparent that there is still 
a major inherent flaw for use of these systems in conjunction with CPL, and that is the very 
small degree of circular polarisation in the emission output, resulting from the intrinsic nature 
of the transitions. The magnitude of the consequential emission dissymmetry values is very 
small, typically 10-3-10-4, and are thus difficult to measure. 
The emission of CPL from lanthanide complexes dominates the literature in this area and this 
is a result of the attractive spectroscopic features they possess.8,49,50 From early examples of 
carboxylic acid based Eu3+ and Tb3+ complexes studied by Luk and Richardson in the 1970s,51 
to the highest ever recorded gem value of +1.38  from a europium complex of a chiral tetrakis(3-
heptafluoro-butyryl-(+)-camphorato) ligand (~85% of emitted photons are left circularly 
polarised),52 it is clear why lanthanide complexes make such attractive candidates for CPL 
applications. 
 
1.3.3.1. Lanthanide luminescence properties 
In order to fully understand the importance of chiral luminescent lanthanide-based probes, their 
unusual photophysics must be considered. Most lanthanide complexes are luminescent but their 
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emissiveness depends on a variety of factors. The specific requirements to consider when 
determining which lanthanides are the most suited to luminescence studies are: i) the ease at 
which the excited state can be populated and ii) the energy gap between the lowest level excited 
state and the highest energy level of the ground state multiplet.53 If the energy gap is too small, 
it can give rise to non-radiative deactivation pathways, such as quenching by high energy 
vibrations, for example O-H or N-H oscillators. As can be seen from the energy diagram 
(Figure 9), Eu3+, Gd3+ and Tb3+ have a sufficiently large energy gap between the emissive state 
and the highest energy level of the ground state multiplet (ΔE = 12 300, 32 200 and 14 800 cm-
1 respectively). Gd3+ emits in the UV region of the spectrum and so has limited use in biological 
applications. For the remainder of this review, examples of Eu3+ and Tb3+ complexes as chiral 
luminescent probes will be considered. 
 
Figure 9 - Partial energy level diagram for lanthanide (III) ions. 53 
 
The lanthanoids are a unique set of elements, as they resemble each other so closely in their 
chemical properties. The electronic configuration of their tripositive ions, [Xe]4fn where n = 0-
14, demonstrates that the 4f electrons are shielded by the filled 5p66s2 subshells giving rise to 
their interesting spectroscopic features. The sharp, narrow emission bands arise from the 
Laporte-forbidden f-f transitions. They are characteristic of the particular metal in question and 
are well separated from the broad fluorescence of organic fluorophores. The forbidden nature 
of these transitions gives rise to long luminescent lifetimes (milliseconds in the case of Eu3+ 
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and Tb3+). However, this feature also leads to low molar extinction coefficients for direct 
excitation of the lanthanide metal.  
The poor absorption and emission efficiency of the lanthanide ion can be overcome through 
integration of a chromophore ligand into the complex. Such an approach has been termed the 
‘antenna effect’ and was discovered by Weissmann in 1942 in his study of europium 
complexes.54  He observed europium luminescence following irradiation of light that 
selectively excited the organic components of the system. The energy of the ligand triplet 
excited-state must lie at least 1700 cm−1 above the energy of an accepting lanthanide energy 
level in order to prevent thermally activated back-energy transfer to the sensitiser triplet state.55 
On the other hand, if the energy gap is too great, then the efﬁciency of the ligand to metal 
energy transfer step is compromised. Therefore, it is important to optimise the energy gap 
between the lowest lying triplet energy level of the ligand and the Ln3+ emitting state, taking 
into account these two opposing factors. 
 
 
Figure 10 – Simplified Jablonski diagram illustrating sensitised emission of a Eu3+ complex, via an intermediate ligand triplet 
or solvent-relaxed internal charge transfer excited state. 
 
The sensitising moiety is initially excited from its ground state to its singlet state (S1). 
Vibrational relaxation then occurs to the lowest vibrational level of the S1 excited state, 
according to Kasha’s rule.56 Intersystem crossing (ISC) from the sensitiser singlet state (S1) to 
the triplet state (T1) then occurs. This spin-forbidden process is facilitated by spin-orbit 
coupling from the heavy metal. Energy is finally transferred to the metal centre which relaxes 
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and emits light from the excited state (Figure 10). There are a number of possible quenching 
and deactivation processes that occur along this pathway which can affect the luminescence 
output of the system, as shown in Figure 11.  
 
Figure 11 - Photophysical processes occurring during sensitised emission, presenting the different quenching processes that 
can occur to modulate lanthanide luminescence (eT: energy transfer; ET: electron transfer).5 
 
The mechanism of energy transfer between the organic chromophore and the lanthanide centre 
may proceed via the Dexter mechanism, involving electron transfer between the chromophore 
and the lanthanide centre through-bond interaction and therefore requires good overlap 
between ligand and metal orbitals.57 An alternative, more likely pathway is the Förster 
mechanism, in which energy is transferred through space and is dependent on r-6 (r = the 
distance between the antenna and the metal centre).58 It relies upon the dipole moment 
associated with the T1 state of the ligand coupling with the dipole moment of the Ln 4f orbitals.  
 
For a complex to be effectively employed in chiroptical and biological applications, it is 
necessary that it possesses a high quantum yield. This feature ensures that the probe produces 
signals that are easy to measure with good accuracy above background noise. For a sensitised 
lanthanide complex, the overall quantum yield can be defined by equation 1.7. 
 
 ɸ =  𝜂𝐼𝑆𝐶𝜂𝐸𝑇ɸ
𝐿𝑛 (1.7) 
 
The efficiency of intersystem crossing between the S1 and T1 excited states of the sensitiser is 
denoted by ηISC, the efficiency of energy transfer from the ligand to the lanthanide centre is 
given by ηET and the intrinsic quantum yield of the lanthanide ion is defined as ɸLn.59 From 
equation 1.7 it is evident that ligands possessing high efficiency, η, values will produce a 
lanthanide complex possessing a high quantum yield. This issue has been exemplified in the 
CHAPTER ONE - INTRODUCTION 
18 
 
work of Delbianco et al. for a series of europium complexes based on aromatic sulfonate 
derivatives of phosphinate ligands appended to a 9-N3 macrocyclic core, employing strongly 
absorbing arylalkynyl chromophores [Eu.L2]3- (Figure 12).60 In this study, the authors report a 
quantum yield of 32% in water; one of the highest ever reported vales for a europium complex 
in aqueous solution.  
 
Figure 12 – Structure of the europium complex [Eu.L2]3- which exhibits a quantum yield of 32% in pure water.60 
 
The brightness, B(λ), of a complex is a key parameter to consider when selecting a suitable 
chromophore. It is typically defined as the product of the molar extinction coefficient, ε(λ), and 
the overall quantum yield, ɸem(λ). Therefore, it is important to employ a chromophore that will 
generate a complex with not only a high quantum yield value, but also a large molar extinction 
coefficient, to ensure maximum brightness, B(λ). 
 
A final consideration when selecting a suitable chromophore is to minimise radiationless 
deactivation pathways of the lanthanide metal through interaction with external solvent 
molecules. This can be achieved by maximising the coordination number around the lanthanide 
centre (7-9) using multidentate chelating ligands. The chelate effect also acts to improve the 
thermodynamic and kinetic stability of the resulting lanthanide complex. There is a wealth of 
literature surrounding the selection of appropriate chromophores for Eu3+ and Tb3+ that satisfies 
the factors discussed within this section, and the reader is directed to selected reviews for 
further information.4,61–64 
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1.3.3.2. Chiroptical properties of emissive lanthanide complexes: selection rules 
In a number of experimental studies on lanthanide optical activity, a clear trend has been 
demonstrated concerning the observation that certain electronic transitions exhibit significantly 
greater emission dissymmetry values than others. Lanthanide 4f-4f transitions exhibiting 
particularly large gem values have been termed ‘CPL-sensitive’ transitions.10 The selection rules 
that are operative in determining the CPL-sensitivity of lanthanide 4f-4f transitions are 
discussed in detail by Richardson, in a study considering only the free ion electronic quantum 
numbers and term to term transitions.65 The study highlights lanthanide transitions that are 
most strongly optically active and therefore are most useful in the study of diagnostic 
chiroptical probes. The key selection rules that were presented were based entirely on 
considerations of angular quantum numbers (S, L and J) and parity (Figure 13).  
 ΔJ = 0 or ± 1 (excluding J=J’=0) 
ΔL = 0 
ΔS = 0 
 
Figure 13 – Selection rules governing magnetic dipole allowed transitions between perturbed 4f-electron states. 
 
It is evident at this point that the selection rules and thus related transitions for large 
dissymmetry values are not the same as for large CPL intensities. The largest gem values will 
be exhibited by transitions that are magnetic dipole allowed and electric dipole forbidden, as 
noted in equation 1.6 (Section 1.2.1). The largest CPL intensities will be displayed by 
transitions that are magnetic and electric dipole allowed. The transitions in Eu3+ and Tb3+ 
complexes that are predicted to display the greatest optical activity are shown in Table 1. This 
prediction is in agreement with experimental data in each case.8,10 The largest recorded gem 
value (+1.38) for a Eu3+ complex is associated with the 7F1← 5D0 (ΔJ = 1) transition.52 
 
Table 1 – Transitions that exhibit high optical activity (the largest rotatory strengths and gem values). 
 Electronic Configuration Transition E / cm-1 Wavelength / 
nm 
Eu3+ [Xe]4f6 7F1←5D0 16700-17100 595 
     
Tb3+ [Xe]4f8 7F5←5D4 18000-18500 545 
  7F3←5D4   
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It is also worth noting that no CPL activity should be observed for the ΔJ = 0 transition. This 
transition is purely electric dipole allowed and magnetic dipole forbidden and can be accounted 
for by the axial crystal field splitting. The electric dipole moment of the transition is of odd 
parity and so the 7F1 and 
7F0 states cannot mix; such mixing would be required in order to create 
magnetic dipole intensity in the 7F0←5D0 transition.66 
 
1.3.3.3. Chiroptical spectra-structure correlations 
There is very little literature concerning generalised correlations of lanthanide complex 
structure with CPL spectral form. For the most part, any conclusions are empirical in nature. 
The reason for this is not due to the lack of robust theories relating local symmetry to electronic 
and chiroptical behaviour associated with lanthanide f-f transitions, as demonstrated in the 
preceding section. It may however, be due to the absence of many structurally rigid chiral 
lanthanide complexes that possess well-defined solution speciation. The majority of the work 
in this area dates back to the work of Richardson, surrounding spectra-structure correlation of 
the ΔJ = 1 transition of 9-coordinate Eu3+ complexes using magnetic and time resolved CPL 
methods.67–69 The complexity of analysis has limited the amount of information that can be 
obtained. However, a number of key observations can be drawn leading to some useful spectra-
structure comparisons. 
An unpolarised emission spectrum of a lanthanide complex in itself is very useful for basic 
structural interpretation, as it shows sensitivity to the ligand environment. Europium has a 
simpler crystal field splitting parameter than terbium, which allows for better interpretation of 
its luminescence and CPL spectra. For example, in a europium complex the intensity of the 
hypersensitive electric dipole allowed 7F2←5D0 transition provides information about the 
polarisability of the donor ligand.70,71 The magnetic dipole allowed 7F1←5D0 can reveal 
information concerning the nature of the ligand field and allows the second order crystal field 
parameter, 𝐵0
2, to be estimated.72 CPL spectroscopy can provide another level of resolution 
when compared to the unpolarised emission spectrum. For example, if two peaks are 
overlapping and not fully resolved in the total emission spectrum, the transitions may have 
opposite rotatory strength and can be clearly observed in the CPL spectrum. This behaviour is 
clearly demonstrated in the case of a triphosphinate Eu3+ complex, [Eu.L3], where the ΔJ = 1 
(~595 nm) and ΔJ = 4 (685-720 nm) bands display enhanced resolution in the CPL spectrum 
(Figure 14).73 
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Figure 14 – Total emission (left) and CPL spectra (right) of Δ-[Eu.L3] and Λ-[Eu.L3] (H2O, 295 K).73 
 
The sign of the CPL signal can confirm the relative helicity of the complex, for example, in 
Figure 14 the CPL spectra of the ∆ and Λ complexes are mirror images.73 The calculated 
dissymmetry factors, gem, can also aid in eliciting structural information. The degree of twist 
generating the local helicity at a metal centre, determines the angle between the electric and 
magnetic dipole transition moment vectors and hence the rotatory strength of the transition in 
a static coupling mechanism. The relative CPL is defined by a sin2θcos2θ function as the CPL 
associated with the degree of twist at 0º, 45º and 90º must vanish. This effect has been 
demonstrated for 8 or 9 coordinate antiprismatic complexes based on tri – and tetra-amide 
DOTA; the angle, θ, that gives the maximum CPL signal (and largest gem value) is 22.5°.74 The 
more conformationally rigid tri- and tetra-amide complexes exhibited significantly enhanced 
CPL activity compared to the bis-substituted equivalent, once again highlighting the 
importance of conformational rigidity in maximising CPL output.  
The structure of CsEu-[(+)-(hfbc)4] reveals a robust coordination cage with eight coordination 
sites. The square antiprismatic coordination cage is not unlike the lanthanide complexes 
discussed in the preceding paragraph.74 However, CsEu-[(+)-(hfbc)4] gives a gem value in the 
ΔJ = 1 transition that is an order of magnitude greater than for the amide complexes.  The 
extraordinary value of gem therefore cannot be due to the geometry of the coordination 
polyhedron, as had been originally suggested, in terms of a static coupling mechanism (i.e. 
associated with the value of τ in equation 1.6, section 1.2.1).74 Di Bari suggests that the high 
value may be largely attributed to dynamic coupling involving the diketonate π−π* transition. 
The dynamic coupling mechanism describes an electrostatic interaction between an electric 
multipole, associated with the lanthanide magnetic transition, and the ligand centred electric 
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dipole, µ. The D4 symmetry of the complex is broken if µ is skewed. The related dipoles (ligand 
centred π-π* transition moment) display a skew angle of |ψ| = 27° (Figure 15), with respect to 
the main symmetry axis. This value is relatively close to the ideal value of 45° required to 
induce maximum rotatory strength and maximum polarised luminescence (a |ψ| angle of 0º and 
90º describes an achiral situation).75 
 
 
Figure 15 – Calculated solution structure of CsYb derivative, view perpendicular to the D4 axis showing skew angle, ψ.75 
 
The spectra-structure correlations that have been discussed in this section not only allow for 
determination of the factors that permit enhanced CPL activity and thus aid in probe design, 
but also allow the resulting CPL spectrum to be related back to the stereochemical structure of 
the probe in question, in its excited state. 
 
1.4. Lanthanide complexes based on chiral ligands 
 
Lanthanide complexes based on enantiopure ligand systems have been shown to exhibit strong 
CPL activity and large gem values (section 1.3.3.2). In addition, the lanthanide (III) ions are 
pure spherical emitters avoiding any associated problems with anisotropy. Considerable 
progress has been made to develop this class of compounds into optical chirality probes where 
upon binding of a chiral analyte, there is preferential interaction with one enantiomer or 
diastereoisomer of the chiral Ln3+ complex, resulting in a modulation of the CPL spectrum. 
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1.4.1. Controlling the chirality of a lanthanide complex: ligand design strategy 
There are a number of different approaches that can be adopted in the design of chirally well-
defined lanthanide complexes.8 The chirality of mono- and multi-centre lanthanide complexes 
may arise from the spatial disposition of multiple, well-defined chiral ligands around the 
lanthanide centre (Section 1.4.1.1), by the formation of helices (Section 1.4.1.2), or the 
stereochemical orientation of a multidentate ligand (Section 1.4.1.3). By careful design of an 
enantiomerically pure ligand, the preferential formation of a particular stereoisomer of the 
lanthanide complex can be achieved with high levels of stereocontrol. 
1.4.1.1. Bidentate β-diketonate ligands 
Perhaps the simplest approach is to integrate a chiral ligand into a system, taking advantage of 
multiple bidentate ligand interactions. Lanthanide β-diketonates, particularly Eu3+ complexes, 
have been exploited for numerous applications as highly luminescent materials displaying 
excellent emission quantum yields. The ease of preparation and effectiveness of energy transfer 
to the Ln3+ ion contributes to the wide employment of this type of complex in various 
applications.76–78 Typically, three bidentate β-diketonate ligands will occupy the inner 
coordination sphere of the lanthanide ion (coordination number = 6) to generate a neutral 
complex. This leaves two vacant sites remaining, which can be filled by a Lewis base or an 
additional bidentate ligand. If the additional ligand is chiral, then stereochemical information 
can be transferred to the lanthanide ion, generating a chiral complex that exhibits CPL.  
An example of this approach was given by Harada and co-workers, in which an axially chiral 
phosphine oxide ligand, 2,2’-bis(diphenylphosphoryl)-1,1’-binaphthyl (BINAPO), was 
employed to control the geometry of a europium tris-β-diketonate complex containing 
1,1,1,5,5,5-hexa-fluoropentanedione (hfa) ligands (Figure 16).79 [Eu((R)-BINAPO)(hfa)3] 
displayed an emission quantum yield of 0.53 in CD3CN solution and strong CPL activity in the 
ΔJ = 1 manifold, which was not present in the corresponding achiral complex. However, the 
measured gem value was small (0.03).  
 
Figure 16 – Chemical structure of [(Eu(R)-BINAPO).(hfa)3].79 
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A very similar idea has been documented by Kawai, using an alternative chiral ligand, 
bis(oxazolinyl)pyridine (pybox), to control the geometry of the resulting europium complex.80 
Three complexes were studied in which slight alterations were made to the chiral ligand 
structure: [(Eu(R)-Ph-pybox).(hfa)3], [(Eu(R)-
iPr-pybox).(hfa)3], [(Eu(R)-Me-Ph-
pybox).(hfa)3] (Figure 17). It was found that the [(Eu(R)-Ph-pybox).(hfa)3] complex produced 
a CPL spectrum with opposite sign in the magnetic dipole allowed transition to the other two 
complexes studied. The authors used X-ray crystallography to show that the chiral ligand was 
able to alter the asymmetric arrangement of the hfa ligands around the metal centre, in which 
the geometry varied depending on the ligand-ligand interactions present. This study 
successfully highlights the utility of CPL in providing key structural information about the 
molecule in the excited state. However, no further methods of analysis to assess the structure 
and speciation of the complex in solution were attempted. 
 
 
Figure 17 – ΔJ = 1 transition of the CPL spectra of R- and S-[(Eu-Ph-pybox).(hfa)3], [(Eu-iPr-pybox).(hfa)3] and [(Eu-Me-Ph-
pybox).(hfa)3] (left to right).80 
 
The optical chirality of lanthanide complexes with β-diketonate camphor ligands (hfbc) has 
also been extensively studied, incorporating ligands with axially chiral phosphine oxide 
ligands,81 pybox ligands82 and in the synthesis of  MI[Ln((+)-hfbc)4].
52 CPL sign reversal has 
been observed for a Eu3+ camphorate complex containing the bidentate ligand, 3,3-
bis(diphenylphosphoryl)-2,2-bipyridine (BIPYPO).83 The sign reversal was attributed to the 
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hinge-like twisting of the bidentate ligand, resulting in dynamic cis-trans isomerism of the 
chiral Eu3+ complex in various solvent systems. 
 
1.4.1.2. Triple stranded helicates 
Simple linear oligo-multidentate ligands self-assemble with Ln3+ ions to produce stable mono- 
and di-nuclear triple stranded helicates. The systems are inherently chiral but exist as a rapidly 
interconverting mixture of Δ and Λ conformers.84 One helical enantiomer can be preferentially 
stabilised by the incorporation of a chiral substituent at some point along the multidentate 
ligand, resulting in a net diastereomeric excess and a system that exhibits CPL. 
 
Figure 18 - Structures of C2 symmetric and chiral neopentyl derived ligands for the preparation of enantiopure triple stranded 
helicates.85,86 
Initial work by von Zelewsky and Bünzli defined the first example of diastereoselective 
formation of a lanthanide triple helical complex, based on an enantiopure C2 symmetric ligand, 
L4.85  Bünzli also investigated a series of lanthanide complexes based on chiral tridentate 
bis(benzimadazole)pyridine ligands with different substituents at the R2 and R3 positions, 
Figure 18.86–88 Introduction of a chiral neopentyl group at the R3 position, L6, led to the 
formation of a thermodynamically stable triple helical complex, [Ln.(L6)3]
3+. CPL studies 
confirmed the helical wrapping of the ligand around the metal centre and a small diastereomeric 
excess in solution. On the contrary, incorporation of the bulky chiral moiety at the R2 position, 
L5, precludes helical wrapping around the lanthanide ion. X-ray crystal analysis revealed that 
only two of the ligands can effectively wrap around the metal centre, with the third ligand lying 
perpendicular to the other two. The interaction between the ligand and the Ln3+ ion can be 
quantified by UV-Vis and 1H NMR data. The interactions between L6 and Eu3+ are stronger 
than those with L5 and Eu3+, as indicated by the stability constants where ΔlogK3(L6-L5) = 
3.7.88 
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The ease of which dipicolinic acid (dpa) ligands can be synthetically modified has led to 
another set of lanthanide supramolecular structures that have been developed incorporating this 
useful moiety. Bünzli and co-workers have investigated the influence of a chiral moiety in the 
4-position of the pyridine ring of dipicolinic acid upon assembly with Eu3+.87 The 1H NMR 
data suggests that there is one main M.L3 species present in solution on an NMR timescale with 
overall trigonal symmetry. However, the chiroptical data suggests otherwise and implies fast 
interconversion of the enantiomeric helices, and only a small diastereomeric excess in solution. 
The CPL activity of these complexes was very weak with only small gem values calculated (gem 
= 0.02 at ~ 590 nm). The weak CPL activity can also be attributed to the presence of the M.L2 
species (~8%), evident from the calculated stability constants, which is expected to generate a 
much smaller chiral effect. 
A more promising method of inducing diastereomeric resolution of 9 coordinate triple helical 
lanthanide complexes using chiral dpa ligands has been demonstrated by Muller via inclusion 
of a chiral centre directly on the amide group.89 The enantiomers of N,N’-bis(1-phenylethyl)-
2,6-pyridinedicarboxamide ((R,R) and (S,S)) were shown to effectively self-assemble with Ln3+ 
ions  and induce the resulting helicity in the lanthanide complex ((R,R) =Λ and (S,S) =Δ). The 
main drawback of this class of compounds is the relatively small luminescent quantum yields, 
consistent with poor efficiency of the sensitisation by the ligand (ɸem = 0.01 for [Eu.(L1)3]3+). 
However, the ability of the ligand to induce Δ and Λ helicity in the complex has led to strong 
CPL activity and suggested the application of these complexes as CPL calibration standards 
(section 1.2.4.).23 
 
Figure 19 – Structures of (R,R)-L1 and (S,S)-L1 and their Λ and Δ europium complexes respectively.89 
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The group of Gunnlaugsson has developed a similar range of dpa derivatives.90,91 Chiral 1-
naphthyl, L7, and 2-naphthyl, L8, derivatives of dipicolinic acid were shown to self-assemble 
with Eu3+ ions, generating an enantiopure triple stranded helical complexes in a 1:3 metal to 
ligand ratio. The use of CPL spectroscopy established the chiral nature of the complexes, 
confirming that it is the chirality of the amide centre that dictates the absolute configuration of 
the resulting complex, (R,R) =Λ and (S,S) =Δ. X-ray crystallography was used to investigate 
the solid state structure of the two sets of complexes. The data revealed that the 1-naphthyl 
complex, [Ln.(L7)3], is more tightly packed compared to the 2-naphthyl complex, [Ln.(L8)3], 
due to enhanced π-π stacking interactions. The greater conformational rigidity may account for 
the improved total luminescence and CPL activity of this complex.  
 
 
Figure 20 – a) Ligands L7 and L8 ((R,R) and (S,S)). b) X-ray crystal structure of (R,R)-[Nd.L7] down the crystallographic c 
axis, showing the helical arrangement of the three ligands around the Nd3+ centre (pink).91  
 
Further work investigated a dinuclear system based on a 1-naphthyl antenna, [Eu2.(L9)3] 
(Figure 21).92 The stereochemical configuration was investigated by 1H NMR studies and CPL 
spectroscopy. The results implied that the absolute configuration was once again determined 
by the chirality at the amide centre, generating complexes of the same helicity as the 
corresponding monomers, i.e. (R,R) =ΛΛ and (S,S) =ΔΔ.91 
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Figure 21 – a) Structures of ligand L9 (R,R) and (S,S). b) Model of triple stranded helicate [Eu2.(L9)3]. c) Total luminescence 
of (S,S)-[Eu2.(L9)3] (black) and CPL spectra for (R,R)-[Eu2.(L9)3] (blue) and (S,S)-[Eu2.(L9)3] (red) in MeOH.92 
 
The stereoselective self-assembly of chiral luminescent Eu3+ tetrahedral cages has recently 
been reported employing ligands based on dpa.93 The chirality of the ligand is transferred to 
the metal generating [Eu4.(L10)6] and [Eu4.(L11)4] species with Δ and Λ chirality, Figure 22, (R 
=Λ, S = Δ). Solution CD data was able to confirm the stereochemistry of the complexes in 
agreement with X-ray crystal data and shows that the complexes derived from R and S ligands 
are enantiomeric. No CPL data has been reported for this set of luminescent europium 
tetrahedral cages, probably because the naphthyl excited state is quenched by the Eu3+ ion in 
an electron transfer process.  However, there are a number of other well-defined examples of 
luminescent lanthanide f-f supramolecular structures that give rise to CPL including a 
heptanuclear europium wheel94 and  lanthanide directed interlocked structures.95 
 
Figure 22 - Europium coordination tetrahedral cages with both [Eu4.(L10)6] and [Eu4.(L11)4] stoichiometries. (Eu3+ ions at the 
four vertices are drawn as red spheres; only one ligand is shown on each tetrahedron).93 
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1.4.1.3. Multidentate macrocycles and podates 
The final approach that will be discussed here is the stereochemical orientation of multidentate 
macrocyclic and podate ligands. When designing a chiral lanthanide probe, it is necessary to 
examine complexes with well-defined solution speciation so that correlations of structure with 
spectral form can be confidently made. One of the best ways to achieve this is to design 
relatively rigid systems, for example, those based on a macrocycle such as cyclen (12-N4)
96–99 
or 1,4,7-triazacyclononane (9-N3)
100–102, in which the twist of the macrocyclic arms around the 
lanthanide centre generates a lanthanide complex with well-defined Δ and Λ helicity. The 
second element of chirality is associated with the sign of the torsional angle of the ethylene 
backbone (NCCN) of the macrocyclic ring, resulting in δ and λ chirality.49 Thus, four 
stereoisomers can be obtained in each case. A more detailed description of the chirality of 9-
N3 systems will be discussed in Chapter 2. 
 
Scheme 3 - Representative macrocyclic ligand structures incorporating a remote stereocentre on the pendant arm and through 
C-substitution on the macrocyclic ring.73,103–106 
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 A remote chiral centre can be incorporated into the pendant arms of the ligand framework in 
order to restrict arm rotation. For example, in the series of enantiopure tetraamide-cyclen based 
ligands, L12, investigated by Parker et al., in which the remote chiral centre of the amide dictates 
the helicity of the complex, resulting in the formation of one predominant stereoisomer of the 
lanthanide complex in solution, (RRRR)-Λ and (SSSS)-Δ.103 The sense of chiral induction is the 
same that was seen in the triple helicate complexes of Muller89 and Gunnlaugsson.91 It has also 
been demonstrated that integration of an α-substituent on the acetate arm of 1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) can ‘sterically lock’ the conformation 
of the pendant arms in the lanthanide complex, e.g. L13.104 
Another way to control the chirality of the resulting complex is to inhibit ring inversion through 
incorporation of a C-substituent directly on the macrocyclic ring, generating a stereogenic 
centre. Desreux demonstrated that incorporation of methyl groups onto a DOTA backbone 
resulted in the prevalence of a major stereoisomer upon complexation, L14.105,107 1H NMR 
studies showed that the methyl groups prefer to adopt an equatorial position, thereby locking 
the ring conformation. Thus, (SSSS)-[Yb.(Me4DOTA)] exists only as Δ-(λλλλ) and Λ-(λλλλ) 
isomers with the former being favoured in a 1:0.095 ratio.  A more recent study by Parker has 
also shown that C-substitution on the ring induces formation of a single enantiomer of a 
complex with >96% isomeric purity, this time for mono-substitution of a 9-N3 ligand, e.g. L15 
and L16.60,73 The absolute configuration of each complex was determined by the stereogenicity 
of the C-substituent and was assigned by comparative CPL studies, examining the sign and 
relative magnitude of each transition (S at C gives Λ, R at C gives Δ).  
One may envisage that combining these two approaches, incorporating both a chiral substituent 
on the pendant arm and a C-substituent on the macrocyclic ring, would provide optimal 
stereocontrol and formation of only one isomer, L17.106 The coordination isomer that was 
obtained was determined by the chirality at each stereogenic centre. For example, HR-NMR 
spectroscopy revealed that the S-RRRR complex had SAP (square antiprism) geometry (Δ-
(λλλλ)), and the S-SSSS complex had TSAP (twisted square antiprism) geometry (Δ-(δδδδ)). 
However, a number of COSY experiments later revealed the presence of two possible 
regioisomers for each coordination geometry, as there are two non-equivalent positions where 
the C-substituent can be located.108. The p-nitrobenzyl substituent can either be located on the 
corner or the side of the macrocyclic ring. Therefore, two possible regioisomers can be 
produced for each SAP/TSAP geometry depending upon the direction of approach of the metal 
ion and the conformation of the ligand at the time of reaction. 
CHAPTER ONE - INTRODUCTION 
31 
 
 
Figure 23 – Ligands based on 2-hydroxyisophthalamides (IAM). * highlights the stereocentres in 1st generation complexes 
(sensitiser) and second generation complexes (ligand backbone).109–111 
 
Another class of multidentate ligands that can be used to effectively sensitise lanthanide ions 
(Eu3+, Tb3+, Dy3+ and Sm3+) and transmit chirality to the resulting complex are based on the 
octadentate podate structures of Raymond and co-workers (Figure 23).109,110 The chiral moiety 
is introduced into the sensitiser, 2-hydroxyisophthalamide (IAM), onto the open face of the 
tetrapodal ligand framework, L18 and L19.  The stereocentre transfers chiral information to the 
ligand influencing the helical sense that the arms wrap around the metal centre (1st generation 
complexes). The resulting complexes exhibit good complementarity in the CPL signals 
between R(+) and S(-) enantiomeric forms. The measured gem value at 543 nm for the first 
generation complex [Tb.L18] is +0.044. Unfortunately, the coordination and geometry mode of 
these complexes remains undetermined, and it is clear from the number of observed bands in 
the magnetically allowed ΔJ = 1 transition of the europium complex, that there exists more 
than one major emissive species in solution. Further work saw the development of a second 
generation of complexes based on a different strategy where the stereogenic moiety, 
diaminocyclohexane or diphenylethylenediamine, was incorporated into the ligand backbone 
to create a complex with increased conformational rigidity (2nd generation complexes).111 
Iterations employing an alternative sensitiser for europium, 1-hydroxy-2-pyridinone (1,2-
HOPO), have also been reported with the aim to improve water solubility of the 
complexes.112,113 The second generation complex, [Tb.L20]3+, displays a high quantum yield, 
ɸem 0.60, and improved CPL signal strength, gem(542 nm) = +0.20, in aqueous solution. 
Luminescent lifetime and NMR data suggests that there is one dominant diastereoisomer 
present for these more conformationally rigid systems. 
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1.4.2. Chiral lanthanide complexes as responsive probes 
Reversible anion binding in aqueous media has become an effective means of signalling and 
sensing the presence of selected anions.5 Particular consideration needs to be given to the target 
anion binding affinity and the manner in which selectivity over competing species is to be 
achieved. Well-defined lanthanide complexes are particularly suited to this application, as they 
are relatively stable in aqueous solution and the binding event can be studied using NMR, 
microscopy, chiroptical and emission based techniques.114 Anion binding often accompanies 
the displacement of metal bound water molecules. An increase in the luminescent lifetime, τ, 
is expected since closely diffusing O-H oscillators are known to quench the lanthanide excited 
state (section 1.3.3.1). The ΔJ = 2 and ΔJ = 4 bands are hypersensitive to change in the 
lanthanide coordination environment. Such behaviour allows for ratiometric analysis as the 
intensity of the hypersensitive band can be monitored compared to a magnetically dipole 
allowed transition, that shows little change to the environment allowing internal calibration. 
Chirality probes based on enantiopure lanthanide complexes are therefore endowed with an 
intrinsic CPL fingerprint that can be modified in relative intensity, shape and sign on interaction 
with a target analyte.49,50 
 
1.4.2.1. Lanthanide probes to target oxyanions 
 
 
Scheme 4 – Structures of Eu3+ complexes used in the signalling of a number of oxyanions.115 
 
An early example of a responsive chirality probe saw the employment of the enantiopure 
triamide complex, [Eu.L21]3+, in the sensing of a number of oxyanions.116 In aqueous solution, 
excited state lifetime measurements in H2O and D2O allowed the inner sphere hydration 
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number to be measured.117  Two metal bound water molecules were found to be present within 
the inner coordination sphere. Addition of bicarbonate HCO3
- (pH 6.5) and carbonate CO3
2- 
(pH 11) to [Eu.L21]3+ led to a large increase in the overall emission intensity and an increase in 
the excited state lifetimes. The luminescence data suggested that both metal bound water 
molecules were displaced and the anion was bound as a chelate (Scheme 5). A marked change 
in the CPL spectrum was also observed, particularly in the ΔJ = 1 manifold. The original 
hypothesis attributed the change to an alteration in the helicity of the complex. However, 
subsequent studies quickly determined that it was due to the change in polarisability of the 
axial donor.118 It is worth noting that phosphate, HPO4
2-, was found to bind to [Eu.L21]3+ in 
which a monoaqua species was formed, with phosphate acting as a monodentate ligand.  
 
Scheme 5 – Diagrammatic representation of carbonate binding to a lanthanide centre via displacement of two metal bound 
water molecules.116 
 
The synthesis of related N-alkylated derivatives, [Eu.L22,23]3+ (N-Me, N-
methylphenanthridinium group), allowed further expansion of the scope of this lanthanide 
probe.115 Strong binding affinities, K, for CO3
2-/HCO3
-, lactate, citrate and malonate were 
calculated for the N-alkylated complex, [Eu.L22]3+. Changes in the intensity of the ΔJ = 2 and 
ΔJ = 1 bands were followed as a function of added anion concentration. The resulting binding 
isotherms were fitted to a 1:1 binding model by linear least squares iterative analysis. Citrate 
and malonate exhibited the largest binding affinities due to the increased negative charge on 
the analyte. The interaction of carbonate with [Eu.L23]4+ (N-methylphenanthridinium group) in 
a competitive anionic background was also studied. The reversible anion binding could be 
signalled by emission spectral changes as discussed previously, and also by changes in the 
circular polarisation of emission (Figure 24). The emission spectral changes were consistent 
with carbonate binding, suggesting high selectivity for the chosen analyte. 
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Figure 24 – left: variation in the ΔJ = 2 / ΔJ = 1 bands in the total emission spectrum, right: variation in emission dissymmetry 
value, gem for [Eu.L23]4+ as a function of added NaHCO3 (1.5 mM complex, 0.1 M collidine/HCl buffer, pH 7.4, 100 mM 
NaCl, 0.9 mM Na2HPO4, 0.13 mM sodium citrate, 2.3 mM sodium lactate).115 
 
 
Scheme 6 – Structures of Eu (III) complexes bearing azaxanthone chromophores.119,120 
 
A more recent example has used Eu3+ and Tb3+ complexes bearing an azaxanthone sensitiser, 
[Eu.L24], to estimate equilibrium bicarbonate concentrations inside the mitochondrial region of 
living cells and in neat human serum, using emission spectroscopy.119 The enantiopure 
lanthanide complexes can also signal reversible binding of bicarbonate in the presence of 
endogenous anions, by distinctive modulation of the CPL spectrum. Addition of a weakly 
bound sulfonamide arm to the complex, [Eu.L25]3+, allowed the pH change of the system to be 
monitored by CPL.120 At high pH values, the sulfonamide arm is bound to the metal centre 
generating a conformationally rigid structure with a high gem value. As the pH is decreased, the 
sulfonamide arm protonates and dissociates, and the gem value decreases accordingly. A plot of 
pH versus gem generates a pH curve from which a pKa value of 5.65 was calculated (Figure 25). 
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This value is in agreement with that estimated by emission spectroscopy. This study 
demonstrates the first example of the use of CPL modulation to signal pH variation. 
 
 
Figure 25 – Variation of gem (632 nm) with pH for [Eu.L25]3+ showing the fit to the observed data (pKa = 5.65 ± 0.04, 295 K, 
0.1 M NaCl).120 
 
The family of anions based on pentavalent phosphorus, notably O-phosphorylated amino acids 
and peptides is of particular interest in biological applications. One such application is the 
signalling of the behaviour of O-phosphono-L-tyrosine (O-P-Tyr) sites on a protein. The same 
series of chiral macrocyclic lanthanide complexes based on a heptadentate ligand framework 
have been employed to probe this class of molecules, [Eu.L21]3+ and [Eu.L22]3+.121 1H NMR, 
emission and CPL spectroscopy were employed to assess the binding interactions and a number 
of conclusions can be drawn from this work. Chemoselective ligation of the phosphate moiety, 
over the terminal amino acid residue, was observed for Eu3+ complexes. Such behaviour was 
in contrast to that observed for Tm and Yb complexes, where N-ligation through the terminal 
amino acid was shown to occur. A significant preference for O-P-Tyr binding compared to 
other phosphorylated amino acids (30:1) was observed, most likely due to the decreased 
hydration energy of the amino acid. The emission dissymmetry values did not vary 
significantly and were typically calculated at ±0.06 for the most polarised transitions in each 
case. However, the form of the emission and CPL spectra differed significantly between the 
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non-alkylated, [Eu.L21]3+, and N-alkylated, [Eu.L22]3+ complexes, on addition of the chiral 
phosphate anion. 
 
Figure 26 – CPL (top) and emission spectra (bottom) of: left - (SSS)-Δ-[Eu.L21]3+, right - (SSS)-Δ-[Eu.L22]3+ (dashed) and 
(RRR)-Λ-[Eu.L22]3+ (bold) on the addition of 10 equiv. O-P-Tyr (0.1 M MOPS, pH 7.4).121 
 
1.4.2.2. Lanthanide probes to target DNA 
Focussing on the same 12-N4 ligand framework, enantiopure Ln
3+ triamide complexes bearing 
an N-methylphenanthridinium chromophore, [Ln.L23]4+, have been employed in the sensing of 
oligonucleotides and calf thymus DNA (CT-DNA).122–124 The lanthanide coordination 
environment and helicity remained unchanged upon binding of DNA but distinctive selectivity 
in affinity was observed between the Δ and Λ isomers. [Eu.L23]4+ binds to DNA via reversible 
ligation of the nucleotide phosphate group, as determined by comparison of the emission 
spectrum to the spectral changes on addition of hydrogen phosphate. In the bound form, the 
luminescence of the complex was significantly quenched by a rapid charge-transfer mediated 
deactivation of the chromophore S1 state by the electron-rich base pairs. This behaviour 
prohibited any further studies with this particular chromophore. 
Later studies investigated a series of lanthanide complexes incorporating an alternative 
tetraazatriphenylene chromophore.125,126 Exciton-coupled naphthyl groups and a 
tetraazatriphenylene sensitiser allowed for efficient intramolecular energy transfer, leading to 
population of the naphthyl triplet state.126 Addition of poly(dGdC), poly(dAdT) and CT-DNA 
to [Eu.L26]3+ led to a significant increase in the intensity and lifetime of the emission (Figure 
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27). The increase in emission lifetime upon DNA binding is indicative of the deactivation of a 
process that quenches the Eu3+ excited state. However, the complexity of the photophysical 
processes occurring, competing with Eu emission, limited the amount of structural information 
that could be gathered. 
 
 
Figure 27 – Changes in europium emission spectrum of [Eu.L26]3+ on addition of poly(dGdC), 0.8 mM, from 0 to 1 base-pair 
per complex (λexc = 340 nm, pH 7.4, 10 mM HEPES, 10 mM NaCl).126 
 
1.4.2.3. Lanthanide probes to target proteins 
An alternative mode by which a lanthanide complex can function as a responsive chirality 
probe is through concerted arm rotation or rearrangement of the coordination polyhedron as a 
result of non-covalent interactions. The first report of dynamic helicity inversion following 
enantioselective analyte binding involved the enantioselective regulation of a lanthanide 
complex, following reversible binding to serum albumin.127 Incremental addition of human (or 
bovine) serum albumin to (SSS)-Δ-[Tb.L27]3+ led to a reduction in the intensity and lifetime of 
the terbium luminescence. An apparent 1:1 binding constant was calculated, logK = 5.1, in 
aqueous solution. A very different response was observed for (RRR)-Λ-[Tb.L27]3+, consistent 
with a much lower affinity constant. Arguably the most interesting information was derived 
from the CPL behaviour. With the (RRR)-Λ isomer, no change in the emission polarisation was 
observed upon adding excess protein. However, in the case of the (SSS)-Δ complex, an 
inversion in the sign of the CPL spectrum was evident (Figure 28). Such behaviour is consistent 
with the inversion of complex helicity in the protein-bound complex. Taken together, this 
CHAPTER ONE - INTRODUCTION 
38 
 
information suggests the selective binding of Δ-[Ln.L27]3+ to ‘drug site II’ of serum albumin 
via concerted arm rotation ((SSS)-Δ → (SSS)-Λ).128 
 
 
Figure 28 – Structure of and CPL spectra of (SSS)-Δ-[Tb.L27]3+ (blue) and in the presence of added BSA (pink) (295 K, D2O, 
λexc = 348 nm, 15 µM complex, 30 µM protein).127 
 
More recently, a completely different approach has been adopted by Yuasa and co-workers.129 
The fingerprint CPL signatures were recorded for a 1-biphenyl-3-perfluoroethyldiketonate 
Eu3+ complex covalently bound to various proteins, including Staphylococcus aureus 
recombinant nuclease A, BSA and insulin. The protein itself serves to fill the coordination 
sphere of the β-diketonate Eu3+ complex, providing an asymmetric environment within the 
inner coordination sphere. The authors claim that an optical fingerprint for target proteins can 
be recorded using this method, as well as the ability to monitor protein conformational change. 
However, the CPL intensity and gem values are very small (gem ± 0.005 – 0.05) and there is a 
lack of discussion regarding the nature of the binding interaction. This system is not particularly 
well-defined and the results are more observational in nature than previous examples that have 
been discussed. 
 
1.5. Lanthanide complexes based on achiral ligands 
 
Lanthanide complexes based on achiral ligands can also be employed as responsive CPL 
probes. In contrast to the enantiopure systems that have been discussed where a modulation of 
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the CPL is monitored, for achiral lanthanide systems an induced CPL response can be recorded 
following the addition of a chiral species. 
 
1.5.1. Dynamically racemic CPL probes 
It is assumed that in the absence of any other effects, the perturbation of the racemic 
equilibrium of the ground state via outer sphere non-covalent interactions, will be reflected in 
the excited state, leading to induced optical activity. Therefore, it is expected that the effect of 
adding a chiral biomolecule results in the preferential stabilisation of the more energetically 
favourable diastereomeric outer-sphere association complex. This phenomenon is termed the 
Pffeifer effect.130 Much of the early work by Brittain, Richardson and Riehl focuses on the Δ / 
Λ equilibrium of dynamically racemic D3 lanthanide complexes (Figure 29). The addition of a 
variety of chiral additives including amino acids,131,132 sugars133,134 and chiral carboxylic 
acids,135 has been extensively reviewed.49,50,136,137 The induction of a CD signal from 
dynamically racemic D3 lanthanide complexes based on 2,2’oxydiacetic acid (oda) ligands has 
also been demonstrated, following the addition of the chiral additive L-proline.138 Contrary to 
early studies that assumed the ‘Pfeiffer effect’ is a direct consequence of the absolute 
configuration of the added chiral species, later studies have shown that the explanation is not 
quite so simple in every case. More recently, the effect of various non-covalent chiral 
interactions such as hydrogen bonding, Coulombic forces, π-stacking, hydrophobic and steric 
effects on the CPL sign and magnitude have been investigated.139 However, the sign and 
magnitude of CPL has still shown no meaningful correlation to any specific structural 
characteristics, and the results of these studies tend to be mainly observational in nature. 
 
Figure 29 - Structures of the enantiomeric ∆-[Ln.(dpa)3]3- and Λ-[Ln.(dpa)3]3- viewed down the symmetry axis. 
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The perturbation of a dynamically racemic mixture can also occur in the excited state via an 
enantioselective excited state quenching process. The interconversion between Δ and Λ isomers 
must be fast on the laboratory timescale but slow compared to the excited state lifetime of the 
complex. Collisions with an enantiopure quencher can result in stereoselective electronic 
energy transfer to the acceptor, generating an enantiomeric excess in the excited state and an 
induced CPL signal. This effect has been observed with dynamically racemic D3 lanthanide 
complexes, such as [Ln.(dpa)3]
3- (Ln = Eu3+, Tb3+ and Dy3+), interacting with a number of chiral 
quenchers including transition metal complexes,140–143 proteins144 and corrinoid B12.
145 
A third example of the induction of CPL from a dynamically racemic complex is when there 
is an alteration in the complex constitution upon binding of an analyte directly to the metal 
centre, in the same manner that was discussed in the previous section (1.4.2). However, if the 
chosen analyte is chiral, a particular diastereoisomer may be stabilised and a CPL signal can 
be ‘switched on’. 
 
Figure 30 – Structure of [Eu.L28]+ and proposed binding mechanism with α1-AGP. a) Europium emission spectral changes of 
[Eu.L28]+ in the absence (blue) and on the addition of 50 µM α1-AGP (red) (20 µM complex, pH 7.4, 0.1 M NaCl). b) CPL 
spectrum of [Eu.L28]+ on the addition of 50 µM α1-AGP.146 
 
A recent example of a well- defined dynamically racemic europium complex in the sensing of 
acute phase proteins, α1-AGP and α1-AAT, demonstrates the utility of this class of probes.146 
The achiral complex, [Eu.L28]+, has previously been shown to bind to HSA.147 The complex 
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was shown to bind to α1-AGP (logK = 5.73) by a significant change in the total emission 
spectrum and through the induction of strong CPL signals, gem(598 nm) = -0.23 (Figure 30). A 
similar response was observed for α1-AAT, however the binding affinity was an order of 
magnitude lower (logK = 4.72). A thorough investigation into the binding mechanism of the 
lanthanide complex with the protein was conducted.  A large increase in the relative intensity 
of the ΔJ = 2 band was observed, signalling a significant change in the polarisability of the 
axial donor, perhaps through the displacement of a metal-bound water molecule with a 
glutamate carboxylate of the protein. ECD studies revealed two distinct negative Cotton 
transitions, consistent with a relatively rigid coordination environment. The resolved fine 
structure of each transition showed two bands, suggesting that the two azaxanthone 
chromophores are in slightly different local environments. The authors hypothesised that while 
one azaxanthone is bound to the metal centre, the other becomes dissociated and included in 
the protein binding cavity, providing a secondary binding interaction. This hypothesis was 
further validated by a competition experiment with chlorpromazine, a drug molecule that is 
known to bind to α1-AGP.148 Incremental addition of chlorpromazine to the Eu-protein adduct 
led to a progressive diminution of the induced ECD signal suggesting displacement of the 
complex from the protein binding site. The direct and rapid assessment of the inflammatory 
response of α1-AGP was conducted in human serum solution using emission spectroscopy. 
However, the changes in the induced CPL response were weaker and less well-defined, so this 
method could not be used for in situ analysis. 
 
 
Figure 31 – Structure of [Eu.L29.Rlactate] and variation of gem (621.5 nm) with % R-lactate; error bars indicate the standard 
deviation averaged over 5 runs (R2 0.98 for shown linear ﬁt).15 
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The direct metal binding of α-hydroxy acids, such as lactate to europium complexes, has also 
been demonstrated by [Eu.L28]+ and another dynamically racemic complex based on an achiral 
9-N3 bis-phosphinate ligand, [Eu.L29]
+.15 The complex [Eu.L29]+ has been shown to bind to a 
wealth of different anions, showing selective and signature total emission responses.149 The 
binding of each of these europium complexes to lactate was signalled by strong induced CPL. 
The helicity of the complex, i.e. which enantiomer is preferentially stabilised, is entirely 
dependent on the chirality of the α-hydroxy acid (R or S). The gem values vary linearly with 
enantiomeric composition which allowed a calibration curve to be plotted (Figure 31). 
Therefore, the enantiomeric purity of a sample with unknown enantiomeric composition can 
be measured. This study has shown the potential of monitoring changes in the local chiral 
environment by induced CPL, with particular emphasis on the ability of such complexes to 
determine the enantiomeric purity of a sample after prior calibration. 
 
1.5.2. Achiral CPL probes 
 
 
Figure 32 - Structure of europium complexes based on achiral bda and pda ligands.150,151 
 
The addition of a chiral analyte can induce a CPL signal by a change in the geometry of the 
complex, as opposed to the stabilisation or preferential formation of an enantiomer from a 
racemic mixture. Such an effect has been demonstrated by Iwamura, investigating the effect of 
added chiral species to the achiral complexes [Eu.(bda)2]
- (bda = 2,2’-bipyridine-6,6’-
dicarboxylic acid) and [Eu.(pda)2]
- (pda = 1,10-phenanthroline-2,9-dicarboxylic acid).150,151 
The addition of R- and S-2-pyrrolidine-5-carboxylic acid (PCA) to [Eu.(bda)2]
- induces CPL 
signals of equal and opposite sign, from the previously CPL silent system, with a small 
calculated gem of ±0.03 at λ = 591 nm.150 The total luminescence spectrum remains relatively 
unchanged, providing a good example of a system where CPL can be used to monitor changes 
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that are not apparent in the total emission spectrum. An investigation into the dependence of 
gem on PCA concentration was conducted revealing the presence of a 1:1 species in the resulting 
adduct (Figure 33). The pH response of the system was also studied and showed that the largest 
gem value was observed when the chiral acid was in a deprotonated form. The authors 
hypothesised that the chiral species interacts with the europium complex by direct coordination 
of the carboxylate group to the metal centre. The additional coordination of PCA to the metal 
distorts the structure of the bda ligands, generating a local chiral environment at the europium 
centre.  
 
Figure 33 – a) A plot of the variation of gem at 591 nm with concentration of PCA. b) Dependence of CPL (upper) and total 
luminescence (lower) spectra of [Eu.(bda)2]- on the addition of (S)-PCA.150 
 
Further work examined the interaction of a number of amino acids, specifically with 
[Eu.(pda)2]
-.151 The geometry of the europium complex in solution in the absence of a chiral 
host was ill-defined. The total emission spectrum revealed that the solution structure is 
markedly different from the solid-state crystal structure and there is in fact more than one 
europium species present in solution, indicated by the presence of multiple peaks in the ΔJ = 0 
manifold, Figure 34. Upon binding to the amino acid, a significant change in the total emission 
spectrum occurred. The ΔJ = 2/ΔJ = 1 ratio was altered, indicative of slightly distorted D2d 
symmetry,152 and the presence of one emissive species was suggested by observation of a single 
transition in the ΔJ = 0 band. Large induced CPL was recorded following addition of arginine 
and histidine (gem = ±0.08 in the magnetic dipole allowed ΔJ = 1 transition). The gem 
dependence on amino acid concentration revealed that more than one chiral species was present 
in the adduct that generates CPL. Such behaviour is in contrast to that observed for 
[Eu.(bda)2.(PCA)]
2-. The exact binding interaction remains undetermined and the lack of a 
well-defined adduct structure means that the constitution of the emissive species that is 
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contributing to the induced CPL, is not fully understood. The small gem values suggest the 
presence of other more emissive achiral europium species that may be present in solution. 
Further experiments addressing the constitution of the emissive species, such as ESI-MS, may 
aid in eliciting information about the interaction that is taking place in the chiral adduct. 
 
Figure 34 – Total emission spectrum of [Eu.(pda)2]- in solution (upper) and of a (C6H16N)[Eu.(pda)2] crystal (lower) showing 
the splitting in the ΔJ = 0 band (7F0←5D0) of the solution species (λexc = 310 nm).151 
 
It is worth noting that another example of this type of achiral CPL probe has been published, 
based on a Eu3+ complex coordinated to a β-diketonate unit of an achiral polymer chain.153 
Addition of R- and S-proline induced an intense CPL signal with a high gem value (± 0.41 in ΔJ 
= 1 transition at 590 nm). However, once again, further work must be undertaken to understand 
the nature of the binding interaction and allow further development for this type of probe. 
 
1.6. Project aims 
 
For many years, the majority of lanthanide based probes have exploited changes in emission 
spectral form and the excited state luminescent lifetime as a means of a detection technique. 
The attractive photophysical and chiroptical properties of lanthanide complexes, as discussed 
in Section 1.3.3, have also allowed CPL modulation upon analyte binding, to report on the 
stereochemical environment surrounding the lanthanide ion. Many examples of enantiopure 
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and achiral lanthanide complexes have been reported that have the ability to act as effective 
CPL probes, Sections 1.4.2 and 1.5.  
The aim of the work described in this thesis is to expand the range of lanthanide chirality probes 
that exploit CPL spectroscopy as a signalling mechanism. Chapter 2 describes the synthesis of 
a novel set of enantiopure lanthanide complexes incorporating a remote amide chiral centre. 
The degree of stereocontrol imposed by the chiral ligand is assessed and compared to other 
examples that have previously been reported. Inclusion of four different extended pyridyl-aryl-
alkynyl chromophores into the ligand framework, allows the key photophysical parameters to 
be optimised. 
Chapter 3 investigates a different type of lanthanide chirality probe, based on dynamically 
racemic ligands. The induction of CPL from a lanthanide complex after the binding of a chiral 
analyte is an area of growing interest. To date, there are very few examples of well-defined 
systems that employ this technique for chirality detection and structural determination. This 
work aims to expand the scope of well-defined, dynamically racemic lanthanide complexes 
that exhibit a strong induced CPL response to signal the presence of a chiral analyte of interest. 
The key structural and photophysical properties are identified and incorporated into the ligand 
design of a series of novel dynamically racemic lanthanide chirality probes. 
The work in Chapter 4 embraced the design and syntheses of two novel europium (III) CPL 
probes that sense important chiral biomolecules, including sialic acid (Neu-5-Ac), O-
phosphono-amino acids and peptides and oleoyl-L-α-lysophosphatidic acid. The design of 
these chirality probes set out to meet the following criteria: 
i) the probe must be bright and highly emissive with a high emission quantum yield, 
ɸem, extinction coefficient, ε, and a long excitation wavelength, λexc; 
ii) the probe must be able to bind the target analyte reversibly over the appropriate 
biological concentration; 
iii) interconversion between the Δ and Λ isomers of the lanthanide probe must be fast 
on the emission timescale; 
iv) the analyte-bound adduct must be sufficiently conformationally rigid to generate 
large induced CPL with measurable and accurate gem values; 
v) the probe design should be sufficiently flexible to permit substituted analogues to 
be prepared, allowing enhanced affinity for the chosen analyte with a heightened 
selectivity over competing species.
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2.1. Introduction 
 
There are a number of strategies that have been used to design chiral ligand systems that give 
complexes with well-defined three-dimensional structure, Section 1.4. Complete stereocontrol 
has previously been achieved through incorporation of a remote chiral centre in a 12-N4 tetra-
amide complex derived from R or S α-methylbenzylamine.103 The contents of this chapter will 
detail the work outlining the preparation of a novel enantiopure ligand, L30, based on chiral 
tris-amidepyridyl derivative of triazacyclononane. By employing a similar stereochemical 
approach, our aim was to assess the degree of stereocontrol in lanthanide complex formation. 
By analogy with recent work, the related ligands L31a-d were also prepared, as the introduction 
of the arylalkynyl moiety greatly enhances the absorption characteristics of the ligand and 
permits efficient sensitisation of Eu emission.154 
 
 
Triazacyclononane, 9-N3, is a small macrocycle that is easily functionalised to generate 
thermodynamically and kinetically stable lanthanide complexes. There are two elements of 
chirality that can arise in a nonadentate C3 symmetric lanthanide complex based on 9-N3. One 
element of chirality is associated with the torsional angle of the NCH2CH2N backbone of the 
macrocyclic ring which can be ± 60º. A positive angle results in δ chirality and a negative 
dihedral angle gives a λ configuration. The second element of chirality arises from the twist of 
the pendant arms around the lanthanide centre. If the sign of the NCCNpy angle is positive, then 
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Δ helicity results, and if it is negative then Λ helicity is defined. If we now consider the possible 
combinations of these two elements of chirality, then four stereoisomers, existing as two 
enantiomeric pairs, can be formed (Scheme 7). Interconversion between the stereoisomers may 
occur through cooperative arm rotation, Δ↔Λ. Ring inversion is slow and has not been 
observed by NMR spectroscopy in solution at room temperature, δ↔λ.49 
 
Scheme 7 – The four stereoisomers arising from a C3 symmetric 9-N3 system.49 
 
Nine coordinate tris-pyridyl-carboxylate and amide 9-N3 complexes of Ln
3+ ions have been 
reported by Latva, Mazzanti and co-workers, [Ln.L33] and [Ln.L34]3+.101,155,156 More recent 
variants include a series of tri-pyridylphosphinate systems, [Ln.L32], that were shown to exist 
in the solid state in a tri-capped trigonal prism coordination geometry, and define an 
isostructural series across the lanthanide block.100 The prepared lanthanide complexes 
[Ln.L30]3+, were directly compared to the related tri-phosphinate and tri-carboxylate analogues, 
allowing us to deepen our understanding of ligand field effects in lanthanide complexes of high 
symmetry. 
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Scheme 8 – Structures of related tris-pyridyl 9-N3 complexes based on phosphinate, carboxylate and amide ligands.100,101,155,156 
 
2.2. Synthetic aspects 
 
2.2.1. Synthesis of the parent complex, [Ln.L30](CF3SO3)3 
The parent ligand, L30, was prepared in six steps from commercially available precursors. The 
enantiomeric purity of the primary amine, α-methylbenzylamine, was first established using 
the NMR chiral solvating agent, R-O-acetylmandelic acid.157 The -CHCH3 doublets were well 
resolved in the diastereomeric adducts, and the limit of detection was assessed by analysing 
the relative intensity of the 13C satellite signals (doublet, J = 140 Hz, 1.08% total for the 12C 
signal). The enantiomeric purity of the starting material was calculated as >99% ee and was 
considered sufficiently pure for use in the subsequent amide coupling reaction.  
 
 
Scheme 9 – Synthesis of the pendant arm, as the mesylate, S-1e. 
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The amide coupling reaction of 6-methylpyridine-2-carboxylic acid with S-α-
methylbenzylamine afforded the desired amide, S-1a, in good yield. The amide, S-1a, was 
treated with mCPBA in chloroform to give the N-oxide, S-1b, in 83% yield. Conversion to the 
alcohol was initially attempted using trifluoroacetic anhydride at 60 ºC, followed by in situ 
hydrolysis. However, no formation of the trifluoroacetate ester intermediate was observed. 
Initial thoughts were, that the transformation was inhibited by an energy barrier, associated 
with intramolecular hydrogen bonding between the amide NH and pyridine N atom. The N-
oxide was treated with acetic anhydride as the reaction could then be heated to a higher 
temperature (120 ºC). Under these reaction conditions, the desired ester intermediate was 
obtained. This rearrangement reaction was followed by ester solvolysis, catalysed by ethoxide, 
to furnish the alcohol, S-1d, in 85% yield. Mesylation of the alcohol under standard conditions 
gave S-1e, which was used directly in the next step with no further purification. Alkylation of 
9-N3 was carried out using the crude mesylate in acetonitrile in the presence of K2CO3. A 
mixture of mono-, di- and tri-substituted products was obtained and the ligands were separated 
by column chromatography on neutral alumina. The di- and tri-substituted S-L30 ligands were 
isolated in yields of 22% and 55% respectively. The enantiomeric ligand R-L30 was synthesised 
via an identical pathway starting from R-α-methylbenzylamine. 
 
Scheme 10 – Synthesis of ligand S-L30. 
 
The purified ligand, S-L30, was reacted with the appropriate lanthanide 
trifluoromethanesulfonate (triflate) salt at 80 ºC in dry acetonitrile. Trituration with cold ether 
yielded the lanthanide complexes S-[Ln.L30](CF3SO3)3 in quantitative yield (Ln = Ce, Pr, Nd, 
Eu, Gd, Tb, Dy, Ho, Er, Tm, Yb). For comparative analysis, R-[Eu.L30]3+ and R-[Tb.L30]3+ 
were synthesised using an analogous complexation procedure. 
CHAPTER TWO – DEVELOPMENT OF NOVEL ENANTIOPURE LANTHANIDE COMPLEXES 
50 
 
 
 
Scheme 11 – Formation of the lanthanide complex S-[Ln.L30](CF3SO3)3. 
 
 
2.2.2. Synthesis of the extended chromophore systems, S-[Ln.L31a-d]3+ 
The initial design for the synthesis of ligands L31a-d was adapted from that of the parent ligand 
L30, employing previously reported methodology of the related tri-pyridylphosphinate 
ligand.154 The presence of a halide group in the 4-position on the pyridine ring was required, 
in order to facilitate the cross coupling step that would be used to furnish the alkyne at a later 
point.  
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Scheme 12 – Initial synthetic scheme considered for the preparation of [Ln.L31a-d]3+. 
 
The conversion of 6-methyl-2-carboxylic acid to the N-oxide, 2a, was achieved using mCPBA 
in chloroform in good yield. Subsequent nitration at the 4-position was attempted using an 
equimolar mixture of concentrated HNO3 (70%) and H2SO4 (98%) followed by heating to 100 
ºC. After 24 h, limited conversion to the desired nitrated product, 2b, was observed by ESI-MS 
and 1H NMR spectroscopy. The reaction was retreated with the active species numerous times 
and left for a total of 96 h at 100 ºC before significant conversion to the product was observed 
(~60%). Purification by flash column chromatography on silica was carried out using an 
isocratic gradient system (0.2% acetic acid, 49.8% EtOAc, 50% hexane). However, the product 
was isolated in a poor yield, 35%, suggesting that significant product was lost during the 
purification step. Deoxygenation followed by bromo substitution of the nitro group was carried 
out in good yields using literature methods.154 The substitution reaction was followed by an 
amide coupling employing the same coupling agents, EDC and HOBt, that were used in the 
synthesis of L30. The desired amide, 2e, was isolated in a very poor yield (27%) along with 
multiple by-products. The major by-product was isolated and characterised by LC-MS and 1H 
NMR spectroscopy which revealed substitution of the bromo group in the para position by the 
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amine nucleophile. At this stage, progression along the original synthetic pathway was halted 
and an alternative, more viable route was created, in an attempt to circumvent the problems 
that had been encountered. 
The synthesis began with the preparation of 6-(hydroxymethyl)-4-iodo picolinic acid, 3a, using 
well established literature procedures.154,155 The para-iodo group was incorporated in the hope 
that it would not be displaced in the amide coupling step, as the carbon atom of the C-X bond 
is less electrophilic compared to the bromo analogue. Another advantage of incorporating an 
iodo instead of a bromo group is the enhanced reactivity in the subsequent Sonogashira cross-
coupling reaction. The synthesis of the precursor began with the conversion of the para-
hydroxyl group of chelidamic acid to a chloro group followed by in situ formation of the methyl 
ester. Subsequent transformation of the chloro group to an iodo group was carried out using 
NaI, followed by reaction with acetyl chloride in acetonitrile. The reaction mixture was 
sonicated for 45 minutes to yield the desired p-iodo-pyridine in excellent yield (86%). Selective 
reduction of the di-ester was carried out using NaBH4 in CH2Cl2:CH3OH solvent mixture at 0 
ºC. The reaction was closely monitored by TLC and instantly quenched with 1 M HCl on 
disappearance of the starting material, to avoid over reduction of the compound. 
 
Scheme 13 – Synthesis of the intermediate 3a. 
 
A five step synthetic route starting from 3a was then devised, beginning with the preparation 
of the mono-hydroxymethyl p-iodo mono-carboxylic acid via base catalysed hydrolysis of the 
methyl-ester (Scheme 14). Subsequent formation of the amide bond proved slightly 
troublesome due to a competing oligomerisation reaction between the hydroxyl group of the 
starting material with the reactive activated ester. Systematic variation of the coupling reagents, 
solvent, temperature and order of addition was considered. The optimal reaction conditions 
were found to be; stirring the coupling reagents, base and amine in a solvent mixture of CH2Cl2-
DMF (1:1) followed by slow, dropwise addition of the carboxylic acid. The amide coupling 
reaction was promoted over the competing oligomerisation reaction, by having a large initial 
concentration of amine compared to the carboxylic acid, which gave the amide, S-3c, in a 
reasonable yield (58%).  
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The alkynes, were synthesised by a Sonogashira cross-coupling reaction between the p-iodo-
pyridyl amide and various p-substituted arylalkynes, using catalytic Pd(dppf)Cl2 and CuI in 
THF. Cu (II) complexes are known to facilitate the oxidative dimerisation of alkynes to form 
diynes, known as the Glaser or Hay reaction.158 This competing reaction is catalysed in the 
presence of oxygen159 and so special care was given to ensure a completely oxygen free 
environment by employing Schlenk-line techniques, degassed solvents and an argon 
atmosphere. Mesylation followed by alkylation of 9-N3 was carried out under standard 
conditions to give ligands S-L31a-d. Complexation with Eu(OTf)3 in acetonitrile at 80 ºC gave 
the triflate salt of the europium complexes, S-[Eu.L31a-d](CF3SO3)3, following trituration with 
cold ether. Conversion to the chloride salt was achieved using a strong ion exchange resin in 
the hope that this would improve the water solubility of the lanthanide complexes. 
 
 
Scheme 14 – Reaction pathway for the synthesis of lanthanide complexes S-[Ln.L31a-d]3+. 
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2.3. Structure elucidation of [Ln.L30]3+ and [Ln.L31a-d]3+ 
  
In order to assess the level of stereocontrol imparted on the system by the chosen enantiopure 
ligands, a full structural analysis of both sets of complexes based on ligands L30 and L31, was 
conducted. A variety of techniques were used to identify the isolated complexes and determine 
the absolute configuration of the major isomer in each case. High resolution mass spectrometry 
allowed determination of accurate masses that were compared with predicted isotope patterns, 
confirming the constitution of each complex. 
2.3.1. Solution NMR studies and HPLC 
The 1H NMR spectra for the series of complexes, [Ln.L30]3+, were assigned using 
measurements of the longitudinal relaxation rate, R1 (R1 = 1/T1) of each resonance at different 
fields. The longitudinal relaxation time, T1, was measured using inversion recovery methods 
of different time intervals. The size of R1 depends on the distance of the proton nucleus from 
the paramagnetic centre (r-6) and the field of the spectrometer; values are fastest for the protons 
that are closest to the lanthanide nucleus. In tandem with analysis of X-ray crystallographic 
data, an assignment of the 1H NMR spectrum could be made for every complex where line 
broadening was not too severe. Partial assignment of the 1H NMR spectra of [Eu.L31a-d]3+ were 
made by comparison with that of [Eu.L30]3+. 
 
Table 2 – Proton NMR assignments (δH/ppm) of the major isomeric species observed for paramagnetically shifted ligand 
resonances in [Ln.L30]3+ (295 K, CD3OD)a, showing the distance to the Eu centre based on X-ray analysis. 
Ln Hax H’eq Heq pyCHN CH3 CHNH H
o Hp Hm H’eq H
5 H4 H3 pyCH’N 
Tm -79.8 -30.5 -29.0 -22.0 -7.5 +9.3 10.8 10.7 10.4 11.3 19.2 19.6 23.0 +70.4 
Yb -18.8 -6.7 -4.2 -2.8 -1.1 +6.2 7.6 8.2 8.3 8.9 11.4 11.2 11.6 +22.3 
Eu -6.6 -2.2 -1.5 -0.7 +1.2 +4.0 5.7 6.9 6.7 5.1 7.4 7.3 7.5 +7.6 
aData for other Ln complexes are given in Chapter 5 but were not fully assigned due to severe line broadening of certain 
protons within 4.5 Å of the metal ion. 
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The 1H NMR spectra of the series of lanthanide complexes, [Ln.L30]3+, revealed that two C3 
symmetric species were present in each case. The major:minor isomer ratio was measured, 
where possible, by integration of the corresponding proton peaks in the 1H NMR spectrum. 
The ratio of these diastereoisomers varied as a function of the Ln (III) ion and fell from 9:1 
(Ce) to 4:1 (Yb) across the series. Such a variation is consistent with a trend induced by the 
lanthanide contraction; as the size of the metal ion decreases, the preferential orientation of the 
phenyl and methyl groups is reduced resulting in a smaller diastereomeric induction effect. 
Intriguingly, the diastereoisomer ratio for [Eu.L31a-d]3+ increased to 15:1. We can tentatively 
suggest that in these systems, the more polarisable pyridine N may have a shorter bond to the 
lanthanide ion, enhancing the impact of steric demand of the proximate chiral centre. However, 
in the absence of X-ray crystal data, the difference in Ln-Npy bond length between the parent 
and extended chromophore complex cannot be identified as the primary reason for enhanced 
diastereomeric induction.  The proton NMR spectrum of R-[Eu.L30]3+ was also recorded and 
revealed identical shift values and integration ratios to S-[Eu.L30]3+. These observations 
allowed us to conclude that the major isomer of both S-[Eu.L30]3+ and R-[Eu.L30]3+ are 
enantiomeric. Analytical HPLC was used to corroborate these results in all cases. The isomers 
were separated by crystallisation or reverse-phase HPLC. 
 
Figure 35 – 1H NMR spectra of S-[Eu.L30]3+ (top) and S-[Eu.L31c]3+ (bottom) showing isomeric ratios of 7:1 and 15:1 
respectively (CD3OD, 295 K, 400 MHz). 
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Figure 36 – HPLC trace of [Eu.L31c]3+: major isomer tR = 12.5 min, minor isomer tR = 13.1 min (10-100 MeOH (0.1% formic 
acid) in H2O (0.1% formic acid) over 15 min, detector λ = 350 nm). 
 
Variable temperature 1H NMR spectra were recorded for S-[Yb.L30]3+ in D2O at 600 MHz, to 
determine if isomeric exchange between the major and minor diastereoisomer was occurring 
on an NMR timescale. The Yb complex was selected for this study as it has the simplest 1H 
NMR spectrum to interpret out of the series of synthesised lanthanide complexes. The isomer 
ratio for [Yb.L30]3+ was invariant with temperature over the range 298 – 353 K (4:1). No 
coalescence of the two separate resonances occurred on increasing the temperature, suggesting 
that the two isomers do not interconvert on the NMR timescale within this temperature range. 
This result further supports the hypothesis that the complex exists in two non-exchanging 
diastereomeric forms. It was noted that the chemical shift of a given resonance reduced in size 
as temperature (T) increased, as a result of the paramagnetic shift dependence on temperature: 
δpara α (kT)-2. 
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Figure 37 – Variable temperature 1H NMR spectra of S-Δ-[Yb.L30]3+ highlighting the major and minor isomer resonance of 
the most shifted axial ring proton (D2O, 600 MHz). 
 
2.3.2. X-ray crystallographic analysis 
Crystals of [Ln.L30](CF3SO3)3 grew readily from aqueous methanol (1:1). The complexes R-
[Eu.L30]3+ (CCDC 965910) and S-[Eu.L30]3+ (CCDC 965909) crystallised in the trigonal space 
group R3. Crystallographic analysis of S-[Yb.L30]
3+ (CCDC 965911) revealed that it was 
isostructural with the Eu complexes. This result strongly suggests that the series of lanthanide 
complexes of L30 would adopt a common structure, at least from Eu to Yb, as has been verified 
for the related tri-pyridylphosphinate complex.100 The triflate anions are slightly disordered, 
and a severely disordered solvent molecule is present in each structure. The lanthanide ion is 
nonadentate, coordinated by three N atoms of 9-N3, three pyridyl N atoms and three amide O 
atoms. The complexes adopted a distorted tricapped trigonal prism structure, with a pseudo C3 
axis passing through the metal atom and the centre of the macrocyclic ring. 
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Figure 38 – Views of the structures of the tri-positively charged cations of S-Δ-(λλλ)-[Eu.L30] (left) and R-Λ-(δδδ)-[Eu.L30] 
(right) (120 K). CCDC 965909-965910. 
 
Analysis of the lengths of the lanthanide-donor atom bonds revealed a longer Ln-O bond for 
[Ln.L30]3+ compared to the values reported for [Ln.L32,33]3+,100,102 as expected with a neutral 
amide donor (Table 3). The Ln-Nring distance was shorter, indicating that the lanthanide ion is 
sitting closer to the plane of the 9-N3 ring for [Ln.L30]
3+. 
 
Table 3 – Selected mean distances (Å) of ligand donor atoms to the lanthanide iona for [Ln.L30]3+ and [Ln.L32].100,102 
[Ln.Ln] Eu  Yb 
Ln.L30-O 2.40 2.34 
Ln.L32-O 2.33 2.25 
Ln.L30-Nring 2.63 2.57 
Ln.L32-Nring 2.68 2.62 
a Effective ionic radii (Å) in 9-coordinate systems are 1.12 (Eu) and 1.04 (Yb).160 
 
The crystal structures show that the major diastereoisomer of the complex derived from the 
enantiopure S ligand system has a Δ configuration (NCCNpy = +36.5º) and a λ conformation for 
each 5-ring chelate derived from the 9-N3 ring (NCCN = -46.9º). The europium complex 
derived from the enantiopure R ligand system is enantiomeric, with Λ helicity and a δ LnNCCN 
chelate ring conformation. The same sense of asymmetric induction was observed in tris-
lanthanide Eu complexes of 2,6-picolinamides89 and with related 12-N4 based tetra-amides.
103 
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The 1H NMR spectrum of the isolated crystals confirmed that it was the major diastereoisomer 
that had crystallised in each case. 
 
2.3.3. Chiroptical spectral behaviour 
Before beginning a thorough investigation into the chiroptical properties of the title complexes, 
it was first necessary to calibrate the CPL spectrometer and ensure accurate and reproducible 
results were being obtained. With the help of Prof. Gilles Muller (GM) and his group, we were 
able to record the CPL spectra of [Eu.(L1)3]
3+ and [Eu.L31d]3+ on the instrument at Durham 
University and the GM spectrometer at San José State University and compare the spectra and 
measured gem values. The CPL spectra of the two europium complexes recorded on both the 
custom-built spectrometers were identical in form, despite being slightly less resolved when 
measured using the GM spectrometer. The gem values for [Eu.L31d]
3+ were in good agreement 
when calculated from both sets of spectra. The validation of the CPL spectra and gem values 
recorded on the Durham spectrometer, allows for confident measurement of CPL and the 
presentation of results within the rest of this study. 
 
Figure 39 – CPL (top) and total emission spectra (bottom) of ΔJ = 2 transition of R-[Eu.L31d]3+ (red) and S-[Eu.L31d]3+ (blue)  
measured on Durham spectrometer (left) and GM spectrometer (right), (λexc = 352 nm, D2O, 295 K). 
Table 4 – Measured gem values for S-[Eu.L31d]3+ (λexc = 352 nm, D2O, 295 K). 
S-[Eu.L31d]3+ Wavelength / nm  gem (Durham) gem (GM) 
 615  +0.013 +0.012 
 621  -0.011 -0.012 
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The CPL spectra of the Δ and Λ isomers of [Ln.L30]3+ were examined and showed mirror image 
behaviour (Ln = Eu, Tb). The sign of each transition depends on the sense of the helical twist 
of the macrocyclic arms around the metal centre. The emission dissymmetry values, gem, were 
measured for the europium and terbium complexes of L30, with values of up to +0.35 recorded 
in the ΔJ = 4 transition of S-Δ-(λλλ)-[Tb.L30]3+. There was no significant change to the gem 
values on the inclusion of the arylalkynyl moiety into the ligand framework, suggesting that 
the stereochemical environment and degree of conformational rigidity is similar to that of the 
parent complex. 
Table 5 – Emission dissymmetry values, gem, for S-Δ complexes [Eu.L30]3+, [Eu.L31d]3+ and [Tb.L30]3+. 
 
 
 
 
 
 
Figure 40 – CPL spectra of S-Δ-(λλλ)-[Tb.L30]3+ (green) and R-Λ-(δδδ)- [Tb.L30]3+ (blue) (λexc = 280 nm, H2O, 295 K). 
 
The CPL spectra of [Eu.L30]3+ and [Eu.L31d]3+ were also recorded. With these examples, the ΔJ 
= 1 band was not resolved in the total luminescence spectra but was clearly resolved in the CPL 
spectra, allowing the two Zeeman components of the A1-E transition to be observed. Analysis 
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of the energies of these transitions allows an estimate to be made of the second order crystal 
field term, 𝐵0
2.161 In the case of [Eu.L30]3+, the splitting of the two transitions was found to be 
70 cm-1, corresponding to a 𝐵0
2 value of +233 cm-1, compared to +110 cm-1  for [Eu.L32] and 
+75 cm-1 for [Eu.L33].72  
 
 
Figure 41 - left: CPL spectrum of R-Λ-(δδδ)- [Eu.L30]3+ (λexc = 280 nm, pH 5, H2O, 295 K). right: CPL spectra of S-Δ-(λλλ)-
[Eu.L31d]3+ (grey) and R-Λ-(δδδ)- [Eu.L31d]3+ (red) (λexc = 348 nm, pH 5, H2O, 295 K). 
 
Within a series of complexes based on very similar ligand frameworks, e.g. L30 and L31, 
accurate determinations of absolute configuration and helicity assignment can be made through 
comparison of the lanthanide CPL spectra, as can be seen in (Figure 41). Using this data, we 
were able to confidently assign the absolute configuration of S- and R-[Eu.L31a-d]3+ as Δ-(λλλ) 
and Λ-(δδδ) respectively, by comparison of the CPL spectra with that of [Eu.L30]3+, whose 
absolute configuration was determined by X-ray crystallography. However, at this stage, it 
becomes more challenging to find strict correspondence between CPL spectra of complexes 
derived from different ligand systems. For example, the CPL spectrum of Δ-[Eu.L30]3+ is quite 
different to that of the structurally similar complexes, Δ-[Eu.L32] and Δ-[Eu.L33],73,102 as well 
as related C4-symmetric 12-N4 tetra-amide systems.
115  
 
2.4. Comparative analysis of related C3 symmetrical lanthanide 9-N3 systems 
  
A detailed comparison of the complexes [Eu.L30]3+, [Eu.L32] and [Eu.L33] was undertaken in 
order to gain a deeper understanding of the effect of changing the nature of the oxygen donor 
on the ligand field. Systematic comparison of shift and relaxation data allowed conclusions to 
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be drawn about the main factors that contribute to the size of the ligand field. The work 
discussed in this section is detailed in the referenced communications.162,163 
Paramagnetic longitudinal relaxation in these lanthanide complexes arises from rotational and 
conformational modulation of the electron-nuclear dipolar coupling, when solvent molecules 
approach the metal centre, as in the equation 2.1: 
 
 
(2.1.) 
 
where µ0 is vacuum permeability, τr is the rotational correlation time assuming isotropic 
motion, ωe is the electron Larmor frequency, (µeff)2 is the square of the effective magnetic 
moment, T1e is the relaxation time of the electronic spin and r is the electron-nuclear distance. 
Because R1 is field-dependent, this allows global minimisation methods to be undertaken, 
analysing sets of data for several lanthanide complexes in parallel. With the help of Dr. 
Alexander Funk, the variation of experimental R1 values with field was used to estimate Ln-
proton average distance, r, the rotational correlation time, τr, and the electronic relaxation time, 
T1e. Data obtained in this manner for [Yb.L30]
3+, allowed a comparison to be made with results 
previously obtained for [Yb.L32,33].100,101 The calculated estimates of Ln-proton average 
distance corroborated well with the experimental X-ray distances, Table 6. 
 
 
 
Nuclear Paramagnetic Relaxation
Effective magnetic 
moment for Ln3+:         
4.3-10.4 BM
Electronic relaxation 
time, T1e : 
enhancement of 
nuclear R1 due to 
unpaired electrons Nuclear Larmor frequency
Rotational correlation           
time:  ca.  200-250 psInternuclear distance 
between lanthanide ion 
and nucleus of interest: 
typical range - 4-7 Å
Temperature dependence
μ0 is the vacuum permeability; γN the gyromagnetic ratio; ωe the electronic Larmor frequency
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Table 6 - Tabulated data for calculated and X-ray determined values of r for each Yb complex. Values were calculated fitting nuclear 
relaxation data by Dr. Alexander Funk. 
 [Yb.L30]3+  [Yb.L32]  [Yb.L33]  
Ln r calc / Å r X-ray / Å r calc / Å r X-ray / Å r calc / Å r X-ray / Å 
Hax 4.26 4.06 4.34 4.12 4.01 4.10 
Hax’ 3.28 3.42 3.47 3.45 n.d. 3.43 
Heq 4.46 4.28 4.57 4.35 4.34 4.31 
Heq’ 4.38 4.23 4.51 4.30 4.33 4.27 
pyCHN 4.67 4.31 4.34 4.35 4.42 4.31 
pyCH’N 3.43 3.50 3.45 3.50 3.41 3.47 
pyH3 5.47 5.45 5.68 5.53 5.46 5.46 
pyH4 6.23 6.26 6.68 6.36 6.29 6.22 
pyH5 5.51 5.48 5.68 5.59 4.45 5.40 
 
 
A full analysis of the electronic relaxation time, T1e, and magnetic susceptibility, µeff, of each 
complex in the series (for lanthanide complexes amenable to 1H NMR study) was then 
undertaken using the values of r derived from X-ray analysis, and globally minimising the data 
sets simultaneously (Table 7). Such an approach has been demonstrated to be effective at 
estimating these variables, especially as the rotational correlation time, τr, is not expected to 
vary significantly from one lanthanide complex to another in an isostructural series.72,164 The 
values of T1e fell in the range expected for such complexes with rather weak ligand field i.e. 
less than or close to kT. The data showed that the largest values of T1e were calculated for the 
tri-amide complexes followed by tri-phosphinate and then the tri-carboxylate system. 
Furthermore, the estimates of the magnetic susceptibility values were also found to be in 
reasonable agreement with literature values that, in turn, are derived from aqua ion or solid-
state metal oxide data. Literature µeff values for the aqua ions are typically as follows: Tb, 9.8; 
Dy, 10.3; Ho, 10.4; Er, 9.4; Tm, 7.6 and Yb, 4.3 BM.165–167 
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Table 7 – Calculated values of magnetic susceptibility (µeff /µB) and electronic relaxation times (T1e, ps) for [Ln.Ln] (n = 30, 
31, 32), derived from global fitting of the field dependence of longitudinal relaxation rate (R1) data.a,b (CD3OD, 295 K)c 
 [Ln.L30]3+  [Ln.L32]  [Ln.L33]  
Ln µeff/µB T1e/ps µeff/µB T1e/ps µeff/µB T1e/ps 
Tb 9.59(03) 0.27(03) 9.40(03) 0.21(04) 9.65(02) 0.26(03) 
Dy 10.09(03) 0.29(03) 10.21(03) 0.32(03) 10.47(01) 0.28(02) 
Ho 10.31(02) 0.21(03) 10.22(01) 0.11(02) 10.44(01) 0.17(02) 
Er 8.80(03) 0.22(04) 9.05(02) 0.26(03) 9.23(02) 0.23(03) 
Tm 7.77(02) 0.15(03) 7.66(03) 0.09(03) 7.43(01) 0.08(02) 
Yb 4.56(04) 0.17(04) 4.36(03) 0.12(06) 4.27(02) 0.09(04) 
aValues of τr estimated simultaneously were: [Ln.L30], 196(1) ps; [Ln.L32], 205(6) ps; [Ln.L33], 132(1) ps. bIn each case, for 
every set of resonances considered, the distance r from the proton to the Ln ion was taken from the X-ray crystallographic 
analysis. cData for [Ln.L33] was recorded in D2O; earlier work has shown T1e values are independent of solvent viscosity.72 
 
In 2012, Fries investigated the factors that influence T1e using time correlated functions and 
proposed that 𝑇1𝑒 𝛼 1/𝐵0
2.168 In 2013, Funk conducted a study on a series of isostructural 
lanthanide complexes taking into account higher order terms (𝐵0
4, 𝐵0
6) that had previously been 
neglected, and found that instead, there was a direct proportionality between 𝐵0
2 and T1e.
72  
The calculated values of T1e were in accordance with the 𝐵0
2 values calculated from the energies 
of the relative transitions in the ΔJ = 1 manifold, as discussed on page 60. The highest 𝐵0
2 value 
was obtained for [Ln.L30]3+ (+233 cm-1) followed by [Ln.L32] (+110 cm-1) and finally [Ln.L33] 
(+75 cm-1). As this parameter also determines the magnitude of the dipolar shift in NMR 
spectroscopy (equation 2.2.),169 this trend was reflected in the relative shifts of the ligand 
protons, best illustrated in the 1H chemical shift data for the Yb complexes of L30,32,33 (Table 
8). Thus, the most shifted ring proton (Hax) resonates at -18.8, -13.8 and -4.8 for [Yb.L30]
3+, 
[Yb.L32] and [Yb.L33] respectively. The total spectral width for each complex is 30, 24 and 14 
ppm in that sequence.  
 
𝛿𝑝𝑎𝑟𝑎 =  
−2𝐶𝐽𝛽
2
(𝑘𝑇)2
[
3𝑐𝑜𝑠2𝜃 − 1
𝑟3
] 𝐵0
2 (2.2.) 
 
Therefore, these calculations support the hypothesis of Funk et al., which states that there is 
direct proportionality between the electronic relaxation time and the second order crystal field 
splitting parameter in highly symmetric complexes i.e. 𝑇1𝑒 𝛼 𝐵0
2. These examples also highlight 
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the fact that the sign of 𝐵0
2 in these C3 symmetric complexes is positive and opposite to that of 
the multitudinous C4 12N4 analogues, explaining the different sense of the NMR shifts 
observed.163 
Table 8 – Assignment of furthest shifted proton resonances in the 1H NMR spectra of Yb complexes, highlighting the 
paramagnetic spectral width correlation with 𝐵0
2 (CD3OD, 295 K, 400 MHz). 
1H resonance [Yb.L30]3+ 
(major isomer) 
[Yb.L32] [Yb.L33] 
Hax -18.8 -13.7 -4.8 
pyCH’N 22.3 20.7 11.1 
Spectral Width / ppm 30.2 24.4 13.6 
𝐵0
2 / cm-1 +232 +110 +75 
 
The rigidity of the complex, the symmetry surrounding the lanthanide ion and the polarisability 
of the axial donor are all possible factors that determine the lanthanide electronic relaxation in 
solution.70,72,163 The value of T1e and hence 𝐵0
2 should be greatest for complexes where the axial 
donor ligand is the most highly polarisable. This trend is again observed in the case of the three 
complexes studied, as highest T1e and 𝐵0
2 values were observed for [Ln.L30]3+ containing a 
highly polarisable amide oxygen atom, followed by the less polarisable phosphinate and 
carboxylate oxygen donors. 
 
Figure 42 – X-ray crystal structure of R-Λ-(δδδ)-[Eu.L30]3+ showing the twist angle associated with the trigonal prism 
distortion. 
An investigation into the effect of local symmetry of the complexes on T1e was initiated. The 
complexes each adopted a distorted tricapped trigonal prism structure. The distortion angle is 
defined by the twist of the mean plane of 9-N3 with reference to the three bound oxygen atoms 
of the amide, phosphinate or carboxylate groups (Figure 42). However, no significant 
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differences in twist angle (22 ± 2º) were found for the europium or ytterbium complexes of L30 
compared to the corresponding values of [Ln.L32] and [Ln.L33]. This result suggests, that within 
this set of complexes, the polyhedral distortion is not an influential factor in the determination 
of the size of the ligand field. 
 
2.5. Photophysical studies 
 
2.5.1. Characterisation of parent complex [Eu.L30](CF3SO3)3 
Photophysical studies such as the measurement of total luminescence and determination of 
quantum yield, excited state lifetime data and hence number of metal bound waters, q, can be 
very useful in the characterisation of a lanthanide complex. Therefore, a thorough investigation 
of the photophysical properties of S-[Ln.L30]3+ was undertaken (the S-Δ isomer was studied 
unless stated otherwise). 
2.5.1.1. Absorption and emission spectral properties 
The series of lanthanide complexes of L30 possess an absorption band at 280 nm attributed to 
the π-π* transition in the pyridyl chromophore. The emission spectra for the Eu, Tb and Dy 
complexes were recorded, and revealed spectral profiles that were characteristic for the metal 
in question. The europium emission spectral profile strongly resembled that of the related 9-N3 
pyridylphosphinate complex [Eu.L32] under the same conditions.100 However, the ΔJ = 2/ΔJ = 
1 ratio is 25% greater for [Eu.L30]3+ (5:1) compared to the phosphinate complex [Eu.L32] (4:1), 
which can be tentatively attributed to the greater polarisability of the amide oxygen atoms. 
 
Figure 43 – Total emission spectra of S-Δ-[Eu.L30]3+ (red), S-Δ-[Tb.L30]3+ (green) and S-Δ-[Dy.L30]3+ (yellow) (λexc = 280 nm, 
H2O, 295 K).  
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2.5.1.2. Excited state emission lifetimes and estimation of complex hydration state, q 
In order to determine the hydration state of the complexes, the excited state lifetimes of the 
europium and terbium complexes were measured in H2O and D2O. There is much less efficient 
energy transfer from a lanthanide ion to overtones of X-D oscillators compared to X-H 
oscillators, due to less effective energy matching as a result of the much lower X-D stretching 
frequencies.170 This effect means that for a given complex, the diminution of luminescence 
intensity will occur more slowly in D2O than H2O, and allows the number of metal bound water 
molecules, q, to be estimated according to equations 2.3 and 2.4.117,170 
 
 
𝑞(𝐸𝑢(𝐼𝐼𝐼)) = 𝐴[(
1
𝜏𝐻2𝑂
−
1
𝜏𝐷2𝑂
) − 0.25 − 0.075𝑥] (2.3.) 
 
𝑞(𝑇𝑏(𝐼𝐼𝐼)) = 𝐴[(
1
𝜏𝐻2𝑂
−
1
𝜏𝐷2𝑂
) − 0.06] (2.4.) 
 
Here, A is the proportionality constant and reflects the sensitivity to quenching of the particular 
lanthanide ion by metal bound water molecules (A(Eu3+) = 1.2 ms, A(Tb3+) = 5 ms). The above 
equations also take into account the effect of second sphere water molecules and proximate N-
H oscillators of amide donors, x. A q value of approximately zero was calculated for both 
[Eu.L30]3+ and [Tb.L30]3+, indicating that there are no inner sphere water molecules present in 
the complexes, as expected for these 9 coordinate lanthanide complexes. 
 
Table 9 – Lifetime measurements and derived q values of [Eu.L30]3+ and [Tb.L30]3+ in H2O and D2O (pH 7.4).  
 τ(H2O) / ms τ(D2O) / ms q 
S-Δ-[Eu.L30]3+ 0.98 1.42 -0.19 
S-Δ-[Tb.L30]3+ 1.87 2.12 0.02 
 
2.5.2. Absorption and emission properties of [Eu.L31a-d]Cl3 
After an extensive investigation into the structural and photophysical properties of complexes 
[Ln.L30]3+, work then turned to the preparation of the related complexes [Eu.L31a-d]3+, where 
an extended arylalkynyl chromophore was appended to the ligand framework. Substitution of 
the aromatic group of the chromophore allowed for fine-tuning of the absorption and emission 
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properties, such as the excitation wavelength, λexc, molar extinction coefficient, ε, and quantum 
yield, ɸem, as well as physical properties such as hydrophilicity, logP. The photophysical 
properties were studied and the results revealed the best suited europium complexes for 
application in biological studies and in cellulo. 
 
2.5.2.1. Absorption and emission spectral properties 
The inclusion of an extended arylalkynyl chromophore in the complex system was shown to 
cause a bathochromic shift of the absorption band of up to 75 nm (for [Eu.L31c]3+ and  
[Eu.L31d]3+) compared to the parent complex, [Eu.L30]3+. This property is highly desirable if 
the probes are to be employed in cellulo, as a lower energy excitation source can be used and 
the co-excitation of common biomolecules will be avoided. This absorption band was very 
intense (ε values in MeOH ranged from 63 000 to 69 000 M-1 cm-1 to about 55 000 M-1 cm-1 in 
H2O), in accordance with earlier work on the related phosphinate
154 and carboxylate171 donors, 
and is consistent with significant ICT (internal charge transfer) character in the excited state.  
 
Figure 44 – UV- absorption spectra of [Eu.L31a]3+ (blue), [Eu.L31b]3+(red), [Eu.L31c]3+ (purple), [Eu.L31d]3+ (green) (H2O, 295 
K). 
 
The position of the absorption band was particularly sensitive to solvent polarity, and there was 
a hypsochromic shift of the absorbance maxima observed in solvents of lower polarity (Table 
10). Such behaviour is consistent with the lowering of energy of the relaxed ICT excited state 
in more polar protic solvents.172,173 
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Table 10 – Solvatochromism data observed with [Eu.L31a-d]3+ (295 K). 
 λmax/nm     
Solvent 𝐸𝑇
30normalised [Eu.L31a]3+ [Eu.L31b]3+ [Eu.L31c]3+ [Eu.L31d]3+ 
H2O 1.00 332 328 356 352 
MeOH 0.76 332 328 355 352 
EtOH 0.65 331 327 355 349 
iPrOH 0.55 320 324 336 344 
DMF 0.40 308 316 332 336 
a 𝐸𝑇
30values are based on Reichardt’s normalised solvent polarity scale.174 
The europium emission spectra for all of the complexes were very similar and almost identical 
to the behaviour of [Eu.L32,33] and their extended chromophore analogues, consistent with 
time-averaged C3 symmetry. The spectra of the tri-amide, [Eu.L31c]
3+, and related tri-
carboxylate, [Eu.L35] (Figure 46),171 complexes were compared to C3 symmetrical europium 
complexes with ida (iminodiacetate) and dpa (2,6-pyridinedicarboxylate) ligands. The 
complexes of L31 (D) and L35 (C) showed particularly strong resemblance to [Eu.(dpa)3]
3-(B), 
with a ratio of intensities of ΔJ = 2/ΔJ = 1 of around 4 or 5 in each case (Figure 45).  
 
 
Figure 45 –  Comparison of total emission spectra for C3-symmetric Eu(III) complexes: (A) [Eu.(ida)3]3− (λexc = 395 nm, H2O, 
pH 8.5); (B) [Eu.(dpa)3]3− (λexc = 395 nm, H2O, pH 8.5); (C) [Eu·L35] (λexc = 352 nm, H2O, pH 7.4); (D) [Eu·L31c](λexc = 352 
nm, H2O, pH 6). 
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Figure 46 - Structure of the tri-carboxylate Eu (III) complex, [Eu.L35].171 
 
Quantum yield calculations were carried out by comparison to a known standard [Eu.L36], 
where the quantum yield had been accurately determined using a Labsphere Optical Spectralon 
integrated sphere.149 The arylalkynyl chromophore acts as an efficient sensitiser of europium 
emission, and quantum yields in methanol were between 4 and 8%, for each complex of the 
four ligands L31a-d (Table 11). These quantum yield values were significantly lower than those 
obtained for the related tri-phosphinate (ɸem = up to 54% in methanol)154 and tri-carboxylate 
complexes (ɸem = up to 55% in methanol).171 The luminescence lifetimes for [Eu.L31c]3+ and 
[Eu.L31d]3+ (X = OMe and NHOAc) were also shorter than expected; 0.49 and 0.46 ms 
respectively, compared to 0.81 and 0.80 ms for [Eu.L31a]3+ and [Eu.L31b]3+ in water.  
 
Figure 47 – Structure of europium complex [Eu.L36]+. 
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Table 11 – Photophysical data for the complexes S-[Eu.L31a-d]Cl3 (295 K). 
Complex λmax ε(MeOH)/M-1 cm-1 τ(MeOH)/ms τ(H2O)/ms ɸem(MeOH) ɸem(H2O) 
[Eu.L31a]3+ 332 69 000 0.67 0.80 0.08 0.35 
[Eu.L31b]3+ 328 63 000 0.65 0.81 0.03 0.37 
[Eu.L31c]3+ 355 65 000 0.45 0.49 0.04 0.02 
[Eu.L31d]3+ 352 65 000 0.54 0.46 0.03 0.02 
 
The lower quantum yields and emission lifetimes for [Eu.L31c]3+ and [Eu.L31d]3+ suggested that 
the intramolecular energy transfer step from the relaxed ICT state may be partially reversible, 
and therefore thermally activated. To investigate this hypothesis further, a variable temperature 
emission study of [Eu.L31c]3+ in a glass of EPA (ether-isopentane-methanol 5:5:2) was carried 
out over a temperature range of 298 to 80 K (Figure 48). As the temperature was lowered, the 
emission intensity increased by a factor of five over the range 295 to 235 K, consistent with 
the suppression of thermally activated back energy transfer from the excited Eu (III) 5D0 state 
to the ICT excited state. 
 
Figure 48 – Variation of the Eu (III) emission spectrum of [Eu.L31c]3+ with decreasing temperature from 298 to 80 K (λexc = 
356 nm, ether:isopentane:ethanol 5:5:2). 
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Further evidence for the presence of an ICT centred excited state was gathered by investigating 
the phosphorescence spectrum of [Gd.L31d]Cl3, recorded at 85 K in a glass of EPA (5:5:2). A 
very broad structureless band at low temperature was observed, centred at 450 nm (530 nm 
shoulder). This observation was consistent with the intermediacy of an excited state with 
predominant ICT character, rather than a triplet excited state, where you would expect to 
observe a sharp well-defined band possessing vibrational fine structure. 
 
Figure 49 – Phosphorescence spectra of S-[Gd.L31d]Cl3 at 298 K (red) and 85 K (blue) showing a broad emission band centred 
at 450 nm with a shoulder at 530 nm (ether:isopentane:ethanol 5:5:2).  
 
In water at pH 6.5, the emission quantum yields of [Eu.L31a]3+ and [Eu.L31b]3+ (X = H and 
CO2Me) were 35 and 37% respectively. These are among the highest values reported for 
sensitised emission of any europium complex in aqueous solution, and compare to 39% for the 
closely related tri-phosphinate system.154 As the quantum yields were higher for the two 
complexes containing weak donor and electron withdrawing groups (L31a,31b), we can 
hypothesise that in an aqueous environment, the ICT state of these complexes lies at a higher 
energy and consequently, a contribution from the classical triplet mediated sensitisation 
process may occur.171,175 Such behaviour is in contrast to the complexes containing strongly 
donating moieties (L31c,31d), where sensitisation is most definitely occurring via an ICT excited 
state (Figure 50), as demonstrated in the preceding discussion. 
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Figure 50 – Simplified Jablonski diagram illustrating sensitised Eu (III) emission via a solvent relaxed internal charge transfer 
state.173 
 
The emission intensities of [Eu.L31a]3+ and [Eu.L31b]3+, in the presence of a thousand-fold 
excess of EDTA at pH 6.5, were monitored as a function of time over a period of seven days; 
after an initial 15% reduction, no significant change in intensity was observed in each case, 
consistent with the high kinetic stability of these systems with respect to dissociative ligand 
exchange.  
The water solubility of the complexes was assessed by calculation of the partition coefficient, 
logP. Of the four complexes studied, the chloride salts of [Eu.L31c]3+ and [Eu.L31d]3+ were the 
least soluble in water by empirical observational analysis. A logP value for the most water 
soluble complex, [Eu.L31b]Cl3 (X = CO2Me), was calculated by preparation of three equimolar 
solutions in methanol. The solvent was removed under reduced pressure and the resulting solid 
was dissolved in three 0.9 mL H2O-octanol mixtures (2:1, 1:1 and 1:2 v/v) and stirred for 24 h 
at r.t. (approx. 2 µM complex in each mixture). After equilibration, an emission spectrum for 
each layer was recorded in MeOH (50 µL solution in 1 mL MeOH). For each mixture, the logP 
value was calculated according to equation 2.5. 
 
 
𝑙𝑜𝑔𝑃 = 𝑙𝑜𝑔 (
∫ 𝐼(𝑜𝑐𝑡)
635 𝑛𝑚
605 𝑛𝑚
∫ 𝐼(𝐻2𝑂)
635 𝑛𝑚
605 𝑛𝑚
) (2.5.) 
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A partition coefficient of +0.9 was calculated for [Eu.L31b]Cl3. The small positive number 
indicated that the complex is more soluble in organic solvents, and only partially soluble in 
water.  
2.5.2.2. pH dependent emission behaviour and calculation of pKa of S-[Eu.L31c]Cl3 
 
 
Figure 51 – Variation of the Eu (III) emission spectrum as a function of pH for S-[Eu.L31c]Cl3, pH 4.08 – red, pH 10.52- blue 
(iPrOH-H2O 80:20 v/v, 5 µM complex, 298 K, λexc = 348 nm). Inset shows absorbance changes at 348 nm with pH (filled 
circles), and variation of ΔJ =2/ ΔJ = 4 relative emission intensity ratio with pH (open circles) (pKa 9.1 ± 0.1). 
 
The absorption and emission spectral behaviour of the complexes [Eu.L31c]3+ and [Eu.L31d]3+, 
absorbing at longer wavelength in protic solvents, was also sensitive to the apparent pH. The 
pH response of S-[Eu.L31c]3+ was explored and a pKa value in the ground and excited state was 
calculated. The complex was dissolved in an 80:20 v/v iPrOH-water mixture, as this allowed 
for observation of the most significant changes in emission spectral form and ensured full 
solubility of the complex in solution throughout the titration. The apparent pH was varied using 
conc. NaOH (aq.) and HCl (aq.) solutions to ensure negligible change to the overall volume, 
and thus concentration of the complex. The pH was measured before and after each data point 
was recorded. As the apparent pH was varied, both the absorbance at 348 nm and the europium 
emission spectral form changed. The spectral changes observed were completely reversible. 
The emission spectral changes were particularly striking and led to the appearance of a number 
of additional transitions, consistent with a lowering of the symmetry around the Eu ion, and a 
change in the Eu coordination environment (Figure 51). Of particular note was the change in 
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the ΔJ = 1 transition around 595 nm, which evolved from a broad single manifold into three 
distinct transitions. For a Eu complex, three transitions are symmetry-allowed in systems 
lacking a Cn symmetry axis. The absorption spectral changes were characterised by a shift to 
the blue at higher pH, moving the primary absorption band from 355 to 328 nm (Figure 52). 
The excited state lifetime decreased upon lowering the apparent pH from 0.73 ms at pH 10.52 
to 0.54 ms at pH 4.08. 
 
 
Figure 52 – UV-absorption spectra of S-[Eu.L31c]Cl3 in iPrOH-H2O (80:20 v/v) at an apparent pH of 10.3 (blue) and 4.4 (red). 
 
Values of the apparent pKa for the ground and excited state were derived by iterative fitting of 
the observed spectral changes to a two-state equilibrium, and were estimated to be 9.1 in each 
case. Taken together, this behaviour is consistent with a deprotonation of one amide NH proton, 
reversibly generating an amide enolate in which the anionic oxygen atom is coordinated to the 
europium centre (Figure 53). Indeed, in several examples of 12-N4 lanthanide tetra-amide 
complexes, similar pKa values (range 7.9 – 11.1) have been associated with amide 
deprotonation in aqueous media.176–178  
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Figure 53 – Possible amide deprotonation mechanism of S-[Eu.L31c]Cl3 leading to the observed changes in absorption and 
emission spectral form (apparent pKa 9.10). 
 
2.6. Conclusions 
 
A novel enantiopure ligand system, L30, based on an amide substituted 9-N3 macrocycle 
derived from either R-(+) or S-(-)-α-methylbenzyl amine was synthesised. The series of chiral 
lanthanide complexes based on this model system, [Ln.L30](CF3SO3)3,  were prepared and fully 
characterised using crystallographic, NMR, HPLC and CPL methods.  The remote chiral centre 
of the amide was shown to induce the formation of one major diastereoisomer upon 
complexation with the lanthanide metal. The proportion of the major isomer in solution was 
9:1 for Ce and Pr, 7 or 6:1 from Nd to Tm falling to 4:1 for Yb. The level of remote 
stereocontrol in complexation is inferior to that created by C-substitution directly on the 
macrocyclic ring, where it has been shown that incorporation of one methyl substituent onto 
the ring led to preferential formation of one enantiomeric complex (>96%).73 The stereogenic 
centre of the remote amide determines the helicity of the metal complex in this new range of 
nonadentate Ln (III) complexes based on triazacyclononane. The major species of the parent 
complex, [Eu.L30]3+, was determined by X-ray crystallography, and was found to exist as S-Δ-
(λλλ) and R-Λ-(δδδ). The major species of S-[Yb.L30]3+ was identified as Δ-(λλλ) using similar 
methods, providing strong evidence that the complexes are isostructural across the series. 
A 1H NMR spectroscopic comparative study of [Ln.L30]3+ and the closely related tri-
phosphinate and tri-carboxylate complexes, [Ln.L32] and [Ln.L33], was conducted.  A 
systematic comparison of shift and relaxation data allowed for a full analysis of the electronic 
relaxation time, T1e, of the lanthanide complexes to be assessed.  The study supported previous 
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investigations regarding the proportionality of the pseudocontact shift with the ligand field 
parameter, 𝐵0
2, for an axially symmetric isostructural series of lanthanide complexes.72 The 
values of 𝐵0
2 were determined using emission and CPL data, and compared to the measured 
values of T1e. The results showed that there is direct proportionality between the electronic 
relaxation time and the second order crystal field splitting parameter, which in turn can be 
correlated to the total spectral width of the 1H NMR spectrum of the complex. The highest 
values of T1e and 𝐵0
2 were calculated for the tri-amide complex and were attributed to the 
increased polarisability of the oxygen donor compared to the tri-phosphinate and tri-
carboxylate complexes. 
The parent system was further developed to include para-substituted arylalkynyl 
chromophores which allowed fine-tuning of the photophysical properties of this new class of 
complexes. The diastereomeric induction of four analogous europium complexes, [Eu.L31a-
c]Cl3,  was improved and the complexes were found to exist  as one major isomer in solution 
in a ratio of 15:1. The maximum excitation wavelength was red-shifted up to 75 nm for 
[Eu.L31c]3+ in aqueous solution, compared to  a value of λexc = 280 nm for the parent system, 
[Eu.L30]3+. Each complex absorbs light strongly via an ICT transition in the range 320 to 356 
nm (ε = 55 000 M-1 cm-1 in H2O) that is strongly solvatochromic.  However, in the case of the 
two complexes that absorb at the longer wavelengths ([Eu.L31c,d]3+), the quantum yield and 
excited state lifetime values are low ([Eu.L31c]3+: ɸem = 2%, τ = 0.49 ms, H2O). Variable 
temperature emission spectroscopy revealed a thermally activated back energy transfer process 
was occurring, quenching the excited state of these particular complexes. On the contrary, two 
examples absorbing light at around 332 nm, albeit with a broad transition that extends to 355 
nm, possess overall emission quantum yields at Eu of 35 and 37% in aerated water.  These 
values are amongst the highest recorded for sensitised europium emission in aqueous solution.  
All four complexes display strong CPL activity with well-defined spectral form and high gem 
values (S-[Eu.L31c]3+ gem(592 nm) = -0.15), consistent with a conformationally rigid chiral 
system. 
Taking into account all the physical and photophysical properties, it is clear that a compromise 
must be made between maximum excitation wavelength, and the luminescent lifetime and 
brightness of the complex. This investigation has shown that a high level of stereocontrol can 
be imparted on a complex using this enantiopure ligand system, resulting in the synthesis of 
bright chiral europium complexes that exhibit strong CPL. Such behaviour augurs well for the 
use of analogues of these systems as the basis of CPL probes, in which the sign and intensity 
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of selected CPL transitions can be monitored following addition of a chiral analyte. The 
following chapter investigates the use of dynamically racemic complexes as CPL probes, based 
on analogues of the ligand systems L31a-d. 
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3.1. Introduction 
 
The emissive lanthanide excited state can be perturbed in a variety of different ways, 
including changes in the local solvent structure and static and dynamic charge transfer 
quenching processes.179 In particular, changes in the ligand field can arise from reversible 
binding of an analyte to the metal or the ligand.5,151 The latter modulation is of particular 
use in signalling the presence of a chiral species in solution. 
For Eu (III), perturbation of the ligand field can have a dramatic effect on the emission 
profile, most notably in the intensity of the hypersensitive ΔJ = 2 transition. Several 
practical examples exploiting this effect have been demonstrated, including assays of 
citrate,180 lactate181 and bicarbonate119,182 in biofluids. In each case, the interaction with 
the lanthanide complex is signalled by modulation of the total emission spectrum. 
However, such analyses are not normally sensitive to chiral aspects that arise from 
specific stereochemical interactions.  
Chiroptical methods, such as CPL, must be employed to address such issues. The 
observation of induced CPL has been demonstrated for lanthanide complexes based on 
dpa and dpa-derived ligands, in the presence of a number of chiral additives, as discussed 
in Chapter 1, Section 1.5.1. However, in these examples, the observed effects are 
attributed to an outer sphere association mechanism as opposed to direct binding to the 
metal centre. A recent example of the reversible binding of acute phase proteins, α1-AGP 
and α1-AAT, to a lanthanide complex has been reported, in which induced CPL was used 
to signal the detection.146  
A racemic mixture of Ln (III) complexes in an achiral environment exhibits no CPL. 
However, the addition of a chiral agent can give rise to strong induced CPL, following 
stereoselective interactions between the two species. The relative intensity of the induced 
signal will be a function of the energy difference between the two diastereoisomeric 
adducts, the selectivity and affinity of binding, and the conformational rigidity of the 
complex on the emission timescale. 
The intrinsic brightness of the complex, B(λ) = ε(λ)ɸem(λ), is also an important practical 
aspect, as the acquisition of the total emission (IL+IR) and CPL (IL-IR) should be as rapid 
as possible, with maximum signal to noise. Recent work has introduced a new series of 
very bright Eu (III) complexes based on a 9-N3 core ligand structure, with various 
substituted pyridyl-aryl-alkynyl groups acting as the sensitising chromophore. The 
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substituted pyridyl pendant arms include pyridyl-phosphinates,60,154,183 pyridyl-
carboxylates171 and finally the series of pyridyl-amides162 that were presented in Chapter 
2. Coordinatively unsaturated heptadentate complexes have also been reported that can 
bind to anions reversibly in aqueous media.149 
Determining the enantiomeric purity of chiral therapeutic agents is of great importance in 
the pharmaceutical industry. Traditional methods of assessing the enantiomeric 
composition of a sample include NMR spectroscopy, HPLC and GC. CPL exists as a 
complementary tool that can aid in the chiral analysis of a sample, allowing for 
discrimination between enantiomeric compounds. Several studies using [Ln.(dpa)3]
3- 
have shown the possibility of using lanthanide complexes in the determination of the 
enantiomeric excess of a sample in conjunction with CPL spectroscopy.50 A more recent 
example has reported a linear variation of the enantiomeric composition of a sample with 
gem values for dynamically racemic Eu
3+ and Tb3+ complexes.15  
This chapter describes the preparation of four dynamically racemic heptadentate Eu (III) 
complexes detailed in the referenced publication.184 The complexes differ in nature by 
the overall charge of the system; the bis-phosphinate and bis-carboxylate europium 
complexes are monocationic, whereas the bis-amide complex is tri-positively charged. 
The steric demand around the metal centre led to further distinction between the 
complexes, where the phosphinate ligand creates a more sterically hindered environment 
compared to the analogous carboxylate ligand system. The aryl-alkynyl chromophore of 
each complex was altered leading to variation in the maximum excitation wavelength, 
λexc, and emission quantum yield, ɸem. The work presented will compare and contrast the 
behaviour of these complexes in order to trace the key ligand structural features that allow 
them to act as effective chirality probes for CPL. The rate of racemisation of [Ln.(dpa)3]
3- 
and related complex [Eu.(L1)3]
3+ will be investigated using EXSY (EXchange 
SpectroscopY) and saturation transfer NMR experiments and compared to the observed 
findings regarding the rate of exchange in the title complexes, [Eu.L37-40]. The nature of 
the binding interaction between the complexes and a number of enantiopure α-hydroxy 
acids will be investigated, in order to deepen our understanding of their mode of binding, 
the mechanism of induced CPL and allow us to draw informative structure-spectral 
correlations. The application of these complexes in the determination of enantiomeric 
purity of a sample with unknown composition will also be demonstrated. 
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Figure 54 – Structures of Eu (III) complexes of L37-40. 
 
3.2. Synthetic aspects 
 
The preparation of the di-phosphinate complex, [Eu.L37]+, was reported first by 
McMahon in preliminary work.15,149  
3.2.1. Synthesis of a bis-pyridylamide-9-N3 europium complex, [Eu.L38]3+ 
The synthesis of the pendant arm was based on the pathway outlined in Scheme 14, 
Chapter 2, beginning with intermediate 3a. Base hydrolysis followed by amide coupling, 
using achiral benzylamine as opposed to chiral α-methylbenzylamine, afforded the 
benzylamide, 4b. A Sonogashira cross-coupling reaction with 4-methoxy-phenylalkyne 
employing a Pd(II)/Cu(II) catalyst system, gave the alcohol, 4c, which was converted to 
the mesylate under standard conditions (Scheme 15). 
 
Scheme 15 – Synthesis of the achiral pendant arm of L38. 
 
In order to synthesise the di-substituted ligand L38, it was first necessary to prepare tert-
butyl-1,4,7-triazacyclononane-1-carboxylate (mono-BOC 9-N3).
149 This was achieved 
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using an orthogonal protection strategy. Two sites on the 9-N3 macrocycle were alkylated 
with a bulky carbobenzyloxy (Cbz)-protecting group. The free secondary amine was then 
reacted with N-tertbutoxycarbonylsuccinimide to furnish a BOC protecting group at the 
third site. The Cbz-protecting groups were removed by hydrogenation over a palladium 
hydroxide/C catalyst at 4 atmospheres generating the desired mono-protected macrocycle 
in good yield (Scheme 16). 
 
Scheme 16 – Mono-protection strategy for 1,4,7-triazacyclononane.149 
 
Alkylation of mono-BOC 9-N3 with two equivalents of the mesylate, 4d, gave the 
carbamate, 4e, from which the Eu (III) complex was prepared, following deprotection 
with TFA and reaction with europium triflate in methanol.  
 
Scheme 17 – Synthesis of [Eu.L38](CF3SO3)3. 
 
In the BOC-deprotection step, approximately 40% of the alkyne was converted to the 
hydrated product, catalysed by the presence of strong acid. The two products were 
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inseparable by column chromatography, and so reverse phase HPLC was employed to 
separate the desired ligand from the hydrated by-product. After successful purification by 
preparative HPLC (H2O 0.1% formic acid / MeOH 0.1% formic acid), the ligand was 
passed down an ion exchange column, to ensure complete removal of formate. The 
complexation reaction progressed very slowly, and the observation after 48 h of a broad 
fluorescence band below 550 nm in the emission spectrum, signalled the presence of free 
ligand. Efforts to push the reaction to completion (time, temperature, excess Eu (III)) 
resulted in no significant improvement on the extent of the reaction. The instability of the 
complex meant that HPLC in the presence of formic acid resulted in full decomplexation, 
and no alternative solvent system for purification could be found. The tri-positive nature 
of the complex also prohibited purification using column chromatography. The studies 
outlined in the following sections were carried out on a mixed ligand-complex mixture of 
L38 (~1:5). 
 
3.2.2. Synthesis of bis-pyridylcarboxylate-9N3 europium complexes, [Eu.L39,40]+ 
3.2.2.1. Synthesis of the chromophore 
Based on previous studies of the related tri-carboxylate europium complexes,171 the 
incorporation of an electron rich aromatic group in the chromophore framework, results 
in a significant bathochromic shift of the excitation wavelength. For example, the addition 
of two ortho-methyl substituents to a para-methoxy arylalkyne complex moves the 
excitation wavelength from λexc = 339 nm to λexc = 351 nm. With this in mind, a para-
methoxy di-ortho-methyl arylalkyne was selected as a suitable chromophore. 
 
Scheme 18 – Initial synthetic pathway for the synthesis of the pendant arm.171 
 
The initial synthetic pathway for the synthesis of the pendant arm was designed beginning 
with the aryl-iodide, 3a (Scheme 18). Cross-coupling of 3a with ethynyltrimethysilane 
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was carried out in excellent yield using Pd(dppf)Cl2 and CuI. Attempts were then made 
at in situ deprotection of the silyl protecting group using tetra-n-butylammonium fluoride 
(TBAF) followed by a second cross coupling with the desired aromatic halide. However, 
a very low yield (12%) of the product was obtained and the crude mixture proved very 
difficult to purify in the presence of the excess TBAF. Triethylammonium 
trihydrofluoride was employed as a milder alternative for the silyl deprotection step. 
However, significant formation of a by-product was observed, which MS studies revealed 
to be the dimer of the starting material. This observation suggested that the free pyridyl-
alkyne was unstable and highly reactive towards dimerisation under these conditions. 
 
 
Scheme 19 – Reaction scheme for the synthesis of the aryl-alkynyl chromophore, 5c. 
 
An alternative strategy was then designed, which focussed on the synthesis of the alkyne, 
5c (Scheme 19). Sonogashira coupling of the electron rich aromatic-halide, 5a, to 
ethynyltrimethylsilane proved slightly tricky. The presence of two ortho-methyl groups 
provided significant steric hindrance and the nature of the electron rich aryl-group 
inhibited the oxidative addition step with the palladium catalyst. Taking into account 
these two factors, the selection of the most appropriate palladium catalyst was considered. 
[1,1-Bis(triphenylphosphine)]palladium (II) dichloride was selected, as the catalyst 
contains less sterically bulky groups compared with the previously employed Pd(dppf)Cl2 
catalyst. The presence of strongly electron donating phosphine ligands may also allow 
improvement in the rate of the oxidative addition step. Employing an aromatic iodide as 
the starting material, as opposed to the bromide, also improved the reactivity in the 
oxidative addition step, due to the weaker C-X bond. With these reaction modifications, 
successful formation of the protected alkyne was achieved. A subsequent deprotection 
step gave the desired arylalkyne chromophore, 5c.  
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3.2.2.2. Synthesis of complexes [Eu.L39]Cl and [Eu.L40]Cl 
Cross-coupling of 5c with 3a under standard conditions, gave the alcohol, 5d, in modest 
yield, which underwent a subsequent mesylation reaction. Controlled di-alkylation of 9-
N3 was carried out in order to avoid exposure of the electron rich alkyne to the strongly 
acidic conditions present in the mono-BOC strategy (Scheme 17), as it is sensitive to acid-
catalysed hydration. The formation of the di-alkylated ligand was attained using 
controlled reaction conditions. The number of equivalents of the pendant arm was kept 
below two (1.9 equiv.), a large solvent volume was used, the reaction temperature was 
maintained at a lower value of 60 ºC and the reaction was monitored every 10 minutes by 
LC-MS. After 1 h the reaction was terminated, following observation of significant 
formation of the desired di-alkylated ligand (some mono- and tri-alkylated product were 
also observed by LC-MS). Column chromatography on silica gel allowed separation of 
the alkylated species and isolation of the di-alkylated ligand, L39, in modest yield (35%). 
A simple alkylation reaction between the free secondary amine of ligand L39 and benzyl 
bromide, afforded L40, after purification by column chromatography. 
Base hydrolysis (pH 12) of the methyl ester groups was followed by addition of the 
europium salt, EuCl3.6H2O, at pH 6.5. The reaction was left to stir for 24 h and complete 
complexation was confirmed by ESI-MS (no column) and emission spectroscopy, to give 
the complexes [Eu.L39]Cl and [Eu.L40]Cl. 
 
Scheme 20 – Synthesis of ligands L39 and L40 and their europium (III) complexes. 
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3.3. Photophysical behaviour 
 
Photophysical data of the four europium (III) complexes in MeOH are summarised in 
Table 12, and highlight the difference in the key parameters between the complexes. The 
data for [Eu.L37]+ are taken from reference 149.  
 
Table 12 - Photophysical properties of the Eu (III) complexes of L37-40 (295 K, MeOH; selected emission decay rate 
constant data are given in H2O and D2O)a,b 
 [Eu.L37]+ [Eu.L38]3+ [Eu.L39]+ [Eu.L40]+ 
λ/nm 332 348 352 348 
ε/mM-1 cm-1 38.6 40.0 35.0 36.0 
ɸ 0.19 0.02 0.20 0.18 
k/ms-1 2.94 2.17 2.56 1.20 
k(H2O)/ms-1 2.97 3.85 3.70 2.00 
k(D2O)/ms-1 2.04 2.33 2.63 1.89 
q 0.8 1.3 1.0 0 
a errors on k values are ±10%, errors on quantum yields are ±20%. b q values in water were determined as defined in 
equation 2.3, page 67, at pH 6.117 
 
 
The high absorbance of each complex in the range of 332 to 352 nm is as a result of the 
strongly absorbing ICT excited state. Evidence for the presence of an ICT band was 
provided for the related tris-amide complexes in Chapter 2. A similar solvatochromism 
study was conducted for [Eu.L38]3+, in which a hypsochromic shift of the absorbance band 
was observed in solvents of lower polarity. 
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The amide complex, [Eu.L38]3+, possesses a low overall emission quantum yield, 
presumably due to less favourable intermolecular energy transfer, as discussed in the 
previous chapter. The other three complexes have quantum yields in the range 18 to 20%. 
These are high values, especially for systems with a coordinated amine NH group and a 
bound water molecule ([Eu.L37]+ and [Eu.L39]+). 
The presence of a coordinated amine NH oscillator has been shown to effectively quench 
the Eu (III) excited state, via efficient vibrational coupling.170 Such excited state 
quenching explains the faster emission decay rate of [Eu.L39]+ compared to the N-benzyl 
complex [Eu.L40]+, where the observed rate of emission is nearly twice as slow in 
methanol (Table 12). Measurements of the radiative rate of decay of europium (III) 
emission in water and D2O allowed solvation states to be estimated according to equation 
2.3, page 67.117,170 The complexes of L37-39 are octadentate with one metal-bound water 
molecule. Interestingly, the N-benzyl complex [Eu.L40]+, possesses no coordinated water, 
perhaps owing to the increased steric demand imposed by the N-substituent. It represents 
an unusual example of a seven-coordinate Eu (III) complex in aqueous solution. 
 
3.3.1. pH dependent emission behaviour 
A strong pH influence on the emission spectral output and the luminescence lifetime of 
the bis-amide, [Eu.L38]3+, and bis-carboxylate, [Eu.L39]+, complexes was observed. No 
such behaviour was displayed for the bis-phosphinate, [Eu.L37]+ nor the N-benzyl 
complex [Eu.L40]+. For example, a q value of 1.0 was calculated for [Eu.L39]+ at pH 5.5, 
as expected for an unsaturated europium (III) complex. However, upon increasing the pH 
to 7.6, the lifetime of the complex in water increased from 0.27 ms to 0.37 ms, from 
which, a q value of zero was estimated. Similar behaviour was observed in the total 
emission spectral changes (Figure 55). On increasing the pH from 5 to 7, a four-fold 
increase in emission intensity was observed.  
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Figure 55 – Emission spectra of [Eu.L39]+ at pH 5.35 (red) and pH 7.56 (blue) (λexc = 352 nm, H2O, 295 K). 
 
Bicarbonate anions may be present in solutions of higher pH via the transformation of 
dissolved carbon dioxide, according to the equilibria defined by equations 3.1 and 3.2. 
 
 𝐶𝑂2 + 𝐻2𝑂 𝐻2𝐶𝑂3 (3.1.) 
 𝐻2𝐶𝑂3 𝐻
+ + 𝐻𝐶𝑂3
−
 (3.2.) 
 
The bidentate binding of bicarbonate to a lanthanide centre is a well-known 
phenomenon.5,116 The pH dependent emission response suggests that at high pH, a 
bicarbonate anion may be bound to the Eu3+ centre leading to a displacement of the metal 
bound water molecule, resulting in an increase in total emission intensity and a q value 
of zero. The very low concentration of bicarbonate present in aqueous solution at pH 7.6 
suggests that [Eu.L39]+ has an extremely high binding affinity for bicarbonate. 
A pH emission titration in water was carried out in order to further clarify the putative 
bicarbonate response of [Eu.L39]+. The pH of the solution was adjusted using solutions of 
conc. HCl (aq.) and degassed NaOH (aq.). After each measurement was recorded, the pH 
was lowered to 5, bubbled with argon and readjusted to the desired pH, before the 
measurement was recorded again. The total emission intensity was plotted against pH, 
generating a curve which showed a large exponential increase in intensity, which is most 
likely attributed to the increasing concentration of bicarbonate present in solutions of 
higher pH. 
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Figure 56 – Plot of the total emission intensity versus pH for [Eu.L39]+. 
 
The apparent high binding affinity alludes to the possibility that an alternative binding 
mechanism may be occurring. A tentative suggestion was that the mechanism proceeds 
via the deprotonation of the metal-bound water molecule, resulting in a hydroxide ion 
bound to the metal centre. It is possible that the metal-bound hydroxide is able to promote 
the bicarbonate binding mechanism leading to the particularly high affinity. To prevent 
interference of bicarbonate anions in further studies, emission data was recorded with 
degassed solutions at pH < 6. 
 
3.4. Binding affinity with chiral anions 
 
The anion binding capabilities of the title complexes, [Eu.L37-40], were assessed. Three 
chiral α-hydroxy acids with sterically different R-groups were selected (Figure 57), with 
the expectation that their emission and CPL spectra would provide information 
surrounding the binding mode and chirality in the resulting complexes. 
 
 
Figure 57 – Structures of the selected enantiopure α-hydroxyacids and their pKa values (H2O, I = 0.1, 298 K). 
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Incremental addition of freshly prepared stock solutions of a given chiral anion, to each 
europium complex in turn, was monitored by emission spectroscopy until the limiting 
spectrum was obtained. The pH of the solution was recorded after the addition of each 
aliquot of anion, and readjusted if necessary, using conc. HCl (aq.) and degassed NaOH 
(aq.). The change in the relative intensity and form of the Eu (III) emission spectrum was 
examined. The relative intensity of the ΔJ = 2 and ΔJ = 1 emission bands was plotted as 
a function of anion concentration, and the variation was fitted to a 1:1 binding model by 
iterative non-linear least-squares fitting, to give an estimate of the association constant. 
The limited water solubility of the mono-cationic Eu (III) complexes meant that these 
systems were examined in 50% aqueous methanol. The magnitude of the binding 
constants measured in water and aqueous methanol (1:1, v/v) were very similar, Table 
13, suggesting the presence of localised solvent environments, as opposed to an equal 
dispersion of solvent molecules throughout the sample.185 Overall, the observed emission 
intensity increased as anion was added; changes in spectral form were most significant 
with [Eu.L37],149 and were less marked with [Eu.L38-40] (Figure 58). No significant 
differences were observed in measured binding constants with enantiomeric carboxylates. 
 
 
Figure 58 – Variation of the europium (III) emission profile as a function of added anion; (upper) [Eu.L38]3+ (5 µM, 
λexc = 348 nm, H2O, pH 5.5), (left to right) lactate, mandelate and cyclohexylhydroxyacetate; (lower) [Eu.L39]+ (5 µM, 
λexc = 352 nm, 50% MeOH in H2O, pH 5.5) plus added anions. Insets show fits to experimental data, following iterative 
least-squares fitting to a 1:1 binding model. 
 
The nature of the bound adduct was confirmed by direct observation of the sodium salt 
of the 1:1 adduct in the electrospray mass spectrum (Figure 59). 
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Figure 59 – LRMS data for [Eu.L39]+ m/z 865.4 (top) and [Eu.L39+S-cyclohexylhydroxyacetate+Na]+ m/z 1045 
(bottom) (ESI no column, MeOH, positive ion mode). 
 
A number of important trends were identified from the calculated binding affinities, Table 
13. Binding constants were largest for all four complexes with cyclohexylhydroxyacetate, 
consistent with the major role of anion desolvation in the overall free energy change. 
Cyclohexylhydroxyacetate contains a relatively bulky aliphatic cyclohexyl group and so 
it is more intuitively hydrophobic (cyclohexyl > Ph > Me). Comparing the behaviour of 
[Eu.L39]+ and its N-benzyl analogue [Eu.L40]+, affinity constants were smaller for the 
latter q = 0 complex. The difference in behaviour may be accounted for by the favourable 
free energy term associated with displacement of the weakly Eu-bound coordinated water 
molecule and its return to the bulk, where it enjoys full hydrogen bonding to other water 
molecules. As the estimated hydration state of [Eu.L40]+ is zero, the favourable free 
energy term associated with the displacement of the metal-bound water is not present. A 
final point worth noting is the trend in lactate binding affinity between the four 
complexes. Strongest binding was observed to the most positively charged bis-amide 
complex [Eu.L38]3+, which can be explained by a simple electrostatic argument. The bis-
phosphinate complex [Eu.L37]+ bound anions most weakly, compared to the bis-
carboxylate complex [Eu.L39]+, possibly as a result of the increased steric bulk around the 
metal centre, as revealed by the X-ray crystal structures of the related tri-substituted 
complexes.100,154,155 The weaker affinity for anions of [Eu.L37]+ may also account for the 
observation that there was no significant bicarbonate response at higher pH, as was the 
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case with the bis-amide and bis-carboxylate complexes. Much weaker binding was 
observed for carboxylate anions lacking a coordinating α-substituent, such as 2-
phenylpropionic acid, with a logK value estimated to be less than 1.5 for the complexes 
of L37-40. The addition of Me-S-lactate resulted in no change in the emission spectrum for 
each of the complexes, indicating that the carboxylate group is involved in the binding 
mechanism. No significant change in the emission spectrum was observed with any of 
the complexes, following addition of amino acids, such as S-serine, S-aspartate and S-
glutamate.  
Table 13 – Binding constants, logK, for chiral anion complexation (295 K, 50% aq. MeOH).a 
 R-lactate R-mandelate R-cyclohexylhydroxyacetate 
[Eu.L37]+ 2.76(04)[2.41b] - - 
[Eu.L38]3+ 4.57(05)[4.58b] 4.61(06)b 5.06(05)b 
[Eu.L39]+ 4.01(04) 4.52(06) 5.38(04) 
[Eu.L40]+ 3.15(04) 3.85(04) 4.41(05) 
a errors associated with the fitting analysis of a given data set are given in parentheses; experimental errors were 
estimated to be ±0.1 log unit b measurement in water at pH 5.5 to eliminate the possibility of interference from 
bicarbonate 
 
There are two possible chelation modes that α-hydroxy acids can adopt when binding to 
a lanthanide centre. The acids can bind via a 5-ring chelate (1) involving the α-hydroxyl 
group, or a 4-ring chelate (2) where the binding occurs via the carboxylate group. 
 
Figure 60 – Possible chelation modes of the chiral α-hydroxy anions at a lanthanide centre. * represents chiral centre. 
 
The mode of anion binding was investigated by examination of the radiative rates of 
decay of the complexes and their lactate-adducts in water and D2O (Table 14). A 
coordinated α-hydroxy-carboxylate in a 5-ring chelate, means that there is one OH 
oscillator in the Eu (III) inner coordination sphere. Assuming similar Ln-O bond lengths, 
a quenching effect that is half that of a coordinated water molecule should be observed. 
X-ray studies of chelated lactate and citrate adducts of lanthanide complexes substantiates 
this assumption, which show a Ln-O bond distance that is within 0.05 Å of the 
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corresponding hydrated complexes.118,170 The rate data obtained (Table 14) revealed that 
the lactate-bound adducts of [Eu.L38]3+ and [Eu.L39]+ show a quenching effect that is half 
that of the complexes with a metal-bound water (chelation mode 1). The X-ray crystal 
structure of the related 12-N4 tri-amide lanthanide complex bound to lactate, shows that 
the anion is also coordinated via a 5-ring chelate.118 However, the results imply that in 
the case of the lactate adduct of [Eu.L37]+, there is no coordinated OH group, suggesting 
a dominant carboxylate binding mode (chelation mode 2). The difference in binding mode 
could be attributed to the increased steric demand present at the lanthanide centre, for the 
9-N3 phosphinate complexes. 
 
Table 14 – Radiative rate constants for decay of Eu emission in the presence and absence of R-lactate (295 K, 10 µM 
complex, 50 µM lactate). 
 [Eu.L37]+ [Eu.L37.lactate] [Eu.L38]3+ [Eu.L38.lactate]2+ [Eu.L39]+ [Eu.L39.lactate] 
k(H2O/(ms-1) 2.97 2.33 3.85 2.86 3.70 2.63 
k(D2O)/(ms-1) 2.00 2.00 2.33 1.89 2.63 2.00 
q 0.8 0.08 1.3 0.6 0.9 0.4 
 
 
3.5. Induced CPL studies 
 
3.5.1. Racemisation rates of [Ln.(dpa)3]3-, [Ln.(L1)3]3+ and [Ln.L37-40] 
 
 
Figure 61 – Structure of the ligands dpa and SS-L1. 
 
The majority of studies surrounding the phenomenon of induced CPL are focussed on the 
interaction of chiral additives with dynamically racemic D3 lanthanide complexes based 
on dpa ligands, [Eu.(dpa)3]
3- and [Eu.(SS-L1)]3+ (Figure 61). Solutions of the two 
complexes were prepared in situ using a 1:5 metal to ligand ratio in deuterated 
acetonitrile, [Eu.(SS-L1)3]
3+, and D2O, [Eu.(dpa)3]
3- (6.67 x 10-3 M concentration of 
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ligand). The emission spectra were run and used to characterise the formation of the tris-
complex by comparison with literature spectra.89 
With the help of Dr. Alexander Funk and Dr. Juan Aguilar Malavia, HSQC and EXSY 
(EXchange SpectroscopY) methods were employed to assign the free ligand and complex 
resonances in each 1H NMR spectrum of [Eu.(SS-L1)3]
3+ and [Eu.(dpa)3]
3-.  
An approximate value for the rate of exchange of a system can be measured if the rate of 
exchange is of the same order of magnitude as the longitudinal relaxation time, T1.
186 The 
method is based on the selective saturation of one site in an exchange system by 
irradiation with a second rf field. Transfer of saturated spins from the irradiated site to the 
exchanging site can be monitored by observation of the signal intensity against a reference 
signal. The intensity falls to a new steady state level due to transfer of the saturated spins 
and also its T1 value (longitudinal relaxation time).  
In this experiment, the py-H signal in the complex-bound adduct underwent selective spin 
saturation, and the intensity of the corresponding py-H signal in the free ligand was 
monitored against a reference signal. The rate of exchange was calculated according to 
equation 3.3, where T1 is the longitudinal relaxation time of the free py-H without 
saturation, M0 is the signal intensity of the free py-H resonance observed in the absence 
of saturation (versus a reference signal), and M is the signal intensity of the same py-H 
resonance following saturation of the bound py-H resonance (versus a reference signal). 
The exchange rate data allowed for correlations of the structure of each complex to the 
observed emission and CPL spectra. Most notably, these experiments allow for 
comparison of rates of exchange with the dynamically racemic 9-N3 europium complexes 
[Eu.L37-40]. 
 
𝑘 =  
1
𝑇1
(
𝑀0
𝑀
− 1) (3.3.) 
 
The approximate rate of exchange of [Eu.(dpa)3]
3- was 4 s-1 which was slightly faster than 
the exchange rate calculated for [Eu.(SS-L1)3]
3+ where a value of 1 s-1 was recorded. The 
dissociation of the europium (III) complex based on dpa ligands results in the formation 
of two negatively charged species. The electrostatic repulsion between the two products 
of dissociation may account for the slightly faster observed rate. These results 
demonstrate that under the conditions outlined, the rate of dissociation of the two 
complexes is slow on the emission timescale and the emission and CPL spectra can be 
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confidently attributed to the most emissive species, which would be the [Ln.L3] complex. 
However, it is worth noting that on the addition of a chiral analyte, L*, the adduct 
[Ln.L2.L*] may be the most emissive species when taking into account the rate data, as 
opposed to an outer sphere [Ln.L3]L* species. 
The dynamically racemic europium complexes discussed in this section, [Eu.L37-40], 
exhibit no CPL implying that they exist as a 50:50 mixture of Δ and Λ isomers on their 
emission timescales (Figure 62). Multiple attempts at resolution by chiral HPLC were 
unsuccessful which suggests that there is fast interconversion between the Δ/Λ isomer on 
the laboratory timescale. It was not possible to perform a comparative saturation transfer 
experiment as the 1H NMR spectra of the europium complexes were compromised by 
considerable line broadening and relatively small dipolar shifts related to the small ligand 
field. Nevertheless, addition of R-lactate to [Eu.L39]+ led to a general sharpening of the 
observed resonances and the most shifted axial ring proton (assigned by comparison with 
the 1H NMR spectrum of the related tris-carboxylate complex, [Eu.L35]+)171 was shown 
to shift to lower frequency compared to the solvate species. These 1H NMR observations 
suggest that exchange between the Δ and Λ isomers is too fast to be observed on the NMR 
timescale. However, addition of a chiral additive stabilises one particular isomer 
accompanied by a sharpening and a shift in the proton resonances. 
 
Figure 62 – CPL spectrum of [Eu.L39]+ (λexc = 352 nm MeOH, 295 K), showing no significant signal. 
 
3.5.2. Induced CPL following binding of enantiopure acids 
The addition of enantiopure acids such as lactate, mandelate and 
cyclohexylhydroxyacetate, to the europium complexes of L37-40 resulted in distinct 
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alteration in the total emission spectrum, as discussed in section 3.4, as well as strong 
induced circularly polarised luminescence (Figure 63). The stability data estimated from 
total emission changes represents the weighted sum of all stereoisomeric anion adducts, 
irrespective of their constitution and configuration. As the addition of a given chiral anion 
induced a CPL response, a binding affinity can also be estimated by monitoring the 
change in gem with increasing concentration of anion. This estimated binding constant 
gives information regarding the stability of the major emissive chiral species in solution, 
i.e. Δ over Λ. The stability constant for the R-mandelate adduct of [Eu.L39]+ was estimated 
using this method, and gave a value of logK = 5.79 in pure methanol (Figure 64). This 
value compares to the value of logK = 5.44, based on the total emission spectral changes. 
The slightly higher stability constant estimated from the induced CPL spectral changes 
suggests that it was associated with the formation of the favoured isomer (vide infra: 
inducing a Δ configuration for addition of R-mandelate). Similar behaviour was observed 
for the other systems within this study. 
 
Figure 63 - Emission (left) and CPL (right) spectra of Eu (III) complexes L37-40 (top to bottom respectively), following 
the addition of R-cyclohexylhydroxyacetate (1:1 v/v aq. MeOH, 10 μM complex, 50 μM R-cyclohexylhydroxyacetate). 
0
0.5
1
1.5
2
2.5
570 620 670 720
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength / nm
0
10
20
30
40
50
60
70
80
90
100
570 590 610 630 650 670 690 710
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength / nm
0
10
20
30
40
50
60
70
80
570 620 670 720
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength / nm
0
5
10
15
20
25
30
570 620 670 720
R
e
la
ti
v
e
 I
n
te
n
s
it
y
Wavelength /nm -0.6
-0.5
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
0.5
570 620 670 720
I L
− 
I R
Wavelength / nm
-0.3
-0.25
-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
570 620 670 720
I L
−
 I
R
Wavelength / nm
-0.2
-0.15
-0.1
-0.05
0
0.05
0.1
0.15
0.2
570 620 670 720
I L
−
 I
R
Wavelength / nm
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
570 620 670 720
I L
−
 I
R
Wavelength / nm
CHAPTER THREE – INDUCED CPL FROM DYNAMICALLY RACEMIC EU (III) COMPLEXES 
97 
 
 
Figure 64 - Left: Variation of the ratio of two emission wavelengths vs. the concentration of mandelate; right: variation 
of the emission dissymmetry value gem at 592 nm vs. concentration of mandelate. Experimental data ﬁt to a 1:1 binding 
model following iterative least-squares ﬁtting. (λexc = 352 nm, 6 µM complex, MeOH). 
 
Separate addition of R or S enantiomers of a given chiral anion gave rise to mirror image 
induced circularly polarised luminescence spectra (Figure 65). Identical gem values were 
calculated for a given concentration of R- or S-anion, indicating that the strength of 
interaction and thus the induced CPL, is independent of the absolute configuration of the 
enantiomer. 
 
 
Figure 65 – Induced CPL spectra for [Eu.L39]+ following addition of R- (red) and S-mandelate (blue) (λexc = 352 nm, 
MeOH, 295 K). 
 
The CPL spectra following addition of enantiopure acids lacking a coordinating α-
substituent (e.g. S-ibuprofen, R-camphanic acid, R-phenylsuccinic acid and R-
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phenylpropionic acid) were particularly weak and less well-defined for the complexes 
[Eu.L38-40], consistent with their much weaker binding affinity (logK < 1.5). The CPL 
signature of the adduct of R-phenylpropionic acid and [Eu.L40]+ (Figure 66), was quite 
different to that with an α-hydroxy acid such as cyclohexylhydroxyacetic acid, most 
notably in the ΔJ = 1 and ΔJ = 2 transitions around 590 and 620 nm respectively. The 
difference in spectral form can be attributed to the 4-ring chelation mode of 
phenylpropionate, as opposed to the 5-ring chelation mode of the α-hydroxy acids. 
 
 
Figure 66 – CPL spectra of [Eu.L40]+ following addition of R-phenylpropionic acid (green) and R-
cyclohexylhydroxyacetic acid (red). (λexc = 348 nm, 2 mM anion, 5 µM complex, MeOH, 295 K). 
 
The induced emission dissymmetry values, gem, were smaller than those measured for the 
more conformationally rigid, tri-substituted 9-coordinate systems. These values are 
comparable to values observed in other Eu (III) systems, such as [Eu.(bda)2]
- and 
[Eu.(pda)2]
- reported by Iwamura,150,151 that demonstrate induced CPL on the addition of 
a small molecule chiral analyte. However a 20,000-fold lower concentration of the target 
anion is required to induce such a response for the complexes [Eu.L37-40] (50 µM). Of the 
four systems studied, the smallest induced gem values were measured for the bis-
phosphinate complex [Eu.L37]+ (Table 15). Observation of weaker CPL is consistent with 
the suggestion that in this complex, the added chiral anion binds via a 4-ring chelate 
through the carboxylate moiety, where the stereocentre is situated further from the metal 
centre compared to the alternative 5-ring binding mode. The N-benzyl complex, 
[Eu.L40]+, gave rise to the strongest CPL amongst the systems studied, for the simple 
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carboxylic acids. The spectra were well-defined, with highly resolved transitions and the 
calculated gem values were highest for 70% of the induced CPL transitions. 
 
Figure 67 – Mirror image CPL spectra of [Eu.L40]+ following the addition of R- (red) and S-lactate (blue). (λexc = 348 
nm, 10 µM complex, 50 µM lactate, MeOH, 295 K). 
 
Table 15 – Emission dissymmetry values, gem, for Eu (III) complexes in the presence of excess R-lactate, mandelate or 
cyclohexylhydroxyacetate. 
R-Lactate gem [Eu.L37]+ [Eu.L38]3+ [Eu.L39]+ [Eu.L40]+ 
      
J = 1 (592 nm) +0.01 -0.03 +0.02 +0.05 
 
J = 4 
 
 
(683 nm) 
(692 nm) 
(702 nm) 
(708 nm) 
+0.005 
+0.02 
-0.02 
-0.04 
+0.01 
+0.02 
-0.01 
-0.04 
+0.01 
+0.01 
-0.01 
-0.03 
+0.01 
+0.02 
-0.02 
-0.06 
R-Mandelate      
J = 1 (592 nm) +0.01 -0.05 +0.04 +0.05 
 
J = 4 
 
 
(683 nm) 
(692 nm) 
(702 nm) 
(708 nm) 
+0.01 
+0.02 
-0.03 
-0.09 
+0.01 
+0.02 
-0.01 
-0.05 
+0.01 
+0.03 
-0.03 
-0.06 
+0.01 
+0.03 
-0.02 
-0.09 
R-Cyclohexylhydroxyacetate      
J = 1 (592 nm) +0.02 -0.05 +0.07 +0.06 
 
J = 4 
 
 
(683 nm) 
(692 nm) 
(702 nm) 
(708 nm) 
+0.01 
+0.02 
-0.02 
-0.09 
+0.01 
+0.03 
-0.01 
-0.08 
+0.02 
+0.04 
-0.07 
-0.09 
+0.02 
+0.04 
-0.03 
-0.11 
-0.5
-0.4
-0.3
-0.2
-0.1
0
0.1
0.2
0.3
0.4
570 590 610 630 650 670 690 710
I L
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I R
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3.5.3. Spectral correlation with absolute configuration 
In Chapter 1, attempts were made to highlight the limited number of structural 
comparisons that have been linked to CPL spectral form. In Chapter 2, it was noted that 
it is not obvious to find correlations between helicity of the complex and the form and 
sign of each CPL active transition in systems based on different ligand frameworks, i.e. 
9-N3 tri-phosphinates versus tri-amides versus related 12-N4 complexes. This study has 
rigorously compared the CPL spectra of a number of related europium (III) complexes, 
following addition of R- and S-chiral acids. It can be seen that the R-α-hydroxy acids each 
gave rise to a common induced CPL signature in the ΔJ = 4 region, across the whole series 
of europium complexes involved in this study (Figure 68). This empirical observation 
could not be extended to analysis of every CPL transition, yet provides a simple CPL 
fingerprint in this ‘hypersensitive’ manifold. 
 
Figure 68 – Partial CPL spectra for Eu3+ complexes of L37-40, compared to Δ-[Eu.L31c]3+ (top), showing the similar ΔJ 
= 4 manifold in the presence of excess R-cyclohexylhydroxyacetate (H2O, 10 µM complex, 295 K). 
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The induced CPL for these adducts was compared to the spectral behaviour of related C3-
symmetric enantiopure 9-coordinate complexes, whose structure and absolute 
configuration has been determined by X-ray crystallography (Figure 69).100,155,162 A 
tentative correlation was found within a given series, allowing assignment of the R-acid 
adducts to a Δ complex configuration, with a λλλ configuration in the three EuNCCN 
chelates of the 9-membered macrocyclic ring. This surprising empirical observation 
therefore allows the absolute configuration of the lanthanide complex adduct of a given 
chiral acid to be distinguished simply by using CPL spectroscopy. 
 
 
Figure 69 – Structures of the related 9-N3 C3-symmetric parent complexes, where the absolute configuration was 
determined by X-ray crystallography.100,155,162 
 
3.5.4. Determination of enantiomeric purity 
The development of methods that aid the chiral analysis of a sample and allow for 
accurate determination of its enantiomeric purity is important. Preliminary work by 
McMahon investigated the use of [Eu.L37]+ in the determination of the enantiomeric 
purity of samples of lactate.15 The following study aims to expand on these preliminary 
findings and develop a quick and accurate method for use in the determination of the 
enantiomeric purity of samples of chiral anions of unknown composition.  
The bis-carboxylate complex [Eu.L39]+ was selected for use in this investigation, due to 
the lower steric demand surrounding the lanthanide centre compared to [Eu.L37]+. As 
discussed previously, this allows an α-hydroxy acid to bind via a 5-ring chelate in which 
the chiral centre is situated closer to the lanthanide core. As a result of the close proximity 
of the stereocentre, the measured gem values were found to be greater for [Eu.L39]
+ upon 
addition of selected chiral acids. The brightness of the probe was comparable to [Eu.L37]+ 
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allowing for good signal to noise in the recorded CPL spectra and therefore, an enhanced 
CPL response. 
Scalemic mixtures of predetermined enantiomeric composition of a given chiral acid, in 
this case mandelic acid, were analysed by the CPL output of [Eu.L39]+. A linear variation 
of gem with enantiomeric composition was observed allowing a calibration curve to be 
generated (Figure 70). After initial calibration, accurate determination of the enantiomeric 
excess of samples of mandelic acid with unknown composition was demonstrated. 
Inherently, this technique provides information about sample enantiomeric purity and 
absolute configuration. It is worth noting that this method can only be employed for chiral 
anions that bind directly to the metal centre and induce a CPL response.  
 
Figure 70 - Changes in the CPL spectrum of [Eu.L39]+ following addition of mandelate of varying enantiomeric 
composition (10 μM, λexc = 352 nm, MeOH). Inset (top) shows the ΔJ = 1 manifold; (bottom) variation of gem (592.5 nm) 
with % R-mandelate; error bars indicate the standard deviation averaged over 5 runs (R2 0.98 for shown linear fit). 
 
Figure 71 – Structures of the mandelate adducts of [Eu.L39]+. 
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3.6. Stereochemical analysis: DFT computational studies 
 
In order to gain further understanding of the structures of the isomeric complexes and 
their lactate adducts, hybrid-DFT calculations were performed with the help of Dr. Mark 
Fox. As paramagnetic Eu (III) complexes are very difficult to model computationally, 
optimised geometries of the analogous diamagnetic yttrium (III) complexes were 
investigated. Previous studies have shown that the corresponding yttrium (III) complexes 
act as suitable models for the Eu analogues,171,187–190 as the Y (III) ionic radius in 8 or 9 
coordinate complexes differs from that of a Eu (III) ion by only 0.05 Å. Excellent 
agreement was observed when comparing an Y (III) model geometry to a reported X-ray 
geometry of a related europium complex, [Eu.L30]3+, at B3LYP/3-21G*. The Y-O and Y-
N bond lengths were shorter by 0.05 Å on average compared to the corresponding Eu-O 
and Eu-N bonds, accounted for by the difference in ionic radii of the two lanthanide ions. 
 
 
Table 16 - Comparison of experimental and computed bond lengths in angstroms for the europium complex [Eu.L30]3+ 
(CSD refcode TITQAQ) and its model yttrium analogue, [Y.L30]3+, reflecting the difference in ionic radii of Eu (III) 
and Y(III). 
 X-ray 162  B3LYP/3-21G* Eu-Y difference 
Eu-N 2.628(2) Y-N 2.567 0.061 
Eu-N 2.573(2) Y-N 2.550 0.023 
Eu-O 2.405(2) Y-O 2.357 0.048 
 
Following the outcome of the emission studies that revealed the complex hydration state 
using radiative decay rate data (Table 12, page 86), an investigation into the binding of 
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one water molecule to each of the four complexes was undertaken. The calculated binding 
energies revealed a trend that was consistent with the observed radiative rate constants 
for decay of europium (III) emission. The sequence with increasing strength followed the 
order: [Y.L40]+ < [Y.L37]+ < [Y.L39]+ < [Y.L38]3+ (Table 17).  
The relative energies of free and water bound complexes of [Y.L40]+, did not account for 
the experimental q = 0 hydration state that was estimated, as the steric demand of the 
benzyl group did not appear to prevent water binding to the metal centre. An alternative 
explanation may be, that in the solution state, the rotation of the benzyl group restricts 
secondary stabilising H-bonding interactions with the network of second sphere water 
molecules, thus resulting in a higher energy for the water-bound europium (III) complex. 
 
Table 17 - Water binding energies of [Y.L37-40] and radiative rates of decay of the corresponding Eu (III) complexes. 
The trend reveals binding energies of increasing strength in the order [Y.L40]+ < [Y.L37]+ < [Y.L39]+ < [Y.L38]3+. 
 Water Binding Energy / kJ mol-1 k (H2O) / ms-1 
[Y.L37]+ 47.5 2.97 
[Y.L38]3+ 55.6 3.85 
[Y.L39]+ 50.8 3.70 
[Y.L40]+ 46.4 1.89 
 
A similar approach was taken in order to assess the trend in binding affinities of each of 
the four europium complexes with R-lactate. DFT calculations demonstrated that R-
lactate binds with increasing strength in the order: [Y.L37]+ < [Y.L40]+ < [Y.L39]+ < 
[Y.L38]+. This trend is consistent with the estimated binding affinities that were calculated 
from total emission spectral changes, where R-lactate was shown to bind most strongly 
to the europium complex with the greatest positive charge (Table 18). 
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Table 18 – R-lactate binding energies of [Y.L37-40] in the Δ conformation and estimated association constants of 
[Eu.L37-40]. The trend reveals binding energies of increasing strength in the order [Ln.L37]+ < [Ln.L40]+ < [Ln.L39]+ < 
[Ln.L38]+. 
 R-Lactate Binding Energy / kJ mol-1 
(calculated) 
LogK (lactate) 
(experimental) 
[Y.L37]+ 135.1 2.76 
[Y.L38]3+ 214.4 4.57  
[Y.L39]+ 164.0 4.01 
[Y.L40]+ 155.0 3.15 
 
It was interesting to note, that in the calculated geometries of the lactate-bound adduct of 
[Y.L37]+, the hydroxyl group of the coordinated lactate does not bind as strongly as in 
[Y.L38-40]. A longer Y-O distance of 2.7 Å was calculated, compared to the corresponding 
distances of 2.4-2.5 Å for complexes [Y.L38-40]. Close inspection of the optimised 
geometries of the R-lactate adducts of [Y.L37-40] revealed that the phosphinate groups in 
[Y.L37]+ are more sterically bulky than the corresponding carboxylate and amide donors 
in complexes [Y.L38-40], consistent with the X-ray crystal structures of the related 9-
coordinate parent structures. The increased steric demand around the metal centre results 
in less space for lactate binding via a 5-ring chelation mode. This interpretation lends 
support to the hypothesis that lactate coordinates to [Y.L37]+ via the carboxylate group in 
a 4-ring chelate, in agreement with the experimental radiative decay rate data. 
The constitution and relative configuration of the isomeric adducts with a given 
lanthanide complex are difficult to determine, without X-ray crystallographic data being 
available. Investigation of the optimised geometries of the four europium (III) complexes 
using 1H NMR spectroscopy and DFT calculations was undertaken. In principle, four 
isomeric species can result from the binding of enantiopure lactate to a europium 
complex. These isomers differ according to the orientation of the α-hydroxy chelate and 
also in the configuration of the lanthanide complex, Δ or Λ (Figure 73). 
1H NMR analyses in CD3OD (295 K, 11.7 T) of the solvate and lactate adducts of 
[Eu.L39]+ were compromised by considerable line broadening. Nevertheless, addition of 
R-lactate to [Eu.L39]+ led to a sharpening of the proton resonances and the appearance of 
four isomeric species for the most shifted ring proton, in the relative ratio 3:1:0.8:0.7 
(Figure 72).  
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Figure 72 – 1H NMR spectra of [Eu.L39(H2O)]+ (top) and [Eu.L39.R-lactate] (bottom) showing observation of four 
isomeric species in the ratio 3:1:0.8:0.7 (CD3OD, 295 K, 11.7 T). 
 
 
 
Figure 73 – Structures of the four isomeric species resulting from R-lactate chelation to [Eu.L39]+ and [Eu.L40]+; the 
bottom right (Δ) isomer was hypothesised to predominate in solution. 
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In an attempt to rationalise the preferred formation of a particular stereoisomer 
considering non-bonding steric interactions, calculations were performed to assess the 
relative energies of the four isomeric adducts, as their Y (III) complexes. For each Y (III) 
complex, the preferred orientation of the lactate chelate placed the lactate carboxylate in 
the same plane as the two pyridyl nitrogen atoms of the pendant arms. With this lactate 
constitution in place, the complex with Λ helicity was of higher energy due to 
unfavourable steric interactions between the lactate Me group and the oxygen lone pair 
of the ligand carboxylate donor (Figure 74). Therefore, the lowest energy isomer and the 
predominate isomer in solution was calculated to be R-Δ (Figure 73, bottom right). 
 
 
Figure 74 – Optimised geometries of Λ-[Y.L40.R-lactate] and Δ-[Y.L40.R-lactate] showing two views of each complex; 
the anisyl groups are omitted for clarity. In the Δ configuration, the methyl group is shown to point away from the 
coordinated carboxylate oxygen lone pair resulting in a less unfavourable steric interaction. Thus the Δ-isomer is the 
favoured geometry. 
 
The energy difference between the two lowest energy isomers increases in the order: 
[Y.L38]3+ < [Y.L39]+ < [Y.L37]+ < [Y.L40]+ (Table 19). This sequence accords with the 
observation that the N-benzyl complex, [Eu.L40]+, has the highest gem values for 70% of 
the induced CPL transitions compared to the other complexes in this study. A tentative 
assumption is that the N-benzyl group may align helically in the same sense as the two 
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coordinated pyridyl-carboxylate donors, creating a more rigidified local chiral structure 
around the lanthanide centre. 
 
Table 19 – Relative energies in kJ mol-1 of the four isomeric adducts, [Y.L.R-lactate]. 
 L37 L38 L39 L40 
Δ-Y.L-R-lactate [a] 0 0 0 0 
Λ-Y.L-R-lactate [a] 2.0 0.7 1.5 2.4 
Δ-Y.L-R-lactate [b] 19.5 25.3 27.0 30.3 
Λ-Y.L-R-lactate [b] 21.6 26.7 31.7 36.1 
[a] constitution of lactate chelate with lactate carboxylate in same plane as pyridyl N-atoms. [b] constitution of lactate 
chelate with lactate OH in same plane as pyridyl N-atoms. 
 
 
3.7. Conclusions 
 
A series of unsaturated Eu (III) complexes has been developed with attractive 
photophysical properties and anion binding capabilities.  The ability of the complexes 
[Eu.L37-40] to form ternary adducts with anions was first assessed by monitoring changes 
in the emission spectrum on increasing the concentration of added anion. The overall 
binding affinities were estimated and the strongest binding was observed with the tri-
positively charged bis-amide complex [Eu.L38]+. This observation was accounted for in 
terms of a simple electrostatic effect. The overall trend in binding affinities was 
corroborated by hybrid-DFT calculations of the energies of optimised geometries of the 
lactate-adducts. 
The mode of binding of α-hydroxy acids (lactate, mandelate and 
cyclohexylhydroxyacetate) with the four europium complexes [Eu.L37-40] was 
investigated by examining radiative rates of decay for Eu3+ emission in H2O and D2O. 
The results revealed that the α-hydroxy anion was able to bind to the complexes in two 
different chelation modes. For the complexes [Eu.L38-40], the anion was bound to the 
metal centre via a 5-ring chelate, with an OH oscillator in the Eu3+ inner coordination 
sphere. In the case of [Eu.L37]+, the anion was bound to the lanthanide centre via the 
carboxylate group in a 4-ring chelate. This result was further supported by inspection of 
the calculated DFT geometries which revealed significant steric hindrance at the 
lanthanide centre from the more sterically bulky phosphinate groups, compared to the 
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carboxylate and amide donors. This increase in steric bulk inhibits binding of the acid to 
the metal centre in a 5-ring chelate.    
The utility of such complexes in chiral detection has also been demonstrated and a full 
investigation of the induced CPL of the complexes on addition of selected chiral anions 
was undertaken. The CPL experiments established the use of these europium complexes 
in generating signature or ‘fingerprint’ induced CPL spectra, depending on the nature of 
the chiral analyte. The studies provided further information about the stereochemical 
structure of the resulting complex adduct. A common pattern emerged: an R acid 
configuration favours formation of a Δ complex and leads to a strong induced CPL signal. 
More importantly, empirical analysis of the ΔJ = 4 manifold, allowed assignment of 
absolute configuration. NMR and DFT studies offered some evidence supporting this 
analysis: a preferred stereoisomer was observed (R-Δ and S-Λ), albeit lacking the high 
stereoselectivity and larger gem associated with the more conformationally rigid tri-
substituted 9-coordinate complexes.154,162,171  
The substitution of the third N position on the macrocyclic ring plays a key role. The N-
benzyl complex exhibited the strongest, most well-defined induced circularly polarised 
luminescence, with the highest gem values for 70% of the CPL-active transitions. This 
chiral amplification may result from the cooperative helical alignment of the N-benzyl 
group in the same sense as the two pyridyl pendant arms, creating a more rigid chiral 
structure. 
The work detailed in this chapter has highlighted the key factors that allow us to select a 
suitable complex that can be used as a successful chirality probe. The complex must be 
able to bind to anions with strong affinity. Of the four europium (III) complexes studied, 
the highest binding affinity was observed for the bis-amide complex [Eu.L38]3+. However, 
the poor quantum yield and complex instability with respect to dissociation limits the use 
of this complex as a CPL probe. The bis-carboxylate, [Eu.L39]+, and bis-phosphinate 
complexes, [Eu.L37]+, are bright with high quantum yields. Of these two complexes, the 
bis-carboxylate is able to bind to anions most strongly, with enhanced affinity and CPL 
activity, due to the lack of unfavourable steric interactions imposed on the lanthanide 
centre by the carboxylate donors. A final iteration of the bis-carboxylate complex, 
[Eu.L39]+, via alkylation of the free macrocyclic NH, gave the complex [Eu.L40]+, 
resulting in a chiral amplification effect and enhanced induced CPL. 
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This work provides a starting point for developing enhanced selectivity in the association 
of the chiral analyte. For example, based on the N-benzyl system, introduction of charged 
and directed hydrogen bonding or chelating moieties, e.g. NH2Me
+ or a boronic acid 
group, into the benzyl ring, may allow additional stabilising interactions to occur that can 
enhance affinity and selectivity. The outcome of such work is reported in Chapter 4. 
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4.1. Introduction 
 
In Chapter 3, the mechanism of inducing CPL from dynamically racemic lanthanide 
complexes was discussed, following the binding of a chiral anion directly to the metal 
centre. Enhancing the selectivity for a particular anion can be achieved in a number of 
ways.5 When considering direct binding of an anion to a metal centre via displacement of 
a bound water molecule, incorporation of a moiety that can provide secondary stabilising 
interactions, such as directed hydrogen bonding, can significantly enhance affinity for a 
particular anion. In devising an appropriate synthetic receptor, it is a challenge to develop 
a system that is sufficiently selective for the chosen anion over other competing species, 
to serve as an analytical probe. 
Sialic acid (Neu-5-Ac) is an important biomolecule belonging to the family of 9-carbon 
amino sugars (neuraminic acids). Sialic acid is present in serum as a mixture of α- (5-8%) 
and β-pyranose (92-95%) forms; the absence of the furanose form can be attributed to the 
acetamide moiety that is present at the C-5 position. Sialic acid can also be found 
occupying the terminal positions of carbohydrate chains of glycoproteins and glycolipids 
of biological membranes. It has a biological importance as it is over-expressed on the 
surface of tumour cells191,192 and the variation of its concentration in serum can serve as 
a useful biological marker, indicating the existence of a cancerous state.193  
 
Figure 75 – Structure of sialic acid (Neu-5-Ac) showing the α- and β-pyranose forms, pKa = 2.6 (H2O, I = 0.1, 298K). 
 
A number of lanthanide probes have been reported that target sialic acid selectively and 
signal the detection using MRI194–196 and emission based techniques.197,198 Of particular 
importance is the use of a boronic acid moiety in the selective binding of a diol 
functionality. The reversible formation of five- and six-membered cyclic boronate esters 
results from the interaction with 1,2- and 1,3-diols, and has been extensively exploited in 
the design of various saccharide sensors.199 The incorporation of a phenylboronic acid 
(pba) moiety into the ligand framework of a lanthanide complex has also demonstrated 
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the utility of this moiety in the dynamic covalent binding to the 1,2-diol or the α-hydroxy 
acid group of sialic acid.196,197  
Based on the study of four europium (III) complexes incorporating various ligand 
frameworks, [Eu.L37-40], discussed in Chapter 3, a bis-carboxylate complex was selected 
for application as a chiral probe. The complexes [Eu.L39]+ and [Eu.L40]+ exhibited high 
quantum yield values, anion binding capability and gave rise to strong induced CPL 
following the addition of a chiral analyte. A heptadentate Eu (III) complex based on the 
bis-carboxylate ligand structure containing a pba moiety, [Eu.L41]+, has been designed to 
target sialic acid selectively. Exploiting the inherent chirality of the molecule, binding at 
europium was hypothesised to result in a change in the emission spectral form and 
generate an induced CPL signal. The response of the complex is compared to the bis-
carboxylate complex, [Eu.L39]+, and the N-alkylated derivative, [Eu.L40]+, which serve as 
controls. 
 
Figure 76 - Structures of Eu (III) complexes of L39-41. 
 
Another class of important biologically relevant chiral anions is the family of pentavalent 
phosphorus anions, including O-phosphorylated amino acids and peptides. These O-P-
amino acids and peptides, are perhaps some of the most important anionic species in 
nature, and are involved in the control of many cellular processes, such as, differentiation, 
development and proliferation.200 The first reports of the sensing of such anions using a 
chiral lanthanide complex121 were discussed in detail in Chapter 1, Section 1.4.2.1. These 
initial studies reported that there was a change in the emission and CPL spectral form 
following addition of the selected phosphate anion. A higher binding affinity was 
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estimated for O-P-Tyr, compared to O-P-Ser and O-P-Thr, associated with its lower 
solvation energy in aqueous media. 
 
Figure 77 – Structure of Eu (III) salophene complex (left) and oleoyl-L-α-lysophosphatidic acid (LPA) (right). 
 
A related chiral pentavalent phosphorus anion of interest is oleoyl-L-α-lysophosphatidic 
acid (LPA). Perhaps one of the simplest phospholipids, recent studies have demonstrated 
the presence of increased LPA levels in malignant effusions in patients with cancer, most 
specifically in ovarian cancer.201 Therefore, a specific and quantitative method for the 
detection of LPA in clinical samples is required. Some efforts towards achieving this goal 
have been reported, based on organic and lanthanide-based fluorogenic sensors.202–204 
LPA is apparently thought to bind selectively in methanolic extracts of human plasma 
samples by a europium (III) salophene complex, Figure 77, indicated by an increase in 
the total fluorescence intensity, although it is difficult to understand the chemical basis 
for this selective binding behaviour.204 
A europium heptadentate complex has been designed, employing a charged amino group, 
NH2Me
+, in order to enhance the binding of important chiral phosphorus anions 
selectively, including O-P-amino acids, O-P-peptides and LPA. Accordingly, this 
complex was synthesised and changes in the emission spectral form and the induced 
‘fingerprint’ CPL response were investigated following chiral anion binding. 
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Figure 78 – Structure of the europium (III) complex of L42 containing a charged amino group. 
 
4.2. Synthetic approaches 
 
4.2.1. Synthesis of [Eu.L41]+ 
A phenylboronic acid moiety was appended to the desired ligand framework, L39, via ring 
N-alkylation. Initial protection of the boronic acid group as a cyclic ester was achieved, 
to facilitate purification at a later stage. Boronic esters are less polar and easier to handle 
than the acids, due to the loss of the hydrogen bonding capability of the hydroxyl groups. 
The simple cyclic ester, based on ethylene glycol, was selected as the protecting group. 
Although sensitive to hydrolysis, the boronic ester was considered to be sufficiently stable 
to allow purification using column chromatography, under carefully controlled 
conditions. Subsequent removal of the ester group can be easily achieved using mild base 
hydrolysis. The use of more stable hindered cyclic esters, such as a pinacol derivative was 
avoided, as its conversion back to the boronic acid requires more forcing conditions that 
are not compatible with the presence of other groups in the ligand framework, such as the 
acid-sensitive alkyne. 
 Reaction of commercially available 3-(bromomethyl)phenylboronic acid with ethylene 
glycol in anhydrous pentane over 4 Å molecular sieves, yielded the protected 
phenylboronate in good yield. Subsequent alkylation with L39 gave the ligand L41, which 
was purified using flash column chromatography on silica gel. The presence of the 
boronic ester moiety was confirmed by the observation of a single resonance in the 11B 
NMR spectrum at 31.3 ppm. 
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Scheme 21 – Synthesis of the Eu (III) complex of L41 containing a phenylboronic acid moiety. 
 
Base hydrolysis of both the methyl ester and the cyclic boronic ester groups was carried 
out using NaOH (aq.) in a MeOH-H2O mixture (1:1, v/v) at pH 12. After confirmation of 
completion by LC-MS, the pH of the solution was lowered to 6.5 and EuCl3.6H2O was 
added. Successful formation of the complex after 24 h was confirmed by ESI-MS. 
 
4.2.2. Synthesis of [Eu.L42]2+ and its precursors 
It was necessary first to synthesise an aromatic precursor containing a charged amino 
group that also contains an electrophilic benzylic substituent at the meta position for the 
alkylation step. An N-methylbenzylamine group was selected, as it has an appropriate pKa 
value (~9.7), ensuring that it is positively charged at the desired pH (7.4), is not too 
sterically bulky, and offers scope for stabilising hydrogen-bonding interactions. 
The synthetic pathway (Scheme 22) began with the formation of the mono-amide, 6b, 
from mono-methyl isophthalate via the acid chloride. Reaction of 6a with oxalyl chloride 
and catalytic DMF furnished the acid chloride, followed by addition of methylamine to 
generate the amide, 6b. Simultaneous reduction of the amide and ester groups using 
LiAlH4 in THF gave the amino-alcohol 6c. A high yield was achieved by using the ‘Fieser 
work-up’ procedure, which involved careful addition of x H2O at 0 ºC, followed by x 
NaOH (15%) and finally 3x H2O. The granular aluminium salts that formed were easily 
removed by filtration. Protection of the amine with a formamide group was achieved 
using 2,2,2-trifluoroethyl formate (TFEF). This protecting group was selected as it can be 
removed under basic conditions. Therefore, deprotection can occur at the same time as 
hydrolysis of the methyl ester groups of the ligand. The final step in the synthesis of the 
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precursor was conversion of the alcohol, 6d, to the mesylate, 6e, under standard 
conditions.  
 
 
Scheme 22 – Synthetic pathway for the synthesis of the mesylate 6e. 
 
Alkylation of L39 with the mesylate 6e, gave the ligand pre-L42, after purification by flash 
column chromatography. Deprotection of the formamide protecting group and the methyl 
ester groups was attempted using NaOH in a MeOH-H2O mixture (1:1, v/v). The reaction 
was monitored by LC-MS, which showed that incomplete deprotection of the amine was 
observed after 48 h. The two products (protected and deprotected) were separated by 
reverse-phase HPLC (10-100% MeOH (0.1% formic acid) in H2O (0.1% formic acid) 
over 15 minutes). The ligand was passed down an ion exchange resin to remove the 
presence of any formate salts. The ligand, L42, was dissolved in MeOH-H2O (1:1, v/v) at 
pH 6.5 and EuCl3.6H2O was added to give the complex [Eu.L42]Cl2. 
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Scheme 23 – Synthesis of [Eu.L42]2+ via an alkylation strategy. 
 
4.3. A chiral probe for sialic acid 
 
The photophysical properties of the boronic acid derivative [Eu.L41]+ were assessed in 
comparison to those determined for the N-benzyl complex [Eu.L40]+. The capability of 
the complex to bind anions was tested using lactate in a model study, and the induced 
CPL was correlated to the configuration of the complex using the methods described in 
Chapter 3. The binding affinity of sialic acid was estimated and the emission spectral 
changes and induced CPL signature were compared to [Eu.L39]+ and [Eu.L40]+. 
Investigation into the mode of binding of sialic acid was attempted, by comparison of the 
spectral response with that observed following addition of the methyl-ester derivative of 
Neu-5-Ac. 
 
4.3.1. Photophysical properties of [Eu.L41]+ 
The key photophysical parameters for [Eu.L41]+ were determined and compared to those 
of the related complex, [Eu.L40]+ (Table 20). The hydration state in water of the title 
complex, [Eu.L41]+, was estimated to be q = 0.2, as defined in equation 2.3, page 67.117 
The absence of an inner sphere metal-bound water molecule is consistent with the 
behaviour of the N-benzyl complex, [Eu.L40]+. This observation provides supporting 
evidence that the steric bulk of the N-substituent inhibits coordination of a water molecule 
to the lanthanide centre.  
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The europium emission quantum yield of the boronic acid complex, [Eu.L41]+, was 
measured to be 5%, which is significantly lower than that of the N-benzyl complex, 
[Eu.L40]+ (Table 20). Secondly, the radiative rate of decay of Eu3+ emission in methanol 
was nearly twice as fast for [Eu.L41]+ compared to [Eu.L40]+.  Such behaviour suggests 
that the europium (III) excited state of [Eu.L41]+ is being quenched, in a manner that is 
not possible for [Eu.L40]+.  
 
Table 20 – Photophysical properties of the Eu (III) complexes of L40,41 (295 K, MeOH, selected emission decay rate 
constants given in H2O and D2O). Values of ɸ are (±15%) and the errors on k are (±10%). 
 [Eu.L40]+ [Eu.L41]+ 
λ/nm 348 356 
ε/mM-1 cm-1 36.0 35.0 
ɸ 0.18 0.05 
k/ms-1 1.20 2.04 
k(H2O)/ms-1 2.00 2.63 
k(D2O)/ms-1 1.89 2.17 
q 0 0.2 
 
It is possible for boronic acid compounds to undergo intermolecular association (e.g. 
dimer formation, as shown in the X-ray crystal structure of phenylboronic acid)205 
through hydrogen bonding between the boronic acid groups. However, this interaction is 
typically only observed in the solid state or in non-polar media. A dilution study was 
carried out in MeOH-H2O (1:1, v/v) at pH 7.4. The luminescent lifetime of the excited 
state was monitored as the concentration was successively lowered from 5 µM to 0.63 
µM, at which point the sample was too dilute to obtain reliable results. No significant 
change in the emission lifetime was observed, suggesting that an intermolecular 
association mechanism does not occur over this concentration range.  It is more likely 
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that the excited state of [Eu.L41]+  may undergo an electron transfer quenching process. 
Due the acidic nature of phenylboronic acid in aqueous solution, the trivalent neutral form 
is in equilibrium with the anionic tetrahedral intermediate (pKa 8.7), Figure 79.
206 The 
presence of this anionic intermediate, even at low concentration at physiological pH, may 
be the cause of the observed quenching (electron transfer) of the europium (III) excited 
state. It is also worth noting that no oxygen/air effect on the luminescent excited state 
lifetime was observed. 
 
Figure 79 – Ionisation equilibrium of phenylboronic acid in solution. 
 
4.3.2. Preliminary investigations into interactions with anions 
As was shown in Chapter 3, the europium emission spectrum is particularly sensitive to 
the metal coordination environment. The addition of lactate to a series of structurally 
related Eu (III) complexes ([Eu.L37-40]) was found to cause significant changes in the total 
emission spectral response, consistent with anion binding at the metal centre. With this 
behaviour in mind, the emission spectrum of [Eu.L41]+  was monitored following addition 
of S-lactate (Figure 80). A ten-fold enhancement in the total luminescence intensity was 
observed, following addition of a 4,000-fold excess of S-lactate. The excited state lifetime 
was also found to increase from 0.49 ms to 0.64 ms. The increase in emission intensity 
and emission lifetime indicated that anion binding to the metal centre, at least in part, 
inhibits the quenching mechanism taking place. Lactate can bind to the boronate through 
the carboxylate and hydroxyl group to form a 5-membered chelate,207 as well as to the 
lanthanide centre, consistent with the idea that the electron transfer quenching process 
that may be occurring in the complex, is not possible when lactate binds.  
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Figure 80 – Total emission spectra of [Eu.L41]+ (blue) and following addition of 2 mM S-lactate (red) (5 µM complex, 
λexc = 356 nm, MeOH, 295 K). 
 
The addition of R- and S-lactate to the europium complex, [Eu.L41]+, resulted in the 
appearance of CPL, identical in nature to that of [Eu.L40]+, Figure 81. The sign and form 
of each transition was the same and the measured emission dissymmetry values, gem, were 
comparable. Empirical analysis of the ΔJ = 4 transition allowed assignment of the 
absolute configuration of the complex, as discussed in Chapter 3, where addition of R-
lactate was shown to result in Δ helicity, and S-lactate gives Λ helicity. 
 
Figure 81 – Induced CPL spectra of [Eu.L41]+ following the addition of 2 mM R- (red) and S-lactate (blue); gem(593 
nm) = ± 0.05, gem(654 nm) = ± 0.07 (5 µM complex, λexc = 356 nm, MeOH, 295 K). 
The emission and CPL response of [Eu.L41]+ on addition of a chiral anion, such as lactate, 
demonstrates that anion binding at the metal centre can occur in a similar manner to that 
observed for [Eu.L37-40] (Chapter 3). 
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4.3.3. Investigations into the binding affinity of sialic acid 
Sialic acid is an important biomolecule that is considered to be a tumour marker, as it is 
overexpressed on the surface of tumour cells. Moreover, the level of free sialic acid in 
serum is altered upon entering a cancerous state. Typical concentrations in healthy adults 
of free sialic acid in serum lie in the range of 140 – 200 µM.208 
The interaction of sialic acid with the parent bis-carboxylate europium (III) complex, 
[Eu.L39]+ was investigated. An emission titration was carried out in methanol and the 
spectral changes were monitored as a function of added concentration of sialic acid. A 
binding affinity in methanol of logK = 5.24 was estimated, which demonstrates that there 
is a significant interaction between the complex and the Neu-5-Ac anion in methanol 
(Figure 82). No significant interaction was observed in pure water; presumably the 
solvation energy of the complex and sialic acid are much higher under these conditions. 
 
 
Figure 82 – Variation of the europium (III) emission profile of [Eu.L39]+ as a function of added sialic acid. (5 µM, λexc 
= 352 nm, MeOH). Inset shows the fit to experimental data, following iterative least squares fitting to a 1:1 binding 
model. 
 
The addition of sialic acid to [Eu.L39]+ also induced significant CPL. It was interesting to 
note that the form of the CPL spectrum, particularly in the ΔJ = 1 and ΔJ = 2 manifolds, 
was remarkably different to that seen following addition of simple carboxylates such as 
R-phenylpropionate, and also in the series of α-hydroxy acids that were discussed in 
Chapter 3 (Figure 83). The ‘signature’ CPL response may allow simple differentiation 
between the detection of sialic acid and other chiral carboxylate anions in a competitive 
environment. It is worth noting, however, that the ΔJ = 4 region again resembles that of 
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the R-lactate adduct of [Eu.L39]+ allowing tentative assignment of the complex adduct 
configuration as Δ-[Eu.L39.Neu-5-Ac]. 
 
Figure 83 – CPL spectra of [Eu.L39]+ following addition of R-lactate (left) and sialic acid (right). (5 µM complex, 50 
µM anion, λexc = 352 nm, MeOH). 
 
This proof of concept study demonstrated the capability of lanthanide complexes based 
on a heptadentate bis-carboxylate ligand, to signal the binding of sialic acid. Further 
development of this probe saw the incorporation of a phenylboronic acid moiety into the 
ligand framework, [Eu.L41]+. Phenylboronic acid is a weak acid (pKa = 8.72) that is able 
to bind covalently and reversibly to 1,2-diols,206 such as the glycerol side-chain of sialic 
acid, and to α-hydroxy acids.207 The stability of the esters formed by the tetragonal 
boronate anion is an order of magnitude greater than for the trigonal boronic acid.209 
Therefore, enhanced affinity is observed under basic conditions. It was hoped that the 
addition of this secondary stabilising interaction would enhance the affinity of the 
complex for sialic acid and allow for detection in aqueous solvent systems. 
An emission titration of [Eu.L41]+ and sialic acid in methanol was carried out to allow 
comparison with [Eu.L39]+. Plotting the change in ΔJ = 2 and ΔJ = 1 intensities versus 
concentration of anion generated a curve that did not fit to a 1:1 binding model (Figure 
84). The plot revealed that an initial process occurs before 1:1 binding between the anion 
and the lanthanide ion. It is worth noting that significant changes in the emission spectrum 
were observed at a 3-fold lower concentration of sialic acid, compared to the response 
observed for [Eu.L39]+, suggesting that the addition of a phenylboronic acid moiety 
increases the affinity of the europium (III) complex for sialic acid. It is also interesting to 
note that there was no evidence of sialic acid binding to the control N-benzyl complex, 
[Eu.L40]+, indicating the need for the putative stabilising interaction. 
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Figure 84 - Variation of the europium (III) emission profile of [Eu.L41]+ as a function of added sialic acid. (5 µM, λexc 
= 356 nm, MeOH).  
 
The europium (III) total emission studies have confirmed that there is a binding 
interaction between the parent complex, [Eu.L39]+, and sialic acid. No binding affinity 
was observed for the N-benzyl complex, [Eu.L40]+, most likely as a result of the increased 
steric demand around the metal centre. Interestingly, the addition of a boronic acid group 
to the aromatic ring of the N-benzyl complex, [Eu.L41]+, provided an additional stabilising 
interaction that allowed sialic acid to bind to the europium (III) complex, despite the steric 
hindrance imposed by the benzyl substituent. 
The sign of the induced CPL in the ΔJ = 1 manifold was comparable to that for [Eu.L39]+ 
following addition of sialic acid. However, very little optical activity was observed in the 
ΔJ = 3 and ΔJ = 4 transitions. The difference in the CPL spectral form, suggests that a 
different coordination environment is present in each complex. The emission 
dissymmetry values, gem, were larger for [Eu.L41.Neu-5-Ac] (gem (593 nm) = +0.03, c.f. 
+0.015 for [Eu.L39.Neu-5-Ac]), suggesting that enhanced binding affinity and a higher 
degree of conformational rigidity occurs when sialic acid binds to the metal centre in the 
boronate complex, [Eu.L41]+. Such behaviour may be due to an additional interaction with 
the boronic acid group in the adduct. 
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Figure 85 - CPL spectra of [Eu.L41]+ following addition of sialic acid (5 µM complex, 50 µM anion, λexc = 356 nm, 
MeOH). 
 
No evidence for binding was observed in pure water over the pH range 4-10 for [Eu.L41]+. 
This behaviour could be related to the conformation adopted by sialic acid in different 
solvents. 1H NMR spectra of sialic acid in MeOD and D2O were analysed at a pD of 5.5. 
However, no significant differences were observed between the NMR spectra in each 
solvent, suggesting a minimal difference in the conformation of sialic acid.  
It is still possible that the difference in binding affinity of sialic acid in the two solvent 
systems is a direct result of the difference in solvation energy. There are five hydroxyl 
groups present in the molecule, so hydration of the anion in water is likely to be very high 
and may explain the low affinity it has for the positively charged lanthanide complex in 
aqueous solution. Systematic variation of the solvent composition and the effect on the 
emission spectral output was monitored. It was found that significant change in form and 
intensity was observed when 2 mM sialic acid was added to 1 mL 4:1 MeOH:H2O sample 
of [Eu.L41]+. However, increasing the water composition any higher, resulted in no 
evidence for binding of the anion to the metal centre. The poor aqueous solubility of the 
complex is also a key factor contributing to the decreased affinity for sialic acid in these 
aqueous systems. 
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4.3.4. Investigating the mode of binding of sialic acid 
The mode of binding of sialic acid to the europium (III) complexes, [Eu.L39,41]+, was 
investigated by a comparative study of the induced CPL following addition of sialic acid, 
its methyl ester derivative and the related molecule N-acetyl-D-glucosamine (Figure 86). 
 
Figure 86 – Structures of sialic acid (left), the corresponding methyl ester (middle) and N-acetyl-D-glucosamine (right). 
 
The form and sign of the CPL spectra of [Eu.L39]+ following addition of sialic acid and 
its methyl ester derivative was similar, strongly suggesting that the negatively charged 
carboxylate group of Neu-5-Ac is not involved in the primary binding interaction (Figure 
88, A versus B). Methyl ester carbonyl groups are very poor donors to any Ln3+ ion, as 
shown by the addition of methyl-L-lactate to the complexes [Eu.L37-41], which all showed 
no evidence of binding to the methyl ester.  Therefore, an alternative mechanism for the 
recognition of sialic acid must be considered, based primarily on binding of the acetamide 
oxygen within the inner coordination sphere of the lanthanide complex. Such a binding 
mode was hypothesised recently in the work of Ouchi, who was studying sialic acid 
binding to a [Ln.(ABNOTA] complex (Figure 87).198 However, addition of N-acetyl-D-
glucosamine, a monosaccharide containing the same acetamide moiety, resulted in no 
change to the total emission spectrum and no induced CPL, indicating that other groups 
in the Neu-5-Ac molecule must also be involved in the binding mechanism. 
 
 
Figure 87 – Structure of Ln3+ [Ln.ABNOTA] complex.198 
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Figure 88 – Induced CPL spectra for [Eu.L39]+ following the addition of A: 2 mM sialic acid; B: 2 mM sialic acid 
methyl ester (MeOH, λexc = 352 nm, 295 K). Induced CPL spectra for [Eu.L40]+ following the addition of C: 2 mM 
sialic acid; D: 2 mM sialic acid methyl ester (MeOH, λexc = 356 nm, 295 K). gem values are given for the same ΔJ = 1 
transition at 593 nm. 
 
In contrast to the behaviour of [Eu.L39]+, the induced CPL spectra of [Eu.L41]+ were 
significantly different following addition of sialic acid versus its methyl ester (Figure 88, 
C versus D). Subtle differences in the form of the total emission spectra, particularly in 
the ΔJ = 1 and ΔJ = 4 transition, were also observed. Such behaviour suggests that the 
carboxylate group may yet be involved in some manner, in the interaction between sialic 
acid and the europium (III) complex, but not through direct binding to the lanthanide (III) 
centre. 
In related work on a Gd-based MRI contrast agent for sialic acid detection, lanthanide 
complexes based on diethylenetriamine pentaacetic acid (DTPA) ligands incorporating a 
phenylboronic acid moiety were also used, L43 and L44 (Figure 89).194 The authors 
suggested that the interaction between pba and sialic acid occurred either with the 
glycerine moiety at C-6, or with the carboxylate and hydroxyl group at C-2, to form a 
five-membered cyclic ester. They did not consider any role for the amide carbonyl group 
in binding to the Gd3+ centre, nor was any direct evidence provided to substantiate their 
hypothesis. 
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Figure 89 – DTPA-bis amide (DTPA – diethylenetriamine pentaacetic acid) ligands used in Gd-based MRI contrast 
agents for sialic acid detection.194 
 
The study in this thesis has presented the first example of induced CPL for sialic acid 
recognition. Evidence gathered from the induced CPL response of the pba-europium (III) 
complex [Eu.L41]+ following addition of sialic acid, its methyl ester derivative and NAG, 
allows us to hypothesise that there is a synergistic interaction involved in the binding 
mechanism of the europium complex and sialic acid. It is likely that this interaction 
involves the carboxylate group, perhaps in the formation of a cyclic ester with the boronic 
acid, together with an additional interaction involving metal chelation of the amide 
carbonyl oxygen and the first hydroxyl group of the glycerol side chain. There is 
precedence for this hypothesis, derived from the crystal structure data of sialic acid 
located in the active site of the serum protein complement factor H, in which the 
potentially favourable orientation for chelation of the amide carbonyl oxygen and the first 
glycerol hydroxyl group is suggested (Figure 90).210  
 
Figure 90 – The sialic acid binding site of the serum protein complement factor H, showing the orientation of the amide 
carbonyl oxygen and the first glycerol hydroxyl group.210 
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With the methyl ester of sialic acid, the carbonyl group cannot engage in such a secondary 
interaction with the boronic acid and so the coordination geometry around the metal 
centre is different. As a result, the induced CPL response is distinctive in form and sign, 
comparing the two chiral analytes. As the solubility and weak binding affinity prevented 
studies in an aqueous solvent environment, the pH effect on the mechanism of binding 
could not be investigated.  
Taken together, these results have allowed for the development of a tentative hypothesis 
for the binding mode of sialic acid in both of these complexes [Eu.L39]+ and [Eu.L41]
+. 
However, further evidence is required to gain a more in-depth understanding of how these 
complexes interact with this important chiral biomolecule. For example, the investigation 
in the difference in NMR relaxation rate data between the Eu3+ and Tb3+ complexes with 
a 13C labelled amide carbonyl group, would help elucidate if this group is bound to the 
lanthanide centre. Hybrid-DFT calculations of the lowest energy conformers may also 
provide further evidence regarding the nature of the bound species. 
4.4. A chiral probe for O-phosphorus oxy-anions 
 
Significant progress has been made over the last ten years in the design of lanthanide-
based probes for phosphate oxy-anions.5 Phosphate is considered to bind to the lanthanide 
centre in a monodentate manner, through the negatively charged oxygen atom. This 
hypothesis is based on the analysis of rate data of 12-N4 systems (which are less sterically 
demanding than the 9-N3 systems) where phosphate was confirmed to bind in this 
way.115,118 The data is in line with the established tendency of phosphate to act as a 
monodentate ligand to single metal centres (Na+, Ca2+, Zn2+).211,212 
This section presents a novel dynamically racemic chirality probe, [Eu.L42]2+, that can 
bind to chiral O-phosphorus anions, and signal the binding of the analyte via the induction 
of circularly polarised luminescence. 
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4.4.1. Photophysical characterisation of [Eu.L42]2+ 
A number of photophysical techniques were used to characterise the complex [Eu.L42]2+ 
and the data was compared to the control N-benzyl complex, [Eu.L40]+. The hydration 
state of the complex could not be determined using the methodology outlined in Section 
2.5.1.2. of Chapter 2, as the complex was not fully soluble in H2O and the emission 
intensity was dramatically quenched. Therefore, in order to get an understanding of the 
number of metal bound water molecules, the rate of radiative decay of europium (III) 
emission was determined in methanol and d4-methanol. The derivation of the hydration 
state, q, was estimated using equation 2.3, page 67. The number of metal-bound solvent 
molecules was estimated as zero, consistent with the data obtained for the other N-
alkylated europium (III) complexes presented in this chapter, [Eu.L40,41]+. 
The experimentally determined data in methanol for the emission quantum yield, ɸ, the 
extinction coefficient, ε, and the maximum absorbance wavelength, λ, is given in Table 
21. The related experimental data of the control complex, [Eu.L40]+ is given as a reference 
and no anomalous results were noted. 
Table 21 - Photophysical properties of the Eu (III) complexes of L40,42 (295 K, MeOH). 
 [Eu.L40]+ [Eu.L42]2+ 
λ/nm 348 352 
ε/mM-1 cm-1 36.0 35.0 
ɸ 0.18 0.18 
k(MeOH)/ms-1 0.83 0.77 
k(MeOD)/ms-1 - 1.01 
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Purification of the complex using HPLC, with formic acid as an additive in the solvent 
system, can result in the formation of a formate-adduct. Removal of the formate anion 
was attempted using ion exchange resin. The emission spectral form is comparable to that 
of [Eu.L40]+, allowing confident assignment of the complex as the chloride salt, 
[Eu.L42]Cl2, with no evidence supporting the presence of a formate-adduct (Figure 91).  
 
Figure 91 – Total emission spectra of europium (III) N-benzyl complex [Eu.L40]+ (left) and europium (III) complex 
containing a charged amino group [Eu.L42]2+ (right) showing comparable emission spectral form. (MeOH-H2O 1:1, 
‘pH’ 7.4, 295 K). 
 
4.4.2. Investigation into the anion binding capability of [Eu.L42]2+ 
Previous work has demonstrated the utility of this class of heptadentate europium (III) 
complexes to bind to a number of different anions. A charged amino group (at 
physiological pH) was introduced into the ligand structure, in order to enhance the affinity 
of the complex for anions, via electrostatic interactions, and also to provide the 
opportunity for intermolecular H-bonding interactions. 
It was surprising to note, that no well-defined changes in the total emission spectrum were 
observed on the sequential addition of bicarbonate (HCO3
-), indicating that the anion is 
not binding to the lanthanide centre. However, significant changes in the emission 
spectrum of [Eu.L42]2+ were observed on the addition of R-lactate, Figure 92, 
characteristic of the changes observed for N-alkylated bis-carboxylate europium 
complexes, following addition of α-hydroxy acids. This behaviour allowed a stability 
constant, logK = 4.37, to be estimated using the methodology outlined in Chapter 3, by 
plotting the change in the intensity of the ΔJ = 2 versus ΔJ = 1 emission bands against 
added concentration of anion. The binding affinity for lactate and the di-cation [Eu.L42]2+, 
was an order of magnitude greater than for the N-benzyl complex [Eu.L40]+ (logK = 3.15), 
which can be attributed to the enhanced electrostatic attraction arising as a result of the 
greater positive charge of [Eu.L42]2+. 
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Figure 92 - Variation of the europium (III) emission profile of [Eu.L42]2+ as a function of added R-lactate. (5 µM, λexc 
= 352 nm, MeOH-H2O 1:1, 10 mM HEPES, ‘pH’ 7.4). Inset shows the fit to experimental data, following iterative least 
squares fitting to a 1:1 binding model. 
 
Previous work has shown that the addition of inorganic phosphate, HPO4
2-, to the bis-
carboxylate complex [Eu.L39]+, resulted in significant quenching of the europium 
luminescence and a large increase in ligand fluorescence, indicative of decomplexation. 
A similar study was carried out for the N-benzyl complex [Eu.L40]+, but no observable 
change in the emission spectrum was noted on addition of an increasing concentration of 
phosphate anion. Interestingly, the addition of phosphate to [Eu.L42]2+ resulted in a 
significant change in the emission spectrum, and broadening of the ΔJ = 1 manifold. This 
behaviour allowed an emission titration to be conducted, and an estimated binding affinity 
of logK = 4.20 was calculated (Figure 93).  
 
 
Figure 93 - Variation of the europium (III) emission profile of [Eu.L42]2+ as a function of added inorganic phosphate 
HPO42-. (5 µM, λexc = 352 nm, MeOH-H2O 1:1, 10 mM HEPES, ‘pH’ 7.4). Inset shows the fit to experimental data, 
following iterative least squares fitting to a 1:1 binding model. 
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The presence of the charged amino group on the benzyl ring acts to enhance the affinity 
of the europium (III) complex for phosphate anions. This may be as a result of the greater 
electrostatic interaction, and also the H-bonding nature of the amino group, which can 
direct the binding of the phosphate anion to the lanthanide centre. Hybrid-DFT 
calculations performed by Dr. Mark Fox on the Y (III) analogue at B3LYP/3-21G*, 
revealed the hydrogen bonding capability of the aminium ion (Figure 94). The hydrogen 
atom of the charged amino group is situated directly on the negatively charged oxygen 
atom of the phosphate anion, demonstrating that directed hydrogen bonding is occurring.  
 
 
Figure 94 – Top and side views of the optimised geometry of [Y.L42.HPO4], with the anisyl groups are omitted for 
clarity. A proton of the charged amino group is directed towards the negatively charged oxygen of the phosphate anion. 
 
With this background in mind, we have begun to explore the utility of [Eu.L42]2+ in the 
detection of a number of important chiral O-P-anions, exploiting CPL as the detection 
technique. 
 
4.4.3. Studies using [Eu.L42]2+ and O-P-amino acids  
The binding of [Eu.L42]2+ and three phosphorylated amino acids (O-P-Ser, O-P-Thr and 
O-P-Tyr) was studied. Analysis of the emission and induced CPL spectra allowed an 
estimation of the relative binding affinities and the relative configuration of the adduct 
species. 
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4.4.3.1. Emission and induced CPL studies of [Eu.L42]2+ and O-P-amino acids 
 
 
Figure 95 – Chemical structures of O-phosphono-amino acids at pH 7.4. 
 
The emission spectral changes of [Eu.L42]2+ were investigated following the addition of 
O-P-Ser, O-P-Thr and O-P-Tyr, in a MeOH-H2O solvent system (1:1, v/v), maintaining 
the apparent pH at 7.4 using HEPES buffer (10 mM). The form of the total emission 
spectrum of [Eu.L42]2+ was comparable to that following addition of inorganic phosphate 
(Figure 93). The changes were relatively subtle, except in the hypersensitive ΔJ = 4 
transitions (Figure 96). Moreover, a broadening from one into three transitions in the ΔJ 
= 1 manifold was observed. In each case, it was possible to measure an estimated binding 
constant assuming a 1:1 stoichiometry in the ternary adduct. The stability constant for 
each O-P-amino acid was calculated to be logK = 4.80 ± 0.04, revealing that there is no 
preference for a particular phosphorylated amino acid. This behaviour is in contrast to 
previous work based on a 12-N4 europium (III) complex, where a preference for O-P-Tyr 
was observed in pure water, most likely as a result of the lower hydration energy of 
tyrosine.121 However, the study involving [Eu.L42]2+ was carried out in a 1:1 MeOH-H2O 
solvent system, to aid solubility. Selective solvation of the complex by a cluster of 
methanol molecules is likely to be occurring,185 and so the effect of the differential anion 
hydration energy is diminished. It is worth noting that no change in the emission spectrum 
was observed in the presence of non-phosphorylated amino acids, allowing us to 
confidently hypothesise that the binding occurs through the phosphate group. 
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Figure 96 - Variation of the europium (III) emission profile (left) and CPL spectra (right) of [Eu.L42]2+ as a function 
of added anion; (top) O-phosphono-serine, (middle) O-phosphono-threonine, (bottom) O-phosphono-tyrosine (5 µM 
complex, λexc = 352 nm, MeOH-H2O (1:1, v/v, 10 mM HEPES, ‘pH’ 7.4)). Insets show fits to experimental data, 
following iterative least-squares fitting to a 1:1 binding model. 
 
The change in emission spectral form was accompanied by the induction of a strong CPL 
signal, in the case of O-P-Ser and O-P-Thr (Figure 96). The emission dissymmetry values 
for the ΔJ = 1 transition were bigger for O-P-Thr (gem (592.5 nm) = +0.08 c.f. +0.04 for 
O-P-Ser), perhaps as a result of the additional methyl group providing a slightly higher 
degree of conformational rigidity at the metal centre. No induced CPL signal could be 
recorded for the [Eu.L42.O-P-Tyr] adduct. From the emission studies, it is clear that the 
phosphorylated amino acid binds to the lanthanide centre in a similar manner to O-P-Ser 
and O-P-Thr. Therefore, an alternative explanation must be considered for the lack of 
induced chiroptical activity. The chiral centre is more remote in the O-P-Tyr molecule, 
and simply explains the lack of CPL activity observed from the resulting europium (III) 
complex. 
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Figure 97 – ΔJ = 1 transition of the CPL spectrum of [Eu.L42]2+ following the addition of 50 µM D- (red) and L-O-P-
Ser (blue), gem (593 nm) = ±0.04. (5 µM, λexc = 352 nm, MeOH-H2O 1:1, 10 mM HEPES, ‘pH’ 7.4). 
 
Addition of D- and L-O-P-Ser resulted in induced CPL of equal and opposite form, with 
identical gem values at 593 nm (Figure 97). Comparative analysis with the CPL spectrum 
of the control N-benzyl complex, [Eu.L40]+, on the addition of R and S-lactate, allowed a 
tentative assignment of configuration of the complex adduct, as Δ-[Eu.L42.O-P-L-Ser] 
and Λ-[Eu.L42.O-P-D-Ser]. 
 
4.4.4. Investigation of [Eu.L42]2+ and selected phosphorylated hexapeptides 
Following the promising results regarding the binding of O-P-amino acids with [Eu.L42]2+ 
and the induction of ‘signature’ CPL, attention then turned to a related series of 
phosphorylated hexapeptides.  
 
Figure 98 – Structure of the non-phosphorylated hexapeptide Gly-Ala-Pro-Tyr-Lys-Phe (GAPYKF) and the 
phosphorylated hexapeptides Gly-Ala-Pro-O-P-Tyr-Lys-Phe (GAPY*KF), Gly-O-P-Ser-Pro-Phe-Lys-Phe 
(GS*PFKF) and Gly-O-P-Ser-Pro-O-P-Tyr-Lys-Phe (GS*PY*KF). 
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4.4.4.1. Structural studies of phosphorylated peptides 
Three phosphorylated peptides were selected for this study, varying in the phosphorylated 
residue (Ser or Tyr) and the number of phosphorylated sites (mono or di), Figure 98. The 
corresponding non-phosphorylated peptide, GAPYKF, was also studied as a control. In 
order to try and gain an insight into the solution state structures of the three 
phosphorylated peptides, electronic circular dichroism (ECD) and 2D 1H NMR methods 
were employed. The hexapeptides each contain a proline residue, which can induce a turn 
in the structural backbone of the peptide, particularly if followed by an aromatic 
residue.213 Weak ECD activity (around 200-230 nm) was observed for each of the three 
phosphorylated peptides (Figure 99). The hexapeptides GAPY*KF and GS*PY*KF 
exhibited ECD spectra that were very similar in form and consistent with the assignment 
of an open conformation peptide.214 In the case of GS*PFKF, the ECD spectrum is 
slightly more well-defined with a positive and negative component at 220 and 200 nm 
respectively, indicating that perhaps, the mono-phosphorylated hexapeptide has a greater 
population of a more structured conformer in solution. 
 
 
Figure 99 – Electronic circular dichroism spectra for GS*PFKF (blue), GS*PY*KF (orange) and GAPY*KF (purple) 
(298 K, H2O, pH 7.4). 
 
Further investigation of the solution state structure of GS*PFKF was analysed using 2D 
1H NMR methods with the help of Dr. Juan Aguilar Malavia. Overlaying the ROESY 
with the TOCSY spectra and the NOESY with the COSY spectra, allowed identification 
of pure through-space signals, by eliminating discrepancies arising from through-bond 
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interactions. Assignment of the resonances corresponding to the through-space 
interactions was achieved using HSQC, HMBC, PSYCHE and COSY methods. The 
peaks were identified as the aromatic and benzylic protons of a single phenylalanine 
residue, and are therefore not particularly informative in 3D structure determination. The 
lack of through-space interaction observed between separate amino acid residues, using 
the discussed methods, may be as a result of the distance between the two sections of the 
peptide. If the distance is too great then the interaction will not be observed using NMR 
methods. The rate at which the peptide conformation is exchanging may also be too fast, 
and therefore not observable on an NMR timescale. 
4.4.4.2. Induced CPL studies 
The induced CPL response of [Eu.L42]2+ was investigated, following addition of a 20-
fold excess of each peptide (Figure 100). The addition of the non-phosphorylated control 
peptide, GAPYKF, resulted in no induced CPL (D), providing further evidence that the 
peptide binds to the europium (III) centre via the phosphate group. In the case of the O-
P-Tyr peptide, GAPY*KF, the CPL spectral form (Figure 100, A) resembles that of the 
O-P-amino acids, O-P-Ser and O-P-Thr (Figure 96). However, it is interesting to recall 
that the simple O-P-Tyr amino acid did not induce a CPL response. In contrast, the O-P-
Tyr peptide induced significant CPL, with a measured emission dissymmetry value of gem 
(592.5 nm) = +0.10, which is amongst the highest induced gem values observed from a 
dynamically racemic europium (III) complex.15,150,151  
 
Figure 100 – Induced CPL spectra of [Eu.L42]2+ following the addition of 200 µM peptide: A – GAPY*KF; B – 
GS*PFKF; C – GS*PY*KF and D – non-phosphorylated GAPYKF. (10 µM , λexc = 352 nm, MeOH, 295 K). 
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Another interesting observation, was the induced CPL spectral response of the O-P-Ser 
peptide, GS*PFKF (Figure 100, B), which is opposite in sign and form to that of 
GAPY*KF. The gem value at the same transition, λ = 592.5 nm, was -0.04 and therefore 
much smaller than the O-P-Tyr peptide. Such behaviour, suggests that it may be the chiral 
structure of the entire peptide, when bound to the lanthanide centre that is responsible for 
the induced CPL response.  
A final point worth noting, is the behaviour of the di-phosphorylated peptide, which 
contains both a phosphorylated serine and tyrosine residue. The induced CPL is much 
weaker than for the other two peptides, and appears to be an additive combination of the 
two separate spectra (Figure 100, C). One possible explanation is that the complex has 
no preferential binding site, as demonstrated by the estimated affinity constants of the O-
P-amino acids. Therefore, the most emissive species will be a combination of the 
lanthanide complex bound to the O-P-Ser of the peptide or the O-P-Tyr. The gem values 
for the induced CPL were bigger for the O-P-Tyr residue, which may explain why the 
major chiral emissive species for the GS*PY*KF adduct of [Eu.L42]2+, generated an 
induced CPL spectra that more closely resembled the O-P-Tyr hexapeptide. 
4.4.4.3. Estimation of the stability constants, logK 
Investigation of the binding affinities of the three hexapeptides with [Eu.L42]2+ was 
carried out by monitoring the emission and induced emission dissymmetry values, gem, as 
a function of peptide concentration.  
As can be seen in Figure 101, the emission spectral changes of [Eu.L42]2+ are very subtle, 
following addition of the phosphorylated peptide, GAPY*KF. It is much easier to monitor 
the generation of CPL from the system, particularly when the gem values are as large as 
+0.10. The change in the intensity of the ΔJ = 2 and ΔJ = 1 transitions of the emission 
spectrum was plotted as a function of added concentration of the peptide, and the data 
was fitted to a 1:1 binding isotherm, following iterative least-squares fitting. The 
estimated binding affinity in methanol, logK = 5.9, was very large and consistent with the 
value obtained by plotting the induced gem values against concentration of peptide, logK 
= 6.1. Such behaviour implies that the charged amino complex, [Eu.L42]2+, has a strong 
binding affinity with GAPY*KF, and that the major chiral species in solution is the most 
emissive species. Once again, a slightly higher binding affinity was calculated from the 
CPL data suggesting it is associated with the formation of the favoured isomer (Δ), as was 
observed for the examples discussed in Section 3.5.2. 
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Figure 101 – left: variation in Eu (III) emission spectral profile of [Eu.L42]2+ as a function of added peptide GAPY*KF 
(top) and fit to experimental data, following iterative least-squares fitting to a 1:1 binding model (bottom); right: 
variation in the ΔJ = 1 manifold of the CPL spectrum of [Eu.L42]2+ as a function of added peptide GAPY*KF (top) and 
fit to experimental data, following iterative least-squares fitting to a 1:1 binding model (bottom). (10 µM complex, λexc 
= 352 nm, MeOH, 295 K). 
 
A similar experiment was carried out for the peptide GS*PFKF, however the data did not 
fit to a 1:1 binding model, and so a stability constant could not be reliably estimated. 
 
 
 
Figure 102 – (left) plot of the change in emission dissymmetry value, gem, of [Eu.L42]2+ at 592.5 nm versus the 
concentration of the di-phosphorylated peptide GS*PY*KF; (middle) change in the ΔJ = 1 transition of the CPL 
spectrum of [Eu.L42]2+; (right) variation in the Eu (III) emission spectral profile of [Eu.L42]2+ as a function of added 
peptide GS*PY*KF. (10 µM complex, λexc = 352 nm, MeOH, 295 K). 
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In the case of the di-phosphorylated peptide, GS*PY*KF, unusual behaviour was 
observed following the sequential addition of the peptide to the europium (III) complex. 
The induced CPL signal at 592.5 nm (ΔJ = 1) initially revealed increasingly negative 
values until a critical concentration was reached. At this concentration, the sign of the 
CPL was reversed and increasing positive values were recorded, until a limiting spectral 
response was achieved (Figure 102). Such behaviour provides further evidence that there 
is only a very small energy difference between the binding affinities of the two 
phosphorylated sites (O-P-Ser and O-P-Tyr). However, at higher concentration of added 
peptide, the most emissive chiral species that is observed has a positive gem value at 592.5 
nm, corresponding to binding at the O-P-Tyr residue.  
 
4.4.4.4. Summary of the studies of [Eu.L42]2+ and O-P-peptides 
This study has demonstrated that [Eu.L42]2+ binds to phosphorylated peptides and a CPL 
response is induced. The investigation has shown that accurate determination of the 
stability constant can be achieved by monitoring the CPL spectral changes as an 
alternative to the europium (III) emission spectral change, particularly if the changes in 
the total emission response are small.  
The sign of the gem value in the ΔJ = 1 transition allows differentiation between O-P-Ser 
and O-P-Tyr residues. The magnitude of the induced emission dissymmetry value for the 
O-P-Tyr hexapeptide, GAPY*KF, was +0.10 and is amongst the highest values that have 
been recorded for a dynamically racemic europium (III) system.15,150,151 The large gem 
value allows quick and easy detection of this peptide in methanol, when employing CPL 
as the detection technique. Further work would look to enhance the scope of this complex 
in the detection and recognition of more complex and structurally diverse series of 
peptides incorporating phosphorylated tyrosine residues. 
 
4.4.5. Demonstrating the utility of [Eu.L42]2+ as a chiral probe for oleoyl-
lysophosphatidic acid 
Oleoyl-L-α-lysophosphatidic acid (LPA) is a phospholipid present at a physiological 
concentration of <0.1-6.3 µM and at significantly increased levels (≤43 µM) in ovarian 
cancer cells.215  
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Figure 103 – Chemical structure of the europium (III) salophene complex.204 
 
Some progress has been made in the development of lanthanide probes that are able to 
detect LPA in MeOH by monitoring an increase in the fluorescence intensity of the 
ligand.204 In the study of a coordinatively unsaturated europium (III) salophene complex 
(Figure 103), an apparent selectivity of binding was demonstrated in methanol for a 
number of competitive analytes such as, proteins (BSA), phospholipids 
(phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine) and carboxylates 
(phosphate and citrate). However, the selectivity over bicarbonate and lactate (anions 
present at the highest physiological concentration) was not discussed. Furthermore, the 
chemical origin for the particularly high affinity of the europium (III) complex for LPA 
is not apparent and was not investigated. The study monitored the fluorescence response 
of the europium (III) complex in methanolic extracts of human serum spiked with LPA. 
However, no information regarding the composition of the extract was given, making it 
difficult to determine the exact environment in which LPA was ‘selectively’ detected. A 
final point worth noting, is that this particular lanthanide probe relies on ligand-centred 
emission to detect the biomolecule. Ligand-centred emission is inherently less sensitive 
than lanthanide-based emission, rendering the structural study of the ternary complex 
very complex.  
 
4.4.5.1. Binding mode of LPA 
LPA has a lower pKa2 than phosphatidic acid (PA), the related phospholipid with a simple 
phosphate head group, illustrated by the calculated values in a phosphatidylcholine 
bilayer (PA: pKa1 3.2 ± 0.3, pKa2 7.92 ± 0.03; LPA: pKa1 2.9 ± 0.3, pKa2 7.47 ± 0.03).
216 
Intramolecular hydrogen bonding is observed between the hydroxyl group on the glycerol 
backbone of the molecule and the phosphomonoester head group in the crystal structure, 
and is known to persist at physiological pH (Figure 104).216,217 Therefore, ionisation of 
the phosphate hydroxyl group of LPA occurs more easily than for PA (and other 
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phosphate anions), generating a higher negative charge on the analyte, facilitating 
proposed binding to a positively charged probe, for example [Eu.L42]2+. 
 
Figure 104 – Intramolecular hydrogen bonding of lysophosphatidic acid (LPA) and phosphatidic acid (PA), R = oleoyl 
acid chain.204 
 
LPA binds to the lanthanide centre via the phosphate head group, in the same mode that 
was discussed for the phosphorylated amino acids and peptides in the preceding sections.  
 
4.4.5.2. Emission and induced CPL studies of [Eu.L42]2+ and LPA 
Direct binding to the lanthanide centre, as in the case with this probe, enables structural 
elucidation of the ternary adduct. As LPA is a chiral molecule, detection can be observed 
by the induction of circularly polarised luminescence. 
The emission spectral form changes were particularly apparent in the ΔJ = 1 transition, 
which broadened from a single manifold, into three distinct transitions (Figure 105). This 
change resembles the emission spectral response of [Eu.L42]2+ following addition of the 
other phosphate anions that have been investigated in this study (HPO4
2-, O-P-amino 
acids and O-P-peptides). Upon increasing the concentration of LPA, characteristic 
changes in the total emission spectrum were observed until a limiting spectrum was 
achieved. Beyond which, the total intensity continued to increase consistently across all 
transitions, with no further change to the emission spectral form. Such behaviour may be 
attributed to the long lipophilic chains in the molecule, which may be able to form 
aggregates, preventing the quenching from solvent molecules and significantly enhancing 
the europium emission intensity.  
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Figure 105 – Variation in the europium (III) emission spectral profile of [Eu.L42]2+ as a function of added LPA (left). 
Inset shows the fit to experimental data, following iterative least-squares fitting to a 1:1 binding model, logK = 5.25 ± 
0.02. Variation in the emission spectral profile of [Eu.L42]2+ following addition of 100-600 µM LPA, showing the large 
enhancement in total emission intensity (right). (5 µM complex, λexc = 352 nm, MeOH, 295 K). 
 
The limit of detection of LPA is 5 µM and the limiting spectrum is achieved at a 
concentration of 40 µM, which is in the desired range for LPA detection in ovarian cancer 
cells. The estimated stability constant in methanol, logK = 5.25, was high, demonstrating 
that there is indeed a strong binding affinity in the adduct, [Eu.L42.LPA].  
 
 
Figure 106 – Induced CPL spectrum of [Eu.L42]2+ following addition of 50 µM LPA, inset shows the enlarged ΔJ = 1 
transition (585 – 600 nm). (5 µM complex, λexc = 352 nm, MeOH, 295 K). 
 
The induced CPL response resembled that of O-P-Ser, O-P-Thr and the related 
phosphorylated hexapeptides, with not much activity observed in the ΔJ = 3 and ΔJ = 4 
region. An emission dissymmetry value, gem, of +0.04 at 593 nm was measured. This 
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value is lower than that measured for the O-P-Tyr phosphorylated peptide, suggesting 
that there is a lower degree of conformational rigidity, consistent with the structure of 
LPA, which contains a long, aliphatic carbon chain. 
Comparison of the CPL spectrum with the parent N-benzyl complex, [Eu.L40]+, on 
addition of a number of chiral analytes, allowed a tentative assignment of the 
configuration of the complex adduct as Δ-[Eu.L42.L-LPA]. It is useful to recall that the 
O-P-L-amino acids also induced a similar CPL spectral response, resulting in the same Δ-
assignment of helicity. 
Following the promising results of the emission and CPL studies, further work set out to 
investigate the binding selectivity of the complex and LPA in a competitive environment. 
The nature of the ‘signature’ induced CPL response would provide further evidence for 
the determination of the species that was bound to the europium centre. No evidence of 
an interaction was observed for other phospholipid species including phosphatidyl-serine, 
-inositol and –ethanolamine.  The addition of HSA (human serum albumin) resulted in 
no change in the emission spectral form, and significant quenching of the emission 
intensity was observed at a protein concentration >0.2 mM, with no induced CPL. As 
discussed in Section 4.4.2. the binding affinities of a number of physiologically relevant 
anions were estimated, including lactate, bicarbonate and phosphate (Table 22). 
 
Table 22 – Affinity constants, logK, for analyte complexation and physiological concentrations of relevant 
biomolecules. (MeOH-H2O 1:1, 10 mM HEPES, 295 K). (-) no evidence for a significant binding interaction was 
observed. 
 Concentration in serum / mM logK 
HCO3- 24-27 - 
lactate 0.6-2.3 4.37 
HPO42- 1.2-1.3 4.20 
HSA 0.5-0.75 - 
LPA 0-0.05 5.25a 
a affinity constant estimated in 100% MeOH due to solubility of the biomolecule. 
 
It is important to note that the affinity constant for LPA complexation was estimated in 
100% MeOH and so is expected to be higher than the value measured in MeOH-H2O (1:1, 
v/v), due to the lower solvation energy of the anion. However, with that in mind, analysis 
of the affinity constants revealed that selective binding of LPA may be possible in a 
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competitive environment. In aqueous methanolic solution (1:1, v/v. ‘pH’ 7.4), simulating 
an extracellular fluid containing HSA (0.4 mM), sodium lactate (2.3 mM), hydrogen 
phosphate (0.9 mM), citrate (0.13 mM) and sodium bicarbonate (30 mM), the observed 
emission spectrum of [Eu.L42]2+ (5 µM) was the same as that observed for the complex 
alone. LPA was titrated into the solution in 5 µM aliquots until 100 µM was added. 
However, neither a change in the emission spectrum nor an induction of CPL was 
observed. 
 
4.5. Conclusions and future work 
The utility of dynamically racemic lanthanide probes in the sensing of important chiral 
biomolecules, employing CPL spectroscopy as the detection technique, is a research area 
of growing interest. The sensitivity and selectivity of this type of chirality probe has been 
demonstrated in a number of examples, as highlighted at the beginning of this chapter and 
in Chapter 1. 
This aim of the work outlined in this section was to develop a new set of heptadentate, 
dynamically racemic lanthanide complexes, incorporating functionality on the N-alkyl 
substituent that could be used to target and detect a number of chiral biomolecules, such 
as: sialic acid, O-P-amino acids and peptides and LPA. The design of the dynamically 
racemic europium (III) complexes was based on the results outlined in Chapters 2 and 3 
following a detailed and systematic study into the structural and photophysical properties 
of related systems. The most attractive properties were highlighted and incorporated into 
the ligand framework in the novel set of europium (III) chirality probes, [Eu.L39-42]. 
The detection of sialic acid by the bis-carboxylate complex, [Eu.L39]+, and the boronic 
acid complex [Eu.L41]+ was demonstrated via the induction of a ‘fingerprint’ CPL 
response and changes in the total emission spectrum. This result demonstrates the first 
example of the use of CPL spectroscopy in conjunction with a lanthanide chirality probe 
to detect sialic acid. Further work investigated the sign and form of the CPL spectra to 
elucidate key structural information regarding the ternary adduct, by comparison with the 
methyl-ester derivative of sialic acid. A proposed binding mechanism was hypothesised, 
highlighting the nature of the secondary binding interaction provided by the boronic acid 
moiety.  
A europium (III) complex incorporating a charged amino group on the N-benzyl 
substituent, [Eu.L42]2+, has been shown to target chiral phosphate anions, as a result of 
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the enhanced electrostatic interaction and directed hydrogen-bonding. The utility of this 
probe in the detection of O-P-amino acids, O-P-peptides and oleoyl-L-α-lysophosphatidic 
acid has been demonstrated. The induced CPL signal differs significantly from the 
spectrum obtained in the presence of other simple chiral carboxylic acids and α-hydroxy 
acids. Importantly, the studies have shown that phosphorylated tyrosine residues can be 
differentiated from phosphorylated serine residues in a set of hexapeptides. Emission 
dissymmetry values as high as +0.10 were observed for [Eu.L42]2+ and the O-P-Tyr 
peptide (GAPY*KF), allowing easy, accurate and quick measurement of the CPL 
spectrum for this system. 
The detection of LPA using [Eu.L42]2+as a lanthanide probe has also been demonstrated, 
within the range 5-40 µM. This result is the first example of induced CPL from an LPA 
adduct. The total emission and circularly polarised luminescence of the probe was 
monitored as a function of added lysophosphatidic acid. Due to the bright, strongly 
emissive nature of the lanthanide complex, detection of LPA was readily achieved. 
Analysis of the europium emission and CPL spectra revealed information about the 
structure of the ternary adduct, improving upon previous examples of lanthanide LPA 
probes.204 The absolute configuration of the [Eu.L42.L-LPA] adduct was tentatively 
assigned as Δ, which is consistent with the helicity assigned for the O-P-L-amino acids. 
The selective detection of LPA in simulated extracellular fluid was investigated, however, 
no evidence for the binding of any anion to the lanthanide centre was observed, most 
likely due to low solubility of the complex in water.  
The results that have been discussed in this chapter are particularly encouraging and show 
promise in the ability of this class of heptadentate europium (III) complexes to act as 
effective chirality probes. The complexes are very bright, allowing enhanced signal to 
noise spectra to be obtained within a short acquisition time (3 scans, 20 min), using a very 
low (5-10 µM) concentration of the probe. Structural variation of the N-alkyl substituent 
allows the probe design to be tuned to target a specific chiral anion selectively. The 
complexes are dynamically racemic and fast interconversion between the isomers occurs 
on the emission timescale. The addition of a chiral analyte preferentially stabilises a 
particular stereoisomer, revealing an induced ‘signature’ CPL spectrum that is dependent 
on the nature of the analyte and the binding mode in the ternary adduct.  
With all this in mind, there is a particularly important factor that has not yet been 
addressed. The poor water solubility of these complexes has limited their use to anion 
detection in methanol or mixed methanol-water systems. The incorporation of negatively 
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charged sulfonic acid derivatives into the para position of the aryl ring of the 
chromophore, has been shown to significantly enhance the water solubility of related tri-
phosphinate 9-N3 europium (III) complexes.
183 To improve on the results demonstrated 
in this chapter, the inclusion of such water-solubilising moieties should allow the 
investigation of the detection capabilities of the related complexes in a purely aqueous 
environment (Figure 107). 
 
 
Scheme 24 – The pH dependent equilibria of a phenylboronic acid group containing an aminomethyl group in the 
ortho-position.194 
 
It may also be possible to increase the binding affinity, and thus selectivity, of [Eu.L41]+ 
for sialic acid through the inclusion of an aminomethyl group in the ortho-position of the 
benzyl substituent (Figure 107). Wulff has shown that conversion of the trigonal boronic 
acid to the tetrahedral boronate occurs at a lower pH value in the presence of this 
additional amino group, where the stability of the resulting ester is an order of magnitude 
greater.218 The presence of the tetragonal species over a greater pH range can be attributed 
to the B-N interaction in the phenylboronate and may aid the selective recognition of 
sialic acid at physiological pH levels (Scheme 24).219 
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Figure 107 – Structure of next generation europium (III) complexes containing water-solubilising negatively charged 
sulfonic acid derivatives. 
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5.1. General experimental 
 
5.1.1. Materials 
All reagents were purchased and used as received. Analytical solvents were purchased 
from Fisher Scientific and were laboratory grade. Anhydrous solvents were freshly 
distilled over the appropriate drying agent and stored under argon in a septum capped 
bottle. Water was purified by the ‘PuriteSTILLplus’ system, with conductivity of ≤ 0.04 μS 
cm-1. Air sensitive reactions were carried out under an atmosphere of argon using 
Schlenk-line techniques. 
5.1.2. Analytical methods 
Thin layer chromatography was carried out on neutral aluminium silica plates (Merck 
5554) or neutral aluminium oxide plates (Merck 5550) and visualised under UV 
irradiation (254/365 nm). Preparative column chromatography was performed using silica 
gel (Merck Silica Gel 60, 230-400 mesh) or neutral aluminium oxide (Merck 90, 70-320 
mesh). 
1H, 13C and 11B NMR spectra were recorded on a Varian Mercury-200 (1H 199.975 and 
13C 50.289), Varian Mercury-400 (1H 399.945 and 13C 100.566), Bruker Avance-400 (1H 
400.052, 11B 128.377 and 13C 100.603), Varian Inova-500 (1H 499.722 and 13C 125.671), 
Appleby VNMRS-600 (1H 599.832 and 13C 150.828), or Varian VNMRA-700 (1H 
699.731 and 13C 175.948) spectrometer. Spectra were recorded in commercially available 
deuterated solvents. 13C and 1H chemical shift values are quoted in ppm relative to 
trimethylsilane and all coupling constants are given in Hz. Assignment of the spectra was 
achieved using COSY, HSQC and HMBC experiments. The operating temperature of the 
spectrometers (usually 295 K) was measured with the aid of an internal calibration 
solution of ethylene glycol. The operating temperature of each spectrometer was 
measured before each set of measurements of relaxation data, using the calibration 
sample. 
Proton NMR longitudinal relaxation data were measured in dilute MeOD solutions at 295 
K using the inversion-recovery technique, on spectrometers operating at fields of 4.7, 9.4, 
11.7, 14.1 and 16.4 T. The recorded free induction decays were processed using backward 
linear prediction, optimal exponential weighting, zero-filling, Fourier transform, phasing 
and baseline correction (by polynomial fitting). The signals were integrated by Lorentzian 
line fitting. 
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 Relaxation data was fitted with the help of Dr Alexander Funk at Durham University, 
using a modified algorithm originally provided by Dr Ilya Kuprov at Oxford University. 
The algorithm uses the Solomon-Morgan-Bloembergen equations to fit the measured 
relaxation data using the Matlab internal Levenberg-Marquardt minimisation of the non-
linear squares error function and the results were analysed iteratively.  
Electrospray mass spectra were obtained on a TQD mass spectrometer equipped with an 
Acquity UPLC, an electrospray ion source and an Acquity photodiode array detector 
(Waters Ltd, UK).  Methanol or acetonitrile were used as the carrier solvent. For LC-MS 
analyses a 2.1 x 100 mm 1.7 micron Acquity UPLC BEH C18 column was used. LC-MS 
analyses were performed on a Waters system comprising a 3100 Mass Detector and a 
2998 Photodiode array detector. 
Accurate masses were recorded on a LCT Premier XE mass spectrometer or a QTOF 
Premier mass spectrometer both equipped with an Acquity UPLC, a lock-mass 
electrospray ion source and an Acquity photodiode array detector (Waters Ltd, UK). 
Methanol or acetonitrile was used as the carrier solvent. 
GC-MS data (polar and non-polar mode) was obtained using a Shimadzu QP2010-Ultra 
instrument operating at 70 eV equipped with an Rxi-5Sil MS column (0.15 µm x 10 m x 
0.15 mm) and helium was used as the carrier gas.  
Melting points were recorded using Gallenkamp (Sanyo) apparatus and are uncorrected. 
Elemental analyses were recorded on an Exeter CE-440 elemental analyser. 
 
5.1.3. HPLC analysis 
Reverse-phase preparative HPLC was performed at 295 K using a Shimadzu system 
consisting of a Degassing Unit (DGU-20A5R), a Prominence Preparative Liquid 
Chromatograph (LC-20AP), a Prominence UV/Vis Detector (SPD-20A) and a 
Communications Bus Module (CBM-20A). An XBridge C18 OBD 19 x 100 mm, i.d. 5 
μM column was used with a flow rate of 2 mL/min (analytical) or 17 mL/min (prep). The 
solvent system was H2O +0.1% formic acid / MeOH +0.1% formic acid (gradient elution, 
Table 23 -Table 25). 
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Table 23 – HPLC conditions used for the purification of [Ln.L30, 31a-d]. 
Step Time / min Flow (analytical/ 
prep) / mL min-1 
H2O (0.1% FA) MeOH (0.1% 
FA) 
0 0.0 2.0 / 17.0 90 10 
1 3.0 2.0 / 17.0 90 10 
2 13.0 2.0 / 17.0 0 100 
3 18.0 2.0 / 17.0 0 100 
4 19.0 2.0 / 17.0 90 10 
 
Table 24 – HPLC conditions used for the purification of mono-BOC L38. 
Step Time / min Flow (analytical/ 
prep) / mL min-1 
H2O (0.1% FA) MeOH (0.1% 
FA) 
0 0.0 2.0 / 17.0 70 30 
1 3.0 2.0 / 17.0 70 30 
2 18.0 2.0 / 17.0 0 100 
3 21.0 2.0 / 17.0 0 100 
4 22.0 2.0 / 17.0 90 10 
 
Table 25 – HPLC conditions used for the purification of pre-L42. 
Step Time / min Flow (analytical/ 
prep) / mL min-1 
H2O (0.1% FA) MeOH (0.1% 
FA) 
0 0.0 2.0 / 17.0 90 10 
1 3.0 2.0 / 17.0 90 10 
2 18.0 2.0 / 17.0 0 100 
3 21.0 2.0 / 17.0 0 100 
4 22.0 2.0 / 17.0 90 10 
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5.1.4. Optical techniques 
All samples for optical analyses were contained in quartz cuvettes with a path length of 1 
cm and a polished base. Measurements were recorded at 295 K.  
 
UV/Vis absorbance spectra were recorded on an ATI Unicam UV/Vis spectrometer 
(Model UV2) using Vision version 3.33 software. Samples were measured relative to a 
reference of pure solvent contained in a matched cell. Emission spectra were recorded on 
an ISA Joblin-Yvon Spex Fluorolog-3 luminescence spectrometer using DataMax 
v2.2.10 software.  
 
Lifetime measurements were carried out on a Perkin Elmer LS55 spectrometer using FL 
Winlab software version 4.00.02. The Ln (III) ion was directly excited via the 
chromophore using a short pulse of light at λexc, followed by monitoring the integrated 
intensity of the light emitted at a chose wavelength (612-620 nm for Eu), during a fixed 
gate time, tg, after a delay time, td. Measurements were made for a minimum of 20 delay 
times, covering more than 3 lifetimes. A gate time of 0.1 ms was used and the excitation 
and emission slits were set to 10 nm. The observed decay curves were plotted in Microsoft 
Excel using equation 5.1. 
 
 𝐼 =  𝐴0 + 𝐴1𝑒
−𝑘𝑡 (5.1.) 
 
The excited state lifetime, τ, is the inverse of the radiative decay rate constant, k. 
 
Apparent binding constants were calculated by fitting equation 5.2 to emission or CPL 
data, using a non-linear least squares fitting algorithm in Microsoft Excel 2010, with the 
solver add-in. 
 
[𝑋]  =  
(𝐹 − 𝐹0)
(𝐹1 − 𝐹0)
⁄
𝐾 +
[𝐸𝑢] ∗
(𝐹 − 𝐹0)
(𝐹1 − 𝐹0)
⁄ − [𝐸𝑢] ∗ (
(𝐹 − 𝐹0)
(𝐹1 − 𝐹0)
)
2
1 −
(𝐹 − 𝐹0)
(𝐹1 − 𝐹0)
⁄
 
 
 𝐸𝑢 + 𝑋 ↔ 𝐸𝑢𝑋 
𝐾 =  
[𝐸𝑢𝑋]
[𝑋𝑓][𝐸𝑢𝑓]
 
(5.2) 
 
[X]: Total concentration of selected analyte in solution 
[Eu]: Total concentration of the complex 
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K: Binding constant 
F: Either intensity ratio of selected emission transitions or gem values 
F0: Initial ratio 
F1: Final ratio 
[EuX]: The concentration of the analyte-coordination complex 
[Xf]: The concentration of free analyte 
[Euf]: The concentration of free complex 
 
CPL spectra were recorded on a custom built spectrometer consisting of a laser driven 
light source (Energetiq EQ-99 LDLS, spectral range 170 to 2100 nm) coupled to an Acton 
SP2150 monochromator (600 g/nm, 300 nm Blaze) that allows excitation wavelengths to 
be selected with a 6 nm FWHM band-pass. The collection of the emitted light was 
facilitated (90 º angle set up, 1 cm path length quartz cuvette) by a Lock-In Amplifier 
(Hinds Instruments Signaloc 2100) and Photoelastic Modulator (Hinds Series II/FS2AA). 
The differentiated light was focused onto an Acton SP2150 monochromator (1200 g/nm, 
500 nm Blaze) equipped with a high sensitivity cooled Photo Multiplier Tube 
(Hamamatsu 7155-01 red corrected). The detection of the CPL signal was achieved using 
the field modulation lock-in technique. The electronic signal from the PMT was fed into 
the lock-in amplifier (Hinds Instruments Signaloc 2100). The reference signal for the 
lock-in detection was provided by the PEM control unit. The monochromators, PEM 
control unit and lock-in amplifier were interfaced with a desktop PC and controlled by 
Labview code.  
 
A correction factor for the wavelength dependence of the detection system was 
constructed using a calibrated lamp (Ocean Optics). The measured raw data was 
subsequently corrected using this correction factor. The validation of the CPL detection 
systems was achieved using light emitting diodes (LEDs) at various emission 
wavelengths. The LED was mounted in the sample holder and the light from the LED 
was fed through a broad band polarising filter and ¼ wave plate (Ocean Optics) to 
generate circularly polarised light. Prior to all measurements, this technique was used to 
set the phase of the lock-in amplifier correctly. 
 
Spectra were recorded using a 5 spectral average sequence in the range of 570-720 nm 
with 0.5 nm spectral intervals and 500 μs integration time. The recorded CPL spectrum 
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underwent a Savitzky-Golay smoothening protocol using Origin 8.0 Software (Origin 
Labs) to enhance appearance (all calculations were carried out using raw spectral data).  
 
Figure 108 - schematic diagram of Durham CPL instrumentation. 
 
ECD spectra of the O-phosphono-peptides studied were measured on a JASCO J-810 CD 
Spectropolarimeter using Jasco's Spectra ManagerTM software. The band width was set to 
1.0 nm, response to 2 sec and scan speed to 50 nm/min. 
 
5.1.5. DFT computations 
The model geometries [Y.L37-40,42] and adducts in this thesis were fully optimised without 
symmetry constraints using the hybrid-DFT B3LYP functionali and 3-21G* basis setii for 
all atoms with the Gaussian 09 package.iii Frequency calculations confirmed the 
geometries to be true minima.   The methyl substituents in the anisyl groups in [Eu.L39], 
[Eu.L40] and [Eu.L42] complexes were omitted in the model geometries [Y.L39], [Y.L40] 
and [Y.L41] to reduce computational effort. Geometry optimisations were also carried out 
using B3LYP and PBE0 functionals,i,iv the SVP basis setv and the pseudopotentials, SDD 
and LANL2DZ,vi for comparison with B3LYP/3-21G* and reported X-ray geometries 
(Tables S1-S3). In all computations, the polarised continuum solvent model (PCM)vii with 
the dielectric constant of water was applied. B3LYP/3-21G* is shown to be an appropriate 
functional/basis set for Y (III) complexes and therefore suitable models for Eu (III) 
complexes. The paramagnetic Eu (III) complexes are very difficult to model 
computationally. Figures of the optimised geometries were generated using Mercury 
software.viii 
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The benzyl group is assumed to be orientated like the pyridyl-methyl groups with respect 
to the triazacyclononane ligand in each [Y.L40,42] complex. For optimised geometries of 
R-lactate coordinated [Y.L37-40] complexes, intramolecular hydrogen bonds involving the 
lactate OH group are assumed to be absent as the lactate OH group is likely to be involved 
in hydrogen bonding with the surrounding solvent molecules. All binding energies were 
obtained by differences in total energies between metal bound adducts and the 
corresponding non-metal bound adducts.  
(i)  (a) A. D. Becke, J. Chem. Phys., 1993, 98, 5648-5652; (b) C. Lee, W. Yang and R. G. Parr, Phys. 
Rev. B, 1988, 37, 785-789. 
(ii)   (a) J. S. Binkley, J. A. Pople and W. J. Hehre, J. Am. Chem. Soc., 1980, 102, 939-947; (b) M. S. 
Gordon, J. S. Binkley, J. A. Pople, W. J. Pietro and W. J. Hehre, J. Am. Chem. Soc., 1982, 104, 
2797-2803; (c) W. J. Pietro, M. M. Francl, W. J. Hehre, D. J. Defrees, J. A. Pople and J. S. Binkley, J. 
Am. Chem. Soc., 1982, 104, 5039-5048; (d) K. D. Dobbs and W. J. Hehre, J. Comp. Chem., 1986, 
7, 359-378; (e) K. D. Dobbs and W. J. Hehre, J. Comp. Chem., 1987, 8, 861-879; (f) K. D. Dobbs 
and W. J. Hehre, J. Comp. Chem., 1987, 8, 880-893. 
(iii) Gaussian 09, Revision A.02, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb, 
J. R. Cheeseman, G. Scalmani, V. Barone, B. Mennucci, G. A. Petersson, H. Nakatsuji, M. Caricato, 
X. Li, H. P. Hratchian, A. F. Izmaylov, J. Bloino, G. Zheng, J. L. Sonnenberg, M. Hada, M. Ehara, 
K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T. Nakajima, Y. Honda, O. Kitao, H. Nakai, T. 
Vreven, Jr., J. A. Montgomery, J. E. Peralta, F. Ogliaro, M. Bearpark, J. J. Heyd, E. Brothers, K. N. 
Kudin, V. N. Staroverov, R. Kobayashi, J. Normand, K. Raghavachari, A. Rendell, J. C. Burant, S. 
S. Iyengar, J. Tomasi, M. Cossi, N. Rega, J. M. Millam, M. Klene, J. E. Knox, J. B. Cross, V. 
Bakken, C. Adamo, J. Jaramillo, R. Gomperts, R. E. Stratmann, O. Yazyev, A. J. Austin, R. Cammi, 
C. Pomelli, J. W. Ochterski, R. L. Martin, K. Morokuma, V. G. Zakrzewski, G. A. Voth, P. Salvador, 
J. J. Dannenberg, S. Dapprich, A. D. Daniels, O. Farkas, J. B. Foresman, J. V. Ortiz, J. Cioslowski 
and D. J. Fox, Gaussian, Inc., Wallingford CT, 2009. 
(iv) C. Adamo and V. Barone, J. Chem. Phys. 1999, 110, 6158-6169. 
(v) (a) A. Schaefer, H. Horn and R. Ahlrichs, J. Chem. Phys.1992, 97, 2571-2577; (b) A. Schaefer, C. 
Huber and R. Ahlrichs, J. Chem. Phys. 1994, 100, 5829-5835. 
(vi) T. H. Dunning Jr. and P. J. Hay, in Modern Theoretical Chemistry, Ed. H. F. Schaefer III, Vol. 3 
(Plenum, New York, 1977) 1-28. 
(vii) J. Tomasi, B. Mennucci and R. Cammi, Chem. Rev. 2005, 105, 2999-3093. 
(viii) C. F. Macrae, I. J. Bruno, J. A. Chisholm, P. R. Edgington, P. McCabe, E. Pidcock, L. Rodriguez-
Monge, R. Taylor, J. van de Streek and P. A. Wood,  J. Appl. Cryst. 2008, 41, 466–470. 
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5.2. Synthetic Procedures 
 
5.2.1. [Ln.L30]3+ and precursors 
 
 (S)-6-Methyl-N-(1-phenylethyl)picolinamide, S-1a 
 
6-Methylpyridine-2-carboxylic acid (1.00 g, 7.29 mmol), HOBt.H2O (1.48 g, 10.9 mmol), 
EDC (1.70 g, 10.9 mmol) and DIPEA (3.17 mL, 18.2 mmol) were dissolved in anhydrous 
DMF (20 mL). (S)-(-)-α-Methylbenzyl amine (0.93 mL, 7.29 mmol) was added dropwise 
to the solution and the mixture was stirred at r.t. for 22 h under an argon atmosphere. 
Water was added (25 mL) and the mixture extracted with EtOAc (3 x 10 mL). The organic 
layers were combined and washed successively with water (1 x 10 mL) and brine (1 x 10 
mL), dried over MgSO4 and the solvent removed under reduced pressure. The crude 
mixture was purified by flash column chromatography (silica, gradient elution starting 
from 30% EtOAc in hexane to 60% EtOAc in hexane) to afford compound S-1a as a 
yellow oil (1.32 g, 75%). TLC analysis Rf 0.24 (silica, 30% EtOAc in hexane); 
1H NMR 
(295 K, 400 MHz, CDCl3) δH 8.38 (1H, d, 3J 7.5, CONH), 7.94 (1H, d, 3J 7.5, py-H3), 
7.64 (1H, t, 3J 7.5, py-H4), 7.41 (2H, d, 3J 7.5, Ph-Ho), 7.35 (2H, t, 3J 7.5, Ph-Hm), 7.27-
7.25 (2H, m, Ph-Hp, py-H5) 5.26 (1H, dq, 3J 7, 3J 7.5 CHCH3), 2.49 (3H, s, py-CH3), 1.56 
(3H, d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 163.4 (CONH), 157.0 (py-
C6), 149.1 (py-C2), 143.3 (Ph-Ci), 137.4 (py-C4), 128.5 (Ph-Cm), 127.2 (Ph-Cp), 126.2 
(Ph-Co), 125.8 (py-C5), 119.3 (py-C3), 48.6 (CHCH3), 24.1 (py-CH3), 21.9 (CHCH3); m/z 
(HRMS+) 241.1334 [M+H]+ (C15H17ON2 requires 241.1335). 
 
(S)-6-Methyl-2-((1-phenylethyl)carbamoyl)pyridine 1-oxide, S-1b 
 
m-CPBA (1.89 g, 10.9 mmol) was added to a stirred solution of amide S-1a (1.32 g, 5.49 
mmol) in anhydrous CHCl3 (16 mL). The resulting solution was stirred at r.t. for 18 h 
under an argon atmosphere. The solution was washed with NaHCO3 (aq.) (0.5 M, 25 mL) 
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and extracted with CH2Cl2 (3 x 20 mL). The organic layers were combined, dried over 
MgSO4 and the solvent removed under reduced pressure. The crude mixture was purified 
by flash column chromatography (silica, gradient elution starting from 40% EtOAc in 
hexane to 70% EtOAc in hexane) to yield compound S-1b as a white crystalline solid 
(1.17 g, 83%). TLC analysis Rf 0.21 (silica, 60% EtOAc in hexane); m.p. 70 -71 °C; 
1H 
NMR (295 K, 400 MHz, CDCl3) δH 11.91 (1H, d, 3J 7.5, CONH), 8.34 (1H, dd, 3J 8, 4J 
2, py-H3), 7.40 (2H, m, Ph-Ho), 7.38 (1H, dd, 3J 8, 4J 2, py-H5), 7.34 (3H, m, Ph-Hm, Ph-
Hp), 7.25-7.23 (1H, m, py-H4), 5.31 (1H, dq, 3J 7, 3J 7.5 CHCH3), 2.57 (3H, s, py-CH3), 
1.62 (3H, d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC   159.4 (CONH), 150.3 
(py-C6), 143.5 (Ph-Ci) , 141 (py-C2), 128.9 (Ph-C), 128.1 (py-C5), 127.4 (py-C4), 127.1 
(py-C3), 126.5 (Ph-C), 126.4 (Ph-Co), 49.8 (CHCH3), 22.8 (CHCH3), 18.4 (py-CH3); m/z 
(HRMS+) 257.1280 [M+H]+ (C15H17N2O2 requires 257.1290). 
 
(S)-(2-((1-Phenylethyl)carbamoyl)pyridin-2-yl)methyl acetate, S-1c 
 
The N-oxide S-1b (700 mg, 2.73 mmol) was dissolved in acetic anhydride (14 mL) and 
the solution was heated to 120 °C for 24 h with stirring. The reaction progress was 
monitored by LCMS and TLC (silica, 50% EtOAc in hexane, Rf (product) 0.38, Rf 
(reactant) 0.16). The solvent was removed under reduced pressure and the residue purified 
by column chromatography (silica, gradient elution starting from 20% EtOAc in hexane 
to 70% EtOAc in hexane) to give S-1c as dark yellow oil (476 mg, 59%). TLC analysis 
Rf 0.38 (silica, 50% EtOAc in hexane); 
1H NMR (295 K, 400 MHz, CDCl3) δH 8.26 (1H, 
d, 3J 7.5, CONH), 8.14 (1H, d, 3J 8, py-H5), 7.86 (1H, t, 3J 8, py-H4), 7.48 (1H, d, 3J 8, 
py-H3), 7.42 – 7.25 (5H, m, Ph-H), 5.36 – 5.28 (1H, dq, 3J 7, 3J 7.5, CHCH3), 5.24 (2H, 
s, py-CH2), 2.16 (3H, s, COCH3), 1.63 (3H, d, 
3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, 
CDCl3) δC 170.6 (COCH3), 163.2 (CONH), 154.7 (py-C6), 149.7 (py-C2), 143.4 (Ph-Ci), 
138.3 (py-C4), 128.8 (Ph-Cm), 127.5 (Ph-Cp), 126.4 (Ph-Co), 124.1 (py-C3), 121.6 (py-
C5), 66.5 (py-CH2), 49.0 (CHCH3), 22.2 (CHCH3), 21.0 (COCH3); m/z (HRMS
+) 
299.1373 [M+H]+ (C17H19N2O3 requires 299.1396). 
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(S)-6-(Hydroxymethyl)-N-(1-phenylethyl)picolinamide, S-1d 
 
The ester, S-1c, (350 mg, 1.16 mmol) was dissolved in anhydrous CH3CH2OH (12 mL). 
A small amount of sodium metal (~ 5 mg) was added and the solution stirred at 40 °C 
under argon for 2 h. The solution was concentrated under reduced pressure and the residue 
dissolved in CH2Cl2 (100 mL). The sodium salts were extracted by washing with water 
(1 x 25 mL) and the aqueous layer was re-extracted with CH2Cl2 (3 x 20 mL). The organic 
layers were combined, dried over MgSO4, filtered and the solvent removed under reduced 
pressure. The crude residue was purified by column chromatography (silica, gradient 
elution starting from 40% EtOAc to 100% EtOAc) to yield compound S-1d as a white 
solid (330 mg, 85%). TLC analysis Rf 0.35 (silica, 70% EtOAc in hexane); m.p. 152 – 
154 °C; 1H NMR (295 K, 400 MHz, CDCl3) δH 8.21 (1H, s, 3J 7.5, CONH), 8.16 (1H, d, 
3J 7.5, py-H3), 7.89 (1H, t, 3J 7.5, py-H4), 7.49 (1H, d, 3J 7.5, py-H5), 7.43-7.25 (5H, m, 
Ph-H), 5.37 – 5.30 (1H, dq, 3J 7, 3J 7.5, CHCH3), 4.83 (2H, s, py-CH2), 2.91 (1H, br s, 
OH), 1.64 (3H, d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 163.1 (CONH), 
158.4 (py-C6), 149.1 (py-C2), 143.2 (Ph-Ci), 138.7 (py-C4), 128.9 (Ph-Cm), 127.6 (Ph-Cp), 
126.4 (Ph-Co), 123.5 (py-C5), 121.7 (py-C3), 64.6 (py-CH2), 49.1 (CHCH3), 22.1 
(CHCH3); m/z (HRMS
+) 257.1282 [M+H]+ (C15H17N2O2 requires 257.1290). 
 
(S)-(6-((1-Phenylethyl)carbamoyl)pyridine-2-yl)methyl methane sulfonate, S-1e 
 
The alcohol, S-1d, (227 mg, 0.886 mmol) was dissolved in anhydrous THF (5.5 mL) and 
NEt3 (0.37 mL, 2.66 mmol) was added. The mixture was stirred at 5 °C, methanesulfonyl 
chloride (0.12 mL, 1.49 mmol) was added and the reaction stirred at r.t. for 30 minutes 
and monitored by TLC (silica, 100% ethyl acetate, Rf (product) 0.63, Rf (reactant) 0.53). 
The solvent was removed under reduced pressure and the residue dissolved in CH2Cl2 (25 
mL) and washed with water (15 mL). The aqueous layer was re-extracted with CH2Cl2 (3 
x 10 mL) and the organic layers were combined, dried over MgSO4, filtered and the 
solvent removed under reduced pressure to leave compound S-1e, as a bright yellow oil, 
CHAPTER FIVE –EXPERIMENTAL DETAILS 
159 
 
which was used directly in the next step without further purification. TLC analysis Rf 0.63 
(silica, 100% ethyl acetate); 1H NMR (295 K, 400 MHz, CDCl3) δH 8.25 (1H, d, 3J 8, 
CONH), 8.19 (1H, d, 3J 8, py-H5), 7.91 (1H, t, 3J 8, py-H4), 7.59 (1H, d, 3J 8, py-H3), 7.42 
– 7.26 (5H, m, Ph-H), 6.36 (2H, s, py-CH2), 5.34 – 5.28 (1H, dq, 3J 7, 3J 8, CHCH3), 3.07 
(3H, s, SO2CH3), 1.63 (3H, d, 
3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 
162.8 (CONH), 152.5 (py-C6), 149.9 (py-C2), 143.3 (Ph-Ci), 138.7 (py-C4), 128.8 (Ph-
Cm), 127.5 (Ph-Cp), 126.4 (Ph-Co), 124.6 (py-C3), 122.4 (py-C5), 70.8 (py-CH2), 49.0 
(CHCH3), 38.3 (OSO2CH3), 22.1 (CHCH3);  m/z (HRMS)
+ 335.1066 [M+H]+ 
(C16H19N2O4S requires 335.1060). 
 
6,6’,6’’-((1,4,7-Triazonane-1,4,7-triyl)tris(methylene))tris(N-((S)-1-
phenylethyl)picolinamide, S-L30 
 
1,4,7-Triazacyclononane (55 mg, 0.427 mmol) and the mesylate, S-1e, (428 mg, 1.28 
mmol) were dissolved in anhydrous CH3CN (19.5 mL) and K2CO3 (59 mg, 0.427 mmol) 
was added. The mixture was stirred under argon at 78 °C. After 21 h the reaction was 
cooled and filtered to remove excess potassium salts. The solvent was removed under 
reduced pressure and the crude material purified by column chromatography (alumina, 
gradient elution starting from 100% CH2Cl2 to 5% CH3OH in CH2Cl2) to give S-L30 as a 
yellow glassy solid (180 mg, 55%); TLC analysis Rf 0.21 (alumina, 1% CH3OH in 
CH2Cl2); 
1H NMR (295 K, 400 MHz, CDCl3) δH 8.53 (3H, d, 3J 7, CONH), 8.08 (3H, d, 
3J 7.5, py-H3), 7.77 (3H, t, py-H4), 7.51 (3H, d, 3J 7, py-H5), 7.43 – 7.17 (15H, m, Ph-H), 
5.35 (3H, dq, 3J 7, 3J 7.5, CHCH3), 3.78 (6H, s, py-CH2), 2.79 (12H, s, ring Hs), 1.62 
(9H, d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 163.7 (CONH), 159.3 (py-
C2), 149.5 (py-C6), 143.6 (Ph-Ci), 137.9 (py-C4), 128.8 (Ph-Cm), 127.5 (Ph-Cp), 126.6 
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(Ph-Co), 125.9 (py-C5), 120.9 (py-C3), 64.6 (py-CH2), 56.3 (ring Cs), 49.0 (ring Cs), 46.0 
(CHCH3), 22.05 (CHCH3); m/z (HRMS
+) 844.4683 [M+H]+ (C51H58N9O3 requires 
844.4663). 
 
S-[Eu.L30](CF3SO3)3 
 
 
Europium (III) triflate (14 mg, 0.024 mmol) was added to a solution of ligand, S-L30, (19 
mg, 0.024 mmol) in anhydrous acetonitrile (2 mL) and the mixture heated at reflux for 20 
h. The solution was concentrated under reduced pressure and cold diethyl ether (2 mL) 
was added dropwise to the solution. The resulting white solid was filtered and dried under 
reduced pressure to yield S-[Eu.L30](CF3SO3)3 as a white solid (20 mg, 85%). 1H NMR 
(295 K, 400 MHz, CD3OD) δH major diastereoisomer: 7.6 (pyCH’N), 7.5 (py-H3),  7.4 
(py-H5),  7.3 (py-H4), 6.9 (Ph-Hp),  6.7 (Ph-Hm), 5.7 (Ph-Ho), 5.1 (NCH’ax), 4.0 (CHCH3), 
1.2 (CHCH3), -0.7 (pyCHN), -1.5 (NCHeq), -2.2 (NCH’eq), -6.6 (NCHax); m/z (HRMS+) 
992.3646 [M-2H]+ (C51H55N9O3
151Eu requires 992.3626); ɸem(H2O) = 0.07, τ(H2O) = 0.98 
ms, τ(D2O) = 1.42 ms, q = -0.1; tR = 5.63 min (analytical HPLC, Table 23).  
Crystals of the europium complex were grown by slow evaporation of aqueous methanol 
(1:1 v/v) and examined by X-ray crystallography: C51H57EuN9O3 x 3 CF3SO3, Mr = 
1443.22, trigonal (R3); a = 21.6392(5) Å, c = 11.4683(4) Å, V = 4650.6(2) Å3,  Z = 3; µ 
= 1.205 mm-1, Dcalc = 1.546 mg.mm
-3, T = 120 K; 62 469 reflections were measured (2.18 
≤ 2Θ ≤ 62.06), 5722 independent reflections (Rint = 0.0336), R1 = 0.0412, ωR2= 0.1043 (I 
≥ 2σ(I)), GOOF = 1.026. Flack parameter -0.0013(11), Hooft parameter 0.004(5), CCDC 
965909.  
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S-[Ce.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using cerium (III) triflate (7 mg, 0.012 
mmol) and the ligand S-L30 (10mg, 0.012 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Ce.L30](CF3SO3)3 as a white solid (10 mg, 85%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 9.6 (py-H3), 9.4 (py-H4), 8.4 (py-H5), 7.7 (Ph-H), 7.6 
(Ph-H), 6.2 (NCH’ax), 4.5 (CHCH3), 4.1 (pyCHN), 1.6 (NCH’eq), 1.3 (CHCH3), 0.3 
(NCHeq), -1.0 (NCHax); m/z (HRMS
+) 981.3506 [M-2H]+ (C51H55N9O3
140Ce requires 
981.3482). 
S-[Pr.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using praseodymium (III) triflate (7 mg, 
0.012 mmol) and the ligand S-L30 (10mg, 0.012 mmol) in dry acetonitrile (2 mL) was 
followed to yield S-[Pr.L30](CF3SO3)3, as a white solid (10 mg, 85%). 1H NMR (295 K, 
400 MHz, CD3OD) δH major diastereoisomer: 11.1 (py-H3), 10.5 (py-H4), 10.1 (py-H5), 
9.4 (NCH’ax), 8.4 (Ph-H), 8.2 (Ph-H), 8.1 (Ph-H), 6.4 (pyCHN), 4.1 (CHCH3),  1.6 
(NCHeq), 1.1 (CHCH3), 0.5 (pyCH’N), -1.3 (NCH’eq), -5.5 (NCHax);  m/z (HRMS+) 
982.3493 [M-2H]+ (C51H55N9O3
141Pr requires 982.3499). 
S-[Nd.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using neodymium (III) triflate (7 mg, 0.012 
mmol) and the ligand S-L30 (10mg, 0.012 mmol) in dry acetonitrile (2 mL) was followed 
to yield [Nd.L30]3+, as a white solid (9 mg, 72%). 1H NMR (295 K, 400 MHz, CD3OD) 
δH major diastereoisomer:  10.2 (py-H3), 9.3 (py-H4), 8.9 (py-H5), 7.5 (Ph-H), 7.2 
(pyCHN), 6.4 (Ph-H), 5.8 (NCHax), 5.3 (CHCH3), 4.1 (NCH’ax), 2.7 (NCHeq), 2.6 
(NCH’eq), 1.6 (CHCH3), 0.4 (pyCH’N); m/z (HRMS+) 983.3505 [M-2H]+ 
(C51H55N9O3
142Nd requires 983.3530). 
S-[Tb.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using terbium (III) triflate (10 mg, 0.017 
mmol) and the ligand S-L30 (15 mg, 0.017 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Tb.L30](CF3SO3)3, as a white solid (16 mg, 92%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 57.5 (NCHax), 29.9 (NCH’eq), 23.9 (NCHeq), 8.6 
(CHCH3), 5.8 (CHCH3), 4.5 (Ph-H
m), 2.0 (Ph-Ho), -3.2 (py-H4), -4.4 (py-H5), -11.0 (py-
H3), -12.4 (NCH’ax), -45.5 (pyCH’N); m/z (HRMS+) 1000.369 [M-2H]+ 
(C51H55N9O3
159Tb requires 1000.368); ɸem (H2O) = 0.50, τ(H2O) = 1.87 ms, τ(D2O) = 2.12 
ms. 
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S-[Dy.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using dysprosium (III) triflate (11 mg, 
0.017 mmol) and the ligand S-L30 (15 mg, 0.017 mmol) in dry acetonitrile (2 mL) was 
followed to yield S-[Dy.L30](CF3SO3)3, as a white solid (15 mg, 88%). 1H NMR (295 K, 
400 MHz, CD3OD) δH major diastereoisomer, partial assignment: 22.5 (NCH’ax), 18.2, 
11.1, 7.0, 6.5 (Ph-H), 6.2 (Ph-H), 5.6, 5.0 (py-H4), 3.0 (py-H5), 1.9 (py-H3), -1.5, -3.7 
(pyCHN), -4.8, -14.0, 18.0;  m/z (HRMS+) 1002.371 [M-2H]+ (C51H55N9O3
161Dy requires 
1002.370); ɸem (H2O) = 0.01, τ(H2O) = 0.04 ms. 
S-[Ho.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using holmium (III) triflate (8 mg, 0.013 
mmol) and the ligand S-L30 (11 mg, 0.013 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Ho.L30](CF3SO3)3, as a white solid (13 mg, 99%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer, partial assignment: 47.3 (NCHax), 23.3 (NCH’eq), 22.6 
(NCHeq), 11.9, 10.2, 9.8, 7.2 (CHCH3), 5.8 (CHCH3), 5.5 (Ph-H
m), 5.1 (Ph-Ho), 0.5 (py-
H5), -0.4 (py-H4), -3.7 (NCH’ax), -5.5 (py-H3), -32.0 (pyCH’N);  m/z (HRMS+) 1006.374 
[M-2H]+ (C51H55N9O3
165Ho requires 1006.373). 
S-[Er.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using erbium (III) triflate (7 mg, 0.012 
mmol) and the ligand S-L30 (10 mg, 0.012 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Er.L30](CF3SO3)3, as a white solid (12 mg, 99%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 12.8, 8.2 (py-H3), 8.0 (py-H5), 7.9 (py-H4), 7.5 (Ph-
HP), 6.9 (Ph-Hm), 6.1 (Ph-Ho), 3.6, 1.9 (CHCH3), 1.8 (pyCHN), 0.9 (CHCH3), -5.0 
(NCHeq), -5.1 (NCH’eq), -8.8 (NCHax); m/z (HRMS+) 1009.380 [M-2H]+ 
(C51H55N9O3
168Er requires 1009.377). 
S-[Tm.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using thulium (III) triflate (7 mg, 0.012 
mmol) and the ligand S-L30 (10 mg, 0.012 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Tm.L30](CF3SO3)3, as a white solid (11 mg, 91%). 1H NMR (295 K, 400 
MHz, CD3OD) δH major diastereoisomer: 70.4 (pyCH’N), 23.0 (py-H3), 19.6 (py-H4), 
19.2 (py-H5), 11.3 (NCH’ax), 10.8 (Ph-Ho), 10.7 (Ph-Hp), 10.4 (Ph-Hm), 9.3 (CHCH3), -
7.5 (CHCH3), -22.0 (pyCHN), -29.0 (NCHeq), -30.5 (NCH’eq), -79.8 (NCHax); m/z 
(HRMS+) 101.375 [M-2H]+ (C51H55N9O3
169Tm requires 1010.376). 
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S-[Yb.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using ytterbium (III) triflate (10 mg, 0.017 
mmol) and the ligand S-L30 (15 mg, 0.017 mmol) in dry acetonitrile (2 mL) was followed 
to yield S-[Yb.L30](CF3SO3)3, as a white solid (15 mg, 85%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 22.3 (pyCH’N), 11.6 (py-H3), 11.4 (py-H5), 11.2 (py-
H4), 8.9 (NCH’ax), 8.3 (Ph-Hm), 8.2 (Ph-Hp), 7.6 (Ph-Ho), 6.2 (CHCH3), -1.1 (CHCH3), -
2.8 (pyCHN), -4.2 (NCHeq), -6.7 (NCH’eq), -18.8 (NCHax); m/z (HRMS+) 1012.382 [M-
2H]+ (C51H55N9O3
171Yb requires 1012.379).  
Crystals of the ytterbium complex were grown by slow evaporation of aqueous methanol 
(1:1 v/v) and examined by X-ray crystallography: C54H57F9N9O12S3Yb, Mr = 1464.30, 
trigonal (R3); a = 21.836(2) Å, c = 11.1868(17) Å, V = 4619.5(10) Å3,  Z = 3; µ = 1.713 
mm-1, Dcalc = 1.579 mg.mm
-3, T = 120 K; 65 596 reflections measured (2.16 ≤ 2Θ ≤ 
62.06), 5472 independent reflections (Rint = 0.0398), R1 = 0.0437, ωR2= 0.1116 (I ≥ 2σ(I)), 
GOOF = 1.053, Flack parameter -0.018(11), Hooft parameter 0.003(3). CCDC 965911.  
R-L30 was synthesised in an analogous manner to the S series starting from R-(+)-α-
methylbenzyl amine. 
R-[Eu.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using europium (III) triflate (14 mg, 0.023 
mmol) and the ligand R-L30 (20mg, 0.023 mmol) in dry acetonitrile (2 mL) was followed 
to yield R-[Eu.L30](CF3SO3)3 as a white solid (22 mg, 96%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 7.6 (pyCH’N), 7.5 (py-H3),  7.4 (py-H5),  7.3 (py-H4), 
6.9 (Ph-Hp),  6.7 (Ph-Hm), 5.7 (Ph-Ho), 5.1 (NCH’ax) 4.0 (CHCH3), 1.2 (CHCH3), -0.7 
(pyCHN), -1.5 (NCHeq), -2.2 (NCH’eq), -6.6 (NCHax); m/z (HRMS+)  992.3674 [M-2H]+ 
(C51H55N9O3
151Eu requires 992.3626).  
Crystals of the europium complex were grown by slow evaporation of aqueous methanol 
(1:1 v/v) and examined by X-ray crystallography: C51H57EuN9O3 x 3 CF3SO3, Mr = 
1443.22, trigonal (R3); a = 21.6423(8) Å, c = 11.5027 Å, V = 4665.9 Å3,  Z = 3; µ = 1.201 
mm-1, Dcalc = 1.541 mg.mm
-3, T = 120 K; 29 561 reflections were measured (3.76 ≤ 2Θ ≤ 
62), 6082 independent reflections (Rint = 0.0267), R1 = 0.0281, ωR2= 0.0740 (I ≥ 2σ(I)), 
GOOF = 1.029, Flack parameter -0.012(7), Hooft parameter -0.009(2). CCDC 965910.  
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R-[Tb.L30](CF3SO3)3 
An analogous method to that for S-[Eu.L30]3+ using terbium (III) triflate (19 mg, 0.032 
mmol) and the ligand R-L30 (27 mg, 0.032 mmol) in dry acetonitrile (2 mL) was followed 
to yield R-[Tb.L30] (CF3SO3)3 as a white solid (31 mg, 97%). 1H NMR (295 K, 400 MHz, 
CD3OD) δH major diastereoisomer: 57.5 (NCHax), 29.9 (NCH’eq), 23.9 (NCHeq), 8.6 
(CHCH3), 5.8 (CHCH3), 4.5 (Ph-H
m), 2.0 (Ph-Ho), -3.2 (py-H4), -4.4 (py-H5), -11.0 (py-
H3), -12.4 (NCH’ax), -45.5 (pyCH’N); m/z (HRMS+) 1000.368 [M-2H]+ 
(C51H55N9O3
159Tb requires 1000.368). 
 
5.2.2. [Ln.L31a-d]3+ and precursors 
 
Dimethyl 4-chloropyridine-2,6-dicarboxylate, CAS: 5371-70-0 220  
 
 
Chelidamic acid (1.00 g, 5.46 mmol) was dissolved in thionyl chloride (5.6 mL) and a 
few drops of DMF were added. The solution was stirred at 100 °C for 48 h. After complete 
consumption of the starting material (monitored by LC-MS), the thionyl chloride was 
removed by vacuum distillation. The residue was dissolved in dry CH2Cl2 (3 mL) and 
cooled to 0 °C. Dry CH3OH (4 mL) was added dropwise over a period of 10 minutes and 
the reaction mixture was brought to room temperature. The solvent was removed under 
reduced pressure and the residue was washed with NaHCO3 (sat. aq.,15 mL) and extracted 
into CH2Cl2 (3 x 40 mL). The organic layers were combined, washed successively with 
water (1 x 50 mL) and brine (1 x 50 mL), dried over MgSO4, filtered and the solvent 
removed under reduced pressure to yield the title compound as an orange solid (1.196 g, 
95%), which was used directly in the next step with no further purification. TLC analysis 
Rf 0.60 (silica, 5% CH3OH in CH2Cl2); m.p. 141 – 143 °C (lit. 142 °C)221; 1H NMR (295 
K, 400 MHz, CDCl3) δH 8.29 (2H, s, py-H), 4.02 (6H, s, CO2CH3); 13C NMR (295 K, 100 
MHz, CDCl3) δC 164.2 (CO2CH3), 149.5 (py-C), 146.9 (py-C), 128.4 (py-C), 53.6 (CO-
2CH3) ; m/z (HRMS
+) 230.0206 [M+H]+ (C9H9NO4Cl requires 230.0220). 
 
 
CHAPTER FIVE –EXPERIMENTAL DETAILS 
165 
 
Dimethyl 4-iodopyridine-2,6-dicarboxylate CAS: 112776-84-8 220 
 
Sodium iodide (3.16 g, 21.1 mmol) was added to a solution of dimethyl 4-chloropyridine-
2,6-dicarboxylate (478 mg, 2.11 mmol) in dry acetonitrile (25 mL) and the solution was 
sonicated (bath sonicator) for 30 min. Acetyl chloride (0.45 mL, 6.33 mmol) was added 
and the mixture was sonicated for a further 45 min. The solvent was removed under 
reduced pressure and the residue redissolved in CH2Cl2. The solution was washed with 
sat. Na2CO3 (30 mL) and the organic phase separated. The aqueous phase was extracted 
into CH2Cl2 (3 x 25 mL) and all the organic layers were combined, washed successively 
with Na2S2O3.5H2O (sat. aq., 25 mL), water (25 mL), dried over MgSO4, filtered, and the 
solvent removed under reduced pressure. The crude mixture was purified by flash column 
chromatography (silica, gradient elution starting from 100% CH2Cl2 to 1% CH3OH in 
CH2Cl2) to yield the compound as a white solid (546 mg, 81%). TLC analysis Rf 0.62 
(silica, 5% CH3OH in CH2Cl2); m.p. 179-180 °C (lit. 174-175 °C)
222; 1H NMR (295 K, 
400 MHz, CDCl3) δH 8.66 (2H, s, py-H), 4.02 (6H, s, CO2CH3); 13C NMR (295 K, 100 
MHz, CDCl3) δC 164.0 (CO2CH3), 148.4 (py-C), 137.3 (py-C), 107.1 (py-C), 53.6 
(CO2CH3) ; m/z (HRMS
+) 321.9569 [M+H]+ (C9H9NO4I requires 321.9576). 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate, 3a, CAS: 1247012-08-3 223 
 
Dimethyl 4-iodopyridine-2,6-dicarboxylate (376 mg, 1.17 mmol) was dissolved in a 
solution of dry CH2Cl2 (3 mL) and dry CH3OH (2 mL) and cooled to 0 °C. NaBH4 (49 
mg, 1.29 mmol) was added to the solution and the reaction was stirred at 0 °C for 1.5 h. 
The mixture was quenched with the addition of 1 M HCl (2 mL). The volatile components 
were removed under vacuum and the aqueous solution was extracted into EtOAc (3 x 25 
mL). The organic layers were combined, dried over MgSO4, filtered and the solvent 
removed under vacuum. The crude solid was purified using flash column chromatography 
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(silica, gradient elution starting from 100% CH2Cl2 to 2% CH3OH in CH2Cl2) to give 3a 
as a white solid (247 mg, 72%). TLC analysis Rf 0.27 (silica, 5% CH3OH in CH2Cl2); 
m.p. 140 – 141 °C; 1H NMR (295 K, 400 MHz, CDCl3) δH 8.38 (1H, s, py-H3), 7.96 (1H, 
s, py-H5), 4.81 (2H, s, CH2OH), 3.99 (3H, s, CO2CH3); 
13C NMR (295 K, 100 MHz, 
CDCl3) δC 164.5 (CO2CH3), 161.2 (C6), 147.4 (C2), 133.3 (C3/5), 133.2 (C3/5), 106.4 (C4), 
64.2 (CH2OH), 53.3 (CO2CH3); m/z (HRMS
+) 293.9630 [M+H]+ (C8H9NO3I requires 
293.9627); CHN% Found: C, 33.03; H, 2.76; N, 4.80% (C8H8
127INO3 requires C, 32.79; 
H, 2.75; N, 4.78%). 
 
6-(Hydroxymethyl)-4-iodopicolinic acid, 3b 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate (200 mg, 0.683 mmol) was dissolved in a 
mixture of ethanol:water (6 mL, 1:1, v/v) and NaOH (2 M, 0.5 mL) was added dropwise. 
The solution was stirred at room temperature for 1 h. The ethanol was removed under 
reduced pressure and the aqueous layer was acidified to pH = 4 using a 2 M HCl solution 
until a white precipitate was formed. The solid was extracted into EtOAc (4 x 50 mL), 
dried over MgSO4 and concentrated under reduced pressure to yield the compound 3b as 
a white solid (168 mg, 88%) which was used directly in the next step without further 
purification. TLC analysis Rf  0.08 (silica, 15% CH3OH in CH2Cl2); m.p. > 190 °C (dec.); 
1H NMR (295 K, 400 MHz, MeOD) δH 8.38 (1H, s, py-H3), 8.16 (1H, s, py-H5), 4.72 (2H, 
s, py-CH2); 
13C NMR (295 K, 100 MHz, MeOD) δC 166 (COOH), 164 (C6), 149 (C2), 
134 (C5), 133 (C3), 108 (C4), 64.7 (py-CH2); m/z (HRMS
+) 279.9478 [M+H]+ 
(C7H7NO3
127I requires 279.9471). 
(S)-6-(Hydroxymethyl)-4-iodo-N-(1-phenylethyl)picolinamide, S-3c 
 
HOBt.H2O (442 mg, 3.27 mmol), EDC (507 mg, 3.27 mmol), DIPEA (0.76 mL, 4.36 
mmol) and (S)-(-)-α-methylbenzyl amine (0.30 mL, 2.40 mmol) were dissolved in 
anhydrous DMF:CH2Cl2 (4 mL, 1:1, v/v). The carboxylic acid, 3b, (608 mg, 2.18 mmol 
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in 1 mL DMF) was added slowly and dropwise to the solution and the mixture stirred at 
r.t. for 22 h under an argon atmosphere. The solvent was removed under reduced pressure, 
water was added to the crude residue and the mixture extracted with EtOAc (4 x 40 mL). 
The organic layers were combined and washed successively with water (40 mL) and brine 
(40 mL), dried over MgSO4 and the solvent removed under reduced pressure. The crude 
mixture was purified by flash column chromatography (silica, gradient elution starting 
from 20% EtOAc in hexane to 50% EtOAc in hexane) to afford S-3c as a yellow oil (510 
mg, 61%). TLC analysis Rf 0.38 (silica, 50% EtOAc in hexane); 
1H NMR (295 K, 400 
MHz, CDCl3) δH 8.48 (1H, s, py-H3), 8.08 (1H, d, 3J 8.5, CONH), 7.92 (1H, s, py-H5), 
7.39 – 7.38 (2H, m, Ph-Ho), 7.36-7.34 (2H, m, Ph- Hm), 7.29-7.27 (1H, m, Ph-Hp), 5.32 
(1H, dq, 3J 8.5, 3J 7, CHCH3) , 4.76 (2H, s, py-CH2), 1.62 (3H, d, 
3J 7, CHCH3); 
13C NMR 
(295 K, 100 MHz, CDCl3) δC 161.9 (CONH), 159.5 (py-C6), 149.3 (py-C2), 143.0 (Ph-
Ci), 132.6 (py-C5), 130.9 (py-C3), 128.9 (Ph-Cm), 127.6 (Ph-Cp), 126.4 (Ph-Co), 108.0 
(py-C4), 64.3 (py-CH2), 49.1 (CHCH3), 21.9 (CHCH3); m/z (HRMS
+) 383.0271 [M+H]+ 
(C15H16N2O2I
127 requires 383.0257). 
 
(4-(Trimethylsilyl)ethynyl)acetanilide, CAS: 81854-47-9  
 
4-((Trimethylsilyl)ethynyl)aniline (200 mg, 1.06 mmol) was dissolved in anhydrous 
CH2Cl2 (3 mL) and acetic anhydride (0.12 mL, 1.27 mmol) was added dropwise. The 
solution was stirred at room temperature under an argon atmosphere for 2 h. The reaction 
mixture was washed with Na2CO3 solution (sat. aq., 25 mL) and extracted into CH2Cl2 (3 
x 25 mL). The organic layers were combined, dried over MgSO4, filtered and the solvent 
removed under reduced pressure to yield the alkyne as a pale brown solid. TLC analysis 
Rf 0.32 (silica, 50% EtOAc in hexane); m.p. 152 – 153 °C; 1H NMR (295 K, 400 MHz, 
CDCl3) δH 7.47-7.40 (4H, m, Ar-H), 2.17 (3H, s, COCH3), 0.24 (9H, s, Si(CH3)3); 13C 
NMR (295 K, 100 MHz, CDCl3) δC 168.3 (COCH3), 138.2 (Ar-C), 132.9 (Ar-C), 119.3 
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(Ar-C), 118.9 (Ar-C), 104.9 (alkyne C), 93.8 (alkyne C), 24.9 (COCH3), 0.1 (Si(CH3)3); 
m/z (HRMS+) 232.1148 [M+H]+ (C13H18NOSi requires 232.1158). 
 
N-(4-Ethynylphenyl)acetamide, CAS: 35447-83-7 
 
(4-(Trimethylsilyl)ethynyl)acetanilide (213 mg, 0.921 mmol) was dissolved in anhydrous 
THF (3.5 mL) and triethylammonium trihydrofluoride (1.50 mL, 9.21 mmol) was added. 
The mixture was stirred at 35 °C under argon for 48 h. The solvent was removed under 
reduced pressure to give an off-white solid which was purified by column 
chromatography (silica, gradient elution starting from 100% hexane to 40% EtOAc in 
hexane) to afford the alkyne as a white solid (104 mg, 71 %). TLC analysis Rf 0.31 (silica, 
40% EtOAc in hexane); m.p. 115 – 117 °C; 1H NMR (295 K, 700 MHz, CDCl3) δH 7.64 
(1H, s, NH), 7.48 (2H, d, 3J 8.5, Ar-H
2,2’), 7.43 (2H, d, 3J 8.5, Ar-H
3,3’),  3.04 (1H, s, H6), 
2.17 (3H, s, COCH3); 
13C NMR (295 K, 175 MHz, CDCl3) δC 168.7 (COCH3), 138.5  
(C1), 133.0 (C3,3’), 119.5 (C2,2’), 117.8 (C4), 83.5 (C5), 76.8 (C6), 24.8 (COCH3); m/z 
(HRMS+) 160.0751 [M+H]+ (C10H10NO requires 160.0762). 
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(S)-6-(Hydroxymethyl)-N-(1-phenylethyl)-4-(phenylethynyl)picolinamide 
 
 
 
General Sonogashira cross coupling reaction:  
The compound S-3c (100 mg, 0.262 mmol) was dissolved in anhydrous THF (2 mL) and 
the solution was degassed (freeze-thaw cycle) three times. Phenylacetylene (40 μL, 0.393 
mmol) and triethylamine (0.18 mL, 1.31 mmol) were added and the solution was degassed 
(freeze-thaw cycle) once more. [1,1-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (19 mg, 26 µmol) and CuI (10 
mg, 52 µmol) were added and the resulting brown solution was stirred at 65 °C under 
argon for 24 h. The solvent was removed under reduced pressure and the resulting brown 
oil was purified by column chromatography (silica, gradient elution starting from 100% 
CH2Cl2 to 2% CH3OH in CH2Cl2 in 0.2% increments) to give the title compound as a 
yellow oil (91 mg, 98%). TLC analysis Rf  0.32 (silica, 1% CH3OH in CH2Cl2); 
1H NMR 
(295 K, 400 MHz, CDCl3) δH 8.19 (1H, br s, py-H3), 8.15 (1H, d, 3J 9, CONH),  7.57 – 
7.54 (3H, m, H3,3’, py-H5), 7.42-7.27 (8H, m, H1, H2,2’, Ph-H), 5.35 (1H, dq, 3J 9, 3J 7, 
CHCH3), 4.80 (2H, s, py-CH2), 1.63 (3H, d, 
3J 7 CHCH3); 
13C NMR (295 K, 100 MHz, 
CDCl3) δC 162.9 (CONH), 159.1 (py-C6), 149.2 (py-C2), 143.1 (Ph-Ci), 134.0 (C4), 132.1 
(Ar-C), 129.6 (Ar-C), 128.8 (Ph-C), 128.6 (Ph-C), 127.5 (py-C5), 126.4 (Ph-C), 124.9 
(py-C4), 123.4 (py-C3), 121.9 (C1), 95.4 (C5), 86.5 (C6), 64.7 (py-CH2), 49.0 (CHCH3), 
21.9 (CHCH3); m/z (HRMS
+) 357.1608 [M+H]+ (C23H21N2O2 requires 357.1603). 
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(S)-Methyl 4-((2-(hydroxymethyl)-6-(1-phenylethylcarbamoyl)pyridin-4-
yl)ethynyl)benzoate 
 
 The title compound was obtained as a yellow oil (97 mg, 89%) according to the general 
cross coupling procedure. TLC analysis Rf 0.19 (silica, 1% CH3OH in CH2Cl2); 
1H NMR 
(295 K, 400 MHz, CDCl3) δH 8.21 (1H, br s, py-H5), 8.13 (1H, d, 3J 7, CONH), 8.04 (2H, 
d, 3J 8, Ar-H2,2’), 7.62-7.60 (3H, m, Ar-H3,3’, py-H3), 7.42-7.28 (5H, m, Ph-H), 5.35 (1H, 
dq, 3J 7, 3J 7, CHCH3), 4.82 (2H, s, py-CH2), 3.94 (3H, s, CO2CH3), 2.80 (1H, br s, OH), 
(1.64, 3H, d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 166.4 (CO2Me), 
162.8 (CONH), 159.4 (py-C2), 149.4 (py-C6), 143.0 (Ph-Ci), 133.4 (C4), 132.0 (C3,3’), 
130.7 (C1), 129.7 (C2,2’), 128.8 (Ph-Cm), 127.6 (Ph-Cp), 126.4 (Ph-Co), 125.0 (py-C3), 
123.4 (py-C5), 94.1 (C5), 89.0 (C6), 64.7 (py-CH2), 52.5, 49.0 (CHCH3), 21.9 (CHCH3); 
m/z (HRMS+) 415.1643 [M+H]+ (C25H23N2O4 requires 415.1658). 
 
(S)-6-(Hydroxylmethyl)-4-((4-methoxyphenyl)-N-(1-phenylethyl)picolinamide 
 
 
The title compound was obtained as a yellow oil (190 mg, 94%) according to the general 
cross coupling procedure. TLC analysis Rf 0.18 (silica, 1% CH3OH in CH2Cl2); 
1H NMR 
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(295 K, 400 MHz, CDCl3) δH 8.17 (1H, br s, py-H3), 8.12 (1H, d, 3J 7.5, CONH), 7.53 
(1H, br s, py-H5), 7.49 (2H, dt, 4J 2, 3J 9, H3,3’), 7.42-7.35 (4H, m, Ph-Ho, Ph-Hm), 7.29-
7.27 (1H, m, Ph-Hp), 6.90 (2H, dt, 4J 2, 3J 9, H2,2’), 5.36 (1H, dq, 3J 7.5, 3J 7, CHCH3), 
4.80 (2H, s, py-CH2), 3.84 (3H, s, OCH3), 2.77 (1H, br s, OH), 1.64 (3H, d, 
3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 162.9 (CONH), 160.7 (C1), 158.7 (py-C6), 149.4 
(py-C2), 143.2 (Ph-Ci), 134.5 (C4), 133.8 (C3,3’), 128.9 (Ph-C), 127.6 (Ph-C), 126.4 (Ph-
C) 124.7 (py-C5), 123.4 (py-C3), 114.4 (C2,2’), 114.0 (py-C4), 96.0 (C5), 85.6 (C6), 64.7 
(py-CH2), 55.5 (OCH3), 49.0 (CHCH3), 22.0 (CHCH3); m/z (HRMS
+) 387.1701 [M+H]+ 
(C24H23N2O3 requires 387.1709).  
 
(S)-4-((4-acetamidophenyl)ethynyl)-6-(hydroxymethyl)-N-(1-
phenylethyl)picolinamide 
 
The title compound was obtained as a yellow oil (122 mg, 68%) according to the general 
cross coupling procedure. TLC analysis Rf 0.49 (silica, 5% CH3OH in CH2Cl2); m.p. >200 
°C (dec.); 1H NMR (295 K, 400 MHz, d6-DMSO) δH 10.19 (1H, s, NHOAc), 9.01 (1H, d, 
3J 8.5, CONH), 7.89 (1H, br s, py-H3), 7.68-7.67 (3H, m, py-H5, Ar-H3,3’), 7.59-7.57 (2H, 
m, Ar-H2,2’), 7.42-7.33 (4H, m, Ph-Ho, Ph-Hm), 7.24 (1H, t, 3J 7, Ph-Hp), 5.59 (1H, br t, 
3J 6.5, OH), 5.21 (1H, dq, 3J 8.5, 3J 7, CHCH3), 4.68 (2H, d, 
3J 6.3, py-CH2), 2.07 (3H, 
s, NHCOCH3), 1.54 (3H, d, 
3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, d6-DMSO) δC 
168.7 (NHCOCH3), 162.4 (CONH), 161.6 (py-C
6), 149.5 (py-C2), 144.1 (Ci), 140.7 (C1), 
132.7 (C2,2’), 128.3 (Ph-Cm), 126.8 (Ph-Cp), 126.2 (Ph-Co), 123.9 (py-C5), 121.3 (py-C3), 
118.8 (C3,3’), 114.9 (C4), 94.7 (C5), 85.9 (C6), 63.6 (py-CH2), 48.2 (CHCH3), 24.1 
(NHCOCH3), 21.9 (CHCH3); m/z (HRMS
+) 414.1803 [M+H]+ (C25H24N3O3 requires 
414.1818). 
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(S)-(6-(1-Phenylethylcarbamoyl)-4-(phenylethynyl)pyridin-2-yl)methyl 
methanesulfonate 
 
General mesylation procedure: 
The alcohol, (S)-6-(hydroxymethyl)-N-(1-phenylethyl)-4-(phenylethynyl)picolinamide 
(91 mg, 0.256 mmol) was dissolved in anhydrous THF (2 mL) and NEt3 (0.12 mL, 0.896 
mmol) was added. The mixture was stirred at 5 °C (ice / water bath) and methanesulfonyl 
chloride (30 µL, 0.383 mmol) was added. The reaction was allowed to warm r.t. and 
stirred under argon for 30 minutes. The solvent was removed under reduced pressure and 
the residue dissolved in CH2Cl2 (15 mL) and washed with water (15 mL). The aqueous 
layer was re-extracted with CH2Cl2 (3 x 15 mL) and the organic layers were combined, 
dried over MgSO4, filtered and the solvent removed under reduced pressure to yield the 
title compound, as a bright yellow oil (111 mg, 99%), which was used directly in the next 
step without further purification. TLC analysis Rf 0.75 (silica, 100% EtOAc); 
1H NMR 
(295 K, 400 MHz, CDCl3) δH 8.25 (1H, d, 4J 2, py-H5), 8.22 (1H, d, 3J 9, CONH), 7.65 
(1H, d, 4J 2, py-H3), 7.58 – 7.56 (2H, m, Ar-H), 7.43 – 7.27 (8H, m, Ar-H, Ph-H), 5.35 
(2H, s, py-CH2), 5.33 (1H, dq, 
3J 9, 3J 7, CHCH3), 3.10 (3H, s, SO2CH3), 1.64 (3H, d, 
3J 
7, CHCH3); m/z (HRMS
+) 435.1374 [M+H]+ (C24H23N2O4S requires 435.1379). 
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(S)-Methyl 4-((2-((methylsulfonyloxy)methyl)-6-(1-phenylethylcarbamoyl)pyridin-
4-yl)ethynyl)benzoate 
 
The title compound was obtained as a yellow oil (101 mg, 88%) according to the general 
mesylation procedure. TLC analysis Rf 0.75 (silica, 100% EtOAc); 
1H NMR (295 K, 400 
MHz, CDCl3) δH 8.27 (1H, br s, py-H5), 8.21 (1H, d, 3J 8.5, CONH), 8.06 (2H, d, 3J 8.5, 
H2,2’), 7.67 (1H, br s, py-H3), 7.63 (2H, d, 3J 8.5, H3,3’), 7.43-7.35 (4H, m, Ph-Ho, Ph-Hm), 
7.28 (1H, t, 3J 7, Ph-Hp), 5.36 (2H, s, py-CH2), 5.33 (1H, dq 
3J 8.5, 3J 7, CHCH3), 3.94 
(3H, s, CO2CH3), 3.11 (3H, s, SO2CH3), 1.64 (3H, d, 
3J 7, CHCH3); 
13C NMR (295 K, 
100 MHz, CDCl3) δC 166.4 (CO2CH3), 162.2 (CONH), 153.0 (py-C6), 150.2 (py-C2), 
143.1 (Ph-Ci), 134.0 (C4), 132.1 (C3,3’), 130.9 (C1), 129.8 (C2,2’), 128.9 (Ph-Cm), 127.6 
(Ph-Cp), 126.4 (Ph-Co), 125.9 (py-C3), 124.4 (py-C5), 94.9 (C5), 88.5 (C6), 70.2 (py-CH2), 
52.5 (CO2CH3), 49.1 (CHCH3), 38.4 (SO2CH3), 22.1 (CHCH3); m/z (HRMS
+) 493.1421 
[M+H]+ (C26H25N2O6S requires 493.1433). 
 
(S)-(4-((4-Methoxyphenyl)ethynyl-6-((1-phenylethylcarbamoyl)pyridine-2-
yl)methyl methane sulfonate 
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The title compound was obtained as a yellow oil (165 mg, 98%) according to the general 
mesylation procedure. TLC analysis Rf 0.78 (silica, 100% EtOAc); 
1H NMR (295 K, 400 
MHz, CDCl3) δH 8.23 (1H, br s, py-H5), 8.12 (1H, br s, CONH), 7.62 (1H, br s, py-H3), 
7.51 (2H, d, 3J 8.5, H3,3’), 7.42-7.28 (5H, m, Ph-H), 6.91 (2H, d, 3J 8.5, H2,2’), 5.34 (2H, 
s, py-CH2), 5.32 (1H, t, 
3J 7, CHCH3), 3.85 (3H, s, OCH3), 3.10 (OSO2CH3), 1.64 (3H, 
d, 3J 7, CHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 162.5 (CONH), 160.8 (C1), 
152.7 (py-C2), 150.1 (py-C6), 143.2 (Ph-Ci), 135.0 (C4), 133.9 (C3,3’), 128.9 (Ph-C), 127.6 
(Ph-C), 126.4 (Ph-C) 125.7 (py-C3), 124.2 (py-C5), 114.4 (C2,2’), 96.7 (C5), 85.4 (C6), 
70.4 (py-CH2), 55.5 (OCH3), 49.1 (CHCH3), 38.4 (OSO2CH3), 22.1 (CHCH3). 
 
(S)-(4-((4-Acetamidophenyl)ethynyl)-6-(1-phenylethylcarbamoyl)pyridin-2-
yl)methyl methanesulfonate,  
 
The title compound was obtained as a yellow oil (110 mg, 84%) according to the general 
mesylation procedure.  TLC analysis Rf 0.51 (silica, 100 % EtOAc); 
1H NMR (295 K, 
400 MHz, d3-acetonitrile) δH 8.50 (1H, s, NHCOCH3), 8.45 (1H, d, 3J 8.5, CONH), 8.05 
(1H, d, 4J 2, py-H5), 7.67 (1H, d, 4J 2, py-H3), 7.61 (2H, dt, 3J 9, 4J 2, Ar-H3,3’), 7.52 (2H, 
dt, 3J 9, 4J 2, Ar-H2,2’), 7.39-7.21 (5H, m, Ph-H), 5.33 (2H, s, py-CH2), 5.18 (1H, dq, 
3J 
8.5, 3J 7, CHCH3), 3.12 (3H, s, SO2CH3), 2.04 (3H, s, NHCOCH3), 1.53 (3H, d, 
3J 7, 
CHCH3); m/z (HRMS
+) 492.1594 [M+H]+ (C26H26N3O5S requires 492.1593). 
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6,6',6''-(1,4,7-Triazonane-1,4,7-triyl)tris(methylene)tris(N-((S)-1-phenylethyl)-4-
(phenylethynyl)picolinamide), S-L31a 
 
General alkylation procedure: 
1,4,7-Triazacyclononane trihydrochloride (20 mg, 0.085 mmol) and the mesylate, (S)-(6-
(1-phenylethylcarbamoyl)-4-(phenylethynyl)pyridin-2-yl)methyl methanesulfonate, 
(111 mg, 0.256 mmol) were dissolved in anhydrous CH3CN (4.5 mL) and K2CO3 (71 mg, 
0.512 mmol) was added. The mixture was stirred under argon at 78 °C. After 24 h the 
reaction was cooled and filtered to remove excess potassium salts. The solvent was 
removed under reduced pressure and the crude material purified by column 
chromatography (silica, gradient elution starting from 100% CH2Cl2 to 10% CH3OH in 
CH2Cl2) to give S-L31a as a yellow glassy solid (35 mg, 36%). TLC analysis Rf 0.42 
(silica, 5% CH3OH in CH2Cl2); 
1H NMR (295 K, 600 MHz, CDCl3) δH 8.21 (3H, br s, 
py-H3), 7.51 (6H, d, 3J 7, H3,3’), 7.42-7.33 (15H, m, py-H5, H1, H2,2’, Ph-Ho), 7.24 (6H, 
m, Ph-Hm), 7.16 (3H, t, 3J 7.2, Ph-Hp), 5.34 (3H, q, 3J 6.5, CHCH3), 3.87 (6H, s, py-CH2), 
2.84 (12H, br s, ring Hs), 1.63 (9H, d, 3J 6.5, CHCH3); 
13C NMR (295 K, 150 MHz, 
CDCl3) δC 163.1 (CONH), 159.4 (py-C6), 149.8 (py-C2), 143.3 (Ph-Ci), 133.4 (C4), 132.1 
(Ar-C), 129.5 (Ar-C), 128.7 (Ph-Cm), 127.4 (Ph-Cp), 127.1 (py-C5), 126.4 (Ph-Co), 122.9 
(py-C3), 122.0 (C1), 94.8 (C5), 86.8 (C6), 64.1 (py-CH2), 56.2 (ring Cs), 48.9 (CHCH3), 
21.9 (CHCH3); m/z (HRMS
+) 1144.562 [M+H]+ (C75H70N9O3 requires 1144.560). 
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Trimethyl 4,4',4''-(S,S)-6,6',6''-(1,4,7-triazonane-1,4,7-triyl)tris(methylene)tris(2-
((S)-1-phenylethylcarbamoyl)pyridine-6,4-diyl)tris(ethyne-2,1-diyl)tribenzoate, S-
L31b 
 
The compound S-L31b was obtained as a yellow oil (58 mg, 55%) according to the general 
alkylation procedure. TLC analysis Rf 0.47 (silica, 5% CH3OH in CH2Cl2); 
1H NMR (295 
K, 700 MHz, CDCl3) δH 8.41 (3H, d, 3J 6, CONH), 8.17 (3H, br s, py-H3), 8.02 (6H, d, 3J 
8.5, H2,2’), 7.64 (3H, br s, py-H5), 7.56 (6H, d, 3J 8.5, H3,3’), 7.38-7.36 (6H, m, Ph-Ho), 
7.2-7.25 (6H, m, Ph-Hm), 7.20 (3H, t, 3J 7, Ph-Hp), 5.33 (3H, dq, 3J 6, 3J 7, CHCH3), 3.93 
(9H, s, CO2CH3), 3.81 (6H, m, py-CH2), 2.83 (12H, br s, ring Hs), 1.60 (9H, d, 
3J 7, 
CHCH3); 
13C NMR (295 K, 175 MHz, CDCl3) δC 166.4 (CO2CH3), 163.0 (CONH), 159.6 
(py-C6), 149.9 (py-C2), 143.3 (Ph-Ci), 132.9 (C4), 132.0 (C3,3’), 130.7 (C1), 129.8 (C2,2’), 
128.7 (Ph-Cm), 127.5 (Ph-Cp), 127.1 (py-C5), 126.4 (Ph-Co), 123.0 (py-H3), 93.7 (C5), 
89.3 (C6), 64.1 (py-CH2), 56.1 (ring Cs), 52.5 (CO2CH3), 48.9 (CHCH3), 21.9 (CHCH3); 
m/z (HRMS+) 1318.623 [M+H]+ (C78H76N9O6 requires 1318.627). 
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6,6',6''-((1,4,7-Triazonane-1,4,7-triyl)tris(methylene))tris(4-((4-
methoxyphenyl)ethynyl)-N-((S)-1-phenylethyl)picolinamide), S-L31c 
 
The compound S-L31c was obtained as a yellow oil (42 mg, 28%) according to the general 
alkylation procedure.  TLC analysis Rf 0.68 (silica, 7% CH3OH in CH2Cl2); 
1H NMR (295 
K, 600 MHz, CDCl3) δH 8.47 (3H, d, 3J 8.5, CONH), 8.13 (3H, br s, py-H3), 7.45 (6H, d, 
3J 9, H3,3’), 7.38 – 7.18 (18H, m, Ph-H, py-H5), 6.87 (6H, d, 3J 9, H2,2’), 5.33 (3H, dq, 3J 
8.5, 3J 6.5 , CHCH3), 3.82 (9H, s, OCH3), 3.80-3.75 (6H, m, py-CH2), 2.85-2.79 (12H, 
m, ring Hs), 1.60 (9H, d, 3J 6.5, CHCH3); 
13C NMR (295 K, 150 MHz, CDCl3) δC 163.0 
(CONH), 160.4 (C1), 159.1 (py-C6), 149.5 (py-C2), 143.2 (Ph-Ci), 133.6 (C4), 133.5 
(C3,3’), 128.5 (Ph-C), 127.2 (Ph-C), 126.7 (Ph-C), 126.2 (py-C5), 122.6 (py-C3), 114.2 
(C2,2’), 113.9 (py-C4), 95.0 (C5), 85.7 (C6), 63.9 (py-CH2), 56.0 (ring Cs), 55.3 (OCH3), 
48.7 (CHCH3), 21.8 (CHCH3); m/z (HRMS
+) 1234.592 [M+H]+ (C78H76N9O6 requires 
1234.592). 
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6,6',6''-(1,4,7-Triazonane-1,4,7-triyl)tris(methylene)tris(4-((4-
acetamidophenyl)ethynyl)-N-((S)-1-phenylethyl)picolinamide), S-L31d 
 
The compound S-L31d was obtained as a yellow oil (50 mg, 43%) according to the general 
alkylation procedure. TLC analysis Rf 0.63 (silica, 15% CH3OH in CH2Cl2); 
1H NMR 
(295 K, 600 MHz, CD3OD) δH 7.94 (3H, s, py-H3), 7.58 (6H, d, 3J 8.5, H3,3’), 7.54 (3H, 
s, py-H5), 7.36-7.16 (21H, m, Ph-H, H2,2’), 5.20 (1H, s, CHCH3), 4.04 (6H, br s, py-CH2), 
3.02 (12H, br s, ring Hs), 2.10 (9H, s, NHCOCH3), 1.53 (9H, d, 
3J 6.5, CHCH3); 
13C 
NMR (295 K, 150 MHz, CD3OD) δC 171.6 (NHCOCH3), 164.7 (CONH), 151.4 (py-C6), 
144.4 (Ph-Ci), 141.5 (py-C2), 135.4 (C4), 133.8 (C3,3’), 129.7 (Ph-Co), 128.5 (py-C5), 
127.3 (Ph-Cm), 124.2 (py-C4), 123.0 (py-C3), 120.6 (C2,2’), 117.6 (C1), 86.6 (C5), 79.1 
(C6), 64.6 (py-CH2), 50.4 (CHCH3), 24.1 (NHCOCH3), 22.1 (CHCH3); m/z (HRMS
+) 
1315.621 [M+H]+ (C81H76N12O6 requires 1315.624).  
 
R-L31d was synthesised in an analogous manner to the S series starting from R-(+)-α-
methylbenzyl amine. 
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S-[Eu.L31a](CF3SO3)3 
 
General complexation procedure: 
Europium (III) triflate (9 mg, 0.015 mmol) was added to a solution of ligand, S-L31a, (18 
mg, 0.015 mmol) in anhydrous acetonitrile (2 mL) and the mixture heated at reflux for 20 
h. The solution was concentrated under reduced pressure and cold diethyl ether (2 mL) 
was added dropwise to the solution. The resulting solid was isolated and dried under 
reduced pressure to yield S-[Eu.L31a](CF3SO3)3 as a yellow glassy solid (10 mg, 50%). 
1H NMR (295 K, 200 MHz, CD3OD) δH major diastereoisomer, partial assignment: 7.7 
(pyCH’N), 7.6, 7.4, 7.1, 7.0, 5.9, 4.1, 3.5, 1.2 (CHCH3), 0.8, -1.5 (NCHeq), -2.1 (NCH’eq), 
-6.5 (NCHax); m/z (HRMS)
+ 1292.455 [M-2H]+ (C75H67N9O3
151Eu requires 1292.456); 
ɸem(MeOH) = 0.08, ε(MeOH) = 69,000 M-1 cm-1, τ(MeOH) = 0.80 ms; tR = 8.4 min 
(analytical HPLC, Table 23). 
 
S-[Eu.L31b](CF3SO3)3 
The complex S-[Eu.L31b](CF3SO3)3 was obtained according to the general complexation 
procedure, using the ligand S-L31b, as a white solid (10 mg, 52%). 1H NMR (295 K, 400 
MHz, CD3OD) δH major diastereoisomer, partial assignment: 8.2, 7.8, 7.4, 7.3, 7.0, 6.1, 
5.1, 3.9, 1.2 (CHCH3), 0.8, -1.6 (NCHeq), -2.5 (NCH’eq), -6.7 (NCHax);  m/z (HRMS+) 
734.7366 [M-H]2+ (C81H72N9O9
151Eu requires 734.7418); ɸem(MeOH) = 0.03, ε(MeOH) 
= 63,000 M-1 cm-1, τ(MeOH) = 0.81 ms; tR = 8.8 min (analytical HPLC, Table 23). 
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S-[Eu.L31c] (CF3SO3)3 
The complex S-[Eu.L31c](CF3SO3)3 was obtained according to the general complexation 
procedure, using the ligand S-L2c,  as a white solid (20 mg, 70%). 1H NMR (295 K, 400 
MHz, CD3OD) δH major diastereoisomer, partial assignment: 7.6 (pyCH’N), 7.5, 7.3, 7.1, 
7.0, 6.7, 5.8, 4.2, 3.9, 3.5, 2.0 , 1.1 (CHCH3), -0.8 (pyCHN), -1.5 (NCHeq), -2.0 (NCH’eq), 
-6.5 (NCHax); m/z (HRMS
+) 1382.492 [M-2H]+ (C78H73N9O6
151Eu requires 1382.488); 
ɸem(MeOH) = 0.04, ε(MeOH) = 65,000 M-1 cm-1, τ(MeOH) = 0.49 ms; tR = 8.4 min 
(analytical HPLC, Table 23). 
 
S-[Eu.L31d](CF3SO3)3 
The complex S-[Eu.L31d](CF3SO3)3 was obtained according to the general complexation 
procedure, using the ligand S-L31d, as a yellow glassy solid (8 mg, 72%). 1H NMR (295 
K, 200 MHz, CD3OD) δH major diastereoisomer, partial assignment: 7.8, 7.6, 7.4, 7.1, 
7.0, 6.9, 5.9, 4.1, 2.2, 1.2 (CHCH3), 0.7, -1.5 (NCHeq), -2.2 (NCH’eq), -6.6 (NCHax);  m/z 
(HRMS+) 1463.523 [M-2H]+ (C81H76N12O6
151Eu) requires 1463.520); ɸem(MeOH) = 0.03, 
ε(MeOH) = 65,000 M-1 cm-1, τ(MeOH) = 0.54 ms; tR = 8.0 min (analytical HPLC, Table 
23). 
 
R-[Eu.L31d](CF3SO3)3 
The complex R-[Eu.L31d](CF3SO3)3 was obtained according to the general complexation 
procedure, using the ligand R-L31d, as a yellow glassy solid (10 mg, 60%). 1H NMR (295 
K, 400 MHz, CD3OD) δH major diastereoisomer, partial assignment: 7.8, 7.6, 7.4, 7.1, 
7.0, 6.9, 5.9, 4.1, 2.2, 1.2 (CHCH3), 0.7, -1.5 (NCHeq), -2.2 (NCH’eq), -6.6 (NCHax); m/z 
(HRMS+) 1463.523 [M-2H]+ (C81H76N12O6
151Eu) requires 1463.521); tR = 8.0 min 
(analytical HPLC, Table 23). 
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5.2.3. Achiral bis-amide and bis-carboxylate complexes and precursors 
 
1,4-Bis(4-methoxybenzyloxycarbonyl)-1,4,7-triazacyclononane, CAS: 1417729-26-0 
149 
 
The hydrochloric salt of 1,4,7-triazacyclononane (1.00 g, 4.19 mmol) and 2-(4-
methoxybenzyloxycarbonyloxyimino)-2-phenylacetonitrile (2.6 g, 8.38 mmol) were 
dissolved in a mixed dioxane:water solution (50 mL, 4:1, v/v). The resulting solution was 
stirred under argon at r.t. for 5 min before the addition of NEt3 (2.9 mL, 20.53 mmol). 
The reaction mixture was stirred at r.t. for 24 h until completion was observed by TLC. 
The solvent was removed under reduced pressure and the residue was dissolved in CH2Cl2 
(20 mL) and washed with brine (3 x 15 mL). The aqueous layer was re-extracted with 
CH2Cl2 (3 x 15 mL) and the organic layers were combined, dried over MgSO4, filtered 
and concentrated under reduced pressure. The crude mixture was purified by flash column 
chromatography (silica, gradient elution starting from 100% CH2Cl2 to 10% CH3OH in 
CH2Cl2) to give the title compound as a yellow oil (1.37 g, 72%). TLC analysis Rf 0.20 
(silica, 6% CH3OH in CH2Cl2); 
1H NMR (295 K, 400 MHz, CDCl3) δH 7.34 – 7.27 (4H, 
m, H4), 6.90 – 6.87 (4H, m, H5), 5.11 – 5.05 (4H, m, H2), 3.82 (6H, s, H7), 3.58 – 3.48 
(4H, m, ring Hs), 3.29 – 3.24 (4H, m, ring Hs), 2.93 – 2.79 (4H, m, ring Hs); 13C NMR 
(295 K, 100 MHz, CDCl3) δC 159.6, 156.7, 156.6, 130.0, 128.9, 114.0, 67.1, 55.4, 53.6, 
52.8, 52.5, 52.2, 51.2, 50.3, 50.0, 49.2, 48.3, 48.2, 47.8, 47.7 (m, ring Cs); m/z (HRMS+) 
458.2275 [M+H]+ (C24H32N3O6 requires 458.2291). 
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1,4-Bis(4-methoxybenzyloxycarbonyl)-7-(tert-butylcarbonate)-1,4,7-
triazacyclononane, CAS: 1417729-28-2 149 
 
N-(tert-butoxycarbonyl)succinimide (0.935 g, 4.34 mmol) and 1,4-Bis(4-
methoxybenzyloxycarbonyl)-1,4,7-triazacyclononane (1.33 g, 2.90 mmol) were 
dissolved in dry CH2Cl2 (40 mL) and the resulting mixture was stirred under argon at r.t. 
for 24 h. Upon reaction completion, the solution was washed with brine (3 x 25 mL). The 
aqueous layer was re-extracted with CH2Cl2 (3 x 25 mL) and the organic layers were 
combined, dried over MgSO4, filtered and concentrated under vacuum. The crude 
material was purified by flash column chromatography (silica, gradient elution starting 
from 100% CH2Cl2 to 1% CH3OH in CH2Cl2) to give the title compound as a colourless 
oil (1.03 g, 64%). TLC analysis Rf 0.63 (silica, 5% CH3OH in CH2Cl2); 
1H NMR (295 K, 
400 MHz, CDCl3) δH 7.33 – 7.18 (4H, m, H4), 6.88 – 6.83 (4H, m, H5), 5.08 – 4.92 (4H, 
m, H2), 3.78 - 3.77 (6H, m, H7), 3.57 – 3.23 (ring Hs), 1.50 – 1.37 (9H, m, H9); 13C NMR 
(295 K, 100 MHz, CDCl3) δC  159.6, 156.5, 155.7, 129.9, 128.9, 113.9, 80.1 (C9), 67.1, 
55.3, 53.8, 50.0, 49.9, 49.5, 49.2, 48.8, 48.7, 30.1, 20.4 (C7); m/z (HRMS+) 558.2828 
[M+H]+ (C29H40N3O8 requires 228.2856). 
 
 
 
Tert-butyl-1,4,7-triazacyclononane-1-carboxylate hydrochloride salt, CAS: 
1417729-30-6 149 
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1,4-Bis(4-methoxybenzyloxycarbonyl)-7-(tert-butylcarbonate)-1,4,7-triazacyclononane 
(1.03 g, 1.85 mmol) was dissolved in 40 mL CH3OH. Palladium hydroxide on carbon (ca 
300 mg) was added slowly to the solution. The black mixture was hydrogenated at 4 atm. 
for 24 h. After reaction completion the mixture was filtered through celite and the solvent 
was removed under reduced pressure. The crude residue was redissolved in 10 mL 
CH3OH and the apparent pH of the solution was lowered to pH 2 using a 1 M HCl 
solution. The solvent was removed under reduced pressure to give the title compound as 
a pale yellow solid (500 mg, 89%); 1H NMR (295 K, 600 MHz, D2O) δH 3.62 (4H, br s, 
ring Hs), 3.46 (4H, br s, ring Hs), 3.35 (4H, br s, ring Hs), 3.21 (9H, s, OCH(CH3)3); 
13C 
NMR (295 K, 150 Hz, D2O) δC 156.8 (CO2tBu), 183.5 (C(CH3)3), 47.0, 43.1, 42.9 (ring 
Cs), 27.4 (C(CH3)3); m/z (HRMS
+) 230.1873 [M+H]+ (C11H24N3O2 requires 230.1869). 
 
N-benzyl-6-(hydroxymethyl)-4-iodopicolinamide, 4b 
 
HOBt.H2O (254 mg, 1.88 mmol), EDC (292 mg, 1.88 mmol), DIPEA (0.44 mL, 2.51 
mmol) and benzylamine (0.15 mL, 1.38 mmol) were dissolved in anhydrous DMF (3 
mL). The carboxylic acid, 3b, (350 mg, 1.25 mmol in 1 mL DMF) was added slowly and 
dropwise to the solution and the mixture stirred at r.t. for 22 h under an argon atmosphere. 
The solvent was removed under reduced pressure, water was added to the crude residue 
and the mixture extracted with EtOAc (4 x 20 mL). The organic layers were combined 
and washed successively with water (1 x 20 mL) and brine (1 x 20 mL), dried over MgSO4 
and the solvent removed under reduced pressure. The crude mixture was purified by flash 
column chromatography (silica, gradient elution starting from 10% EtOAc in hexane to 
50% EtOAc in hexane) to afford 4b as a yellow oil (284 mg, 62%). TLC analysis Rf 0.35 
(silica, 50% EtOAc in hexane); 1H NMR (295 K, 400 MHz, CDCl3) δH 8.48 (1H, s, py-
H3), 8.22 (1H, s, CONH), 7.91 (1H, s, py-H5), 7.34 – 7.27 (5H, m, Ph-H), 4.72 (2H, s, py-
CH2) , 4.64 (2H, d, 
3J 6, CH2Ph); 
13C NMR (295 K, 100 MHz, CDCl3) δC 162.9 (CONH), 
159.7 (py-C6), 149.2 (py-C2), 138.0 (Ph-Ci), 132.6 (py-C5), 130.8 (py-C3), 128.9 (Ph-Cm), 
128.0 (Ph-Cp), 127.8 (Ph-Co), 107.9 (py-C4), 64.3 (py-CH2), 43.7 (CH2Ph); m/z (HRMS
+) 
390.9893 [M+Na]+ (C14H13N2O2Na
127I requires 390.9919). 
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N-benzyl-6-(hydroxymethyl)-4-((4-methoxyphenyl)ethynyl)picolinamide, 6b 
 
The compound 4b (263 mg, 0.714 mmol) was dissolved in anhydrous THF (4 mL) and 
the solution was degassed (freeze-thaw cycle) three times. 4-Ethynyl anisole (140 μL, 
1.07 mmol) and triethylamine (0.50 mL, 3.57 mmol) were added and the solution was 
degassed (freeze-thaw cycle) once more. [1,1-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (52 mg, 0.07 mmol) and CuI (27 
mg, 0.143 mmol) were added and the resulting brown solution was stirred at 65 °C under 
argon for 24 h. The solvent was removed under reduced pressure and the pale brown solid 
was purified by column chromatography (silica, gradient elution starting from 100% 
CH2Cl2 to 2% CH3OH in CH2Cl2 in 0.2% increments) to give the compound 4c as an off 
white solid (210 mg, 80%). TLC analysis Rf 0.75 (silica, 7% CH3OH in CH2Cl2); m.p. 
152 – 153 °C;  1H NMR (295 K, 700 MHz, CDCl3) δH 8.23 (1H, br t, 3J 6, CONH), 8.21 
(1H, s, py-H3), 7.53 (1H, s, py-H5), 7.50 (2H, dt, 4J 2, 3J 8, H3/3’), 7.37-7.34 (4H, m, Ph-
Ho, Ph-Hm), 7.29 (1H, m, Ph-Hp), 6.91 (2H, dt, 4J 2, 3J 8, H2/2’), 4.77 (2H, s, py-CH2), 
4.68 (2H, d, 3J 6, CH2Ph), 3.85 (3H, s, OCH3); 
13C NMR (295 K, 175 MHz, CDCl3) δC 
163.7 (CONH), 160.7 (C1), 158.7 (py-C6), 149.2 (py-C2), 138.2 (Ph-Ci), 134.6 (C4), 133.8 
(C3,3’), 128.9 (Ph-C), 128.0 (Ph-C), 127.8 (Ph-C), 124.7 (py-C5), 123.5 (py-C3), 114.4 
(C2,2’), 114.0 (py-C4), 96.1 (C5), 85.6 (C6), 64.6 (py-CH2), 55.5 (OCH3), 43.7 (CH2Ph); 
m/z (HRMS+) 373.1561 [M+H]+ (C23H21N2O3 requires 373.1552). 
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(6-(Benzylcarbamoyl)-4-((4-methoxyphenyl)ethynyl)pyridin-2-yl)methyl 
methanesulfonate, 4d 
 
The alcohol 4c (201 mg, 0.54 mmol) was dissolved in anhydrous THF (4 mL) and NEt3 
(0.26 mL, 1.89 mmol) was added. The mixture was stirred at 5 °C (ice / water bath) and 
methanesulfonyl chloride (0.06 mL, 0.81 mmol) was added. The reaction was allowed to 
warm to r.t. and stirred under argon for 30 min. The solvent was removed under reduced 
pressure and the residue dissolved in CH2Cl2 (20 mL) and washed with brine (20 mL). 
The aqueous layer was re-extracted with CH2Cl2 (3 x 20 mL) and the organic layers were 
combined, dried over MgSO4, filtered and the solvent removed under reduced pressure to 
yield the compound 4d, as a bright yellow oil (254 mg), which was used directly in the 
next step without further purification. TLC analysis Rf 0.72 (silica, 100% EtOAc); 
1H 
NMR (295 K, 700 MHz, CDCl3) δH 8.27 (1H, d, 3J 1.5, py-H5), 8.26 (1H, t, 3J 6, CONH), 
7.63 (1H, d, 3J 1.5, py-H3), 7.51 (2H, dt, 4J 2.5, 3J 9, H3/3’), 7.37 – 7.29 (5H, m, Ph-H), 
6.92 (2H, dt, 4J 2.5, 3J 9, H2/2’), 5.30 (2H, s, py-CH2), 4.68 (2H, d, 
3J 6, CH2Ph), 3.85 (3H, 
s, OCH3), 3.07 (3H, s, SO2CH3); m/z (HRMS
+) 451.1320 [M+H]+ (C24H23N2O5S requires 
451.1328). 
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Tert-butyl - 4,7-bis((6-(benzylcarbamoyl)-4-((4-methoxyphenyl)ethynyl)pyridin-2-
yl)methyl)-1,4,7-triazonane-1-carboxylate, 4e 
 
Tert-butyl-1,4,7-triazacyclononane-1-carboxylate dihydrochloride (82 mg, 0.27 mmol) 
and the mesylate, 4d, (243 mg, 0.54 mmol) were dissolved in anhydrous CH3CN (10 mL) 
and K2CO3 (149 mg, 1.08 mmol) was added. The mixture was stirred under argon at 78 
°C. After 24 h the reaction was cooled and filtered to remove excess potassium salts. The 
solvent was removed under reduced pressure and the crude material purified by column 
chromatography (silica, gradient elution starting from 100% CH2Cl2 to 5% CH3OH in 
CH2Cl2 in 0.2% increments) to give the tert-butoxycarbonyl protected ligand, 4e, as a 
yellow oil (170 mg, 67%). TLC analysis Rf 0.39 (silica, 5% CH3OH in CH2Cl2); 
1H NMR 
(295 K, 700 MHz, CDCl3) δH 8.44 (1H, t, 3J 6.5, CONH), 8.39 (1H, t, 3J 6.5, CONH’), 
8.17 (1H, s, py-H5), 8.16 (1H, s, py-H5’), 7.64 (1H, s, py-H3), 7.57 (1H, s, py-H3’), 7.48 
(4H, d, 3J 9, H3/3’), 7.35-7.24 (10H, m, Ph-H), 6.89 (4H, d, 3J 9, H2/2’), 4.65 (4H, d, 3J 6.5, 
CH2Ph), 3.83 (6H, s, OCH3), 3.82 (4H, s, py-CH2), 3.31-3.26 (4H, m, ring Hs), 3.05-2.96 
(4H, m, ring Hs), 2.68-2.62 (4H, m, ring Hs), 1.45 (9H, s, O(CH3)3); 
13C NMR (295 K, 
175 MHz, CDCl3) δC 164.1 (CONH), 164.0 (CONH), 160.6 (C1), 160.5 (py-C2), 159.3 
(py-C2’), 149.5 (py-C6), 149.3 (py-C6’), 138.4 (Ph-Ci), 138.3 (Ph-Ci),  138.4 (C4), 138.3 
(C3/3’), 133.8 (Ph-C), 133.7 (Ph-C), 128.8 (Ph-C), 128.7 (Ph-C), 128.0 (py-C3), 127.9 (py-
C3’), 122.8 (py-C5), 122.7 (py-C5’), 114.3 (C2/2’), 114.1 (py-C4), 114.0 (py-C4’), 95.4 (C5), 
95.1 (C5’), 85.9 (C6), 85.8 (C6’), 62.9 (py-CH2), 56.3 (ring C), 55.4 (OCH3), 54.9 (ring 
C), 54.5 (ring C), 53.9 (ring C), 50.1 (ring C), 49.6 (ring C), 43.6 (CH2Ph), 43.5 (CH2Ph), 
28.7 (O(CH3)3); m/z (HRMS
+) 938.4594 [M+H]+ (C57H60N7O6 requires 938.4605). 
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6,6'-((1,4,7-triazonane-1,4-diyl)bis(methylene))bis(N-benzyl-4-((4-
methoxyphenyl)ethynyl)picolinamide), L38 
 
Tert-butoxycarbonyl-protected ligand, 4e, (60 mg, 0.064 mmol) was dissolved in 
anhydrous CH2Cl2 (3 mL) and trifluoroacetic acid (0.6 mL) was added. The solution was 
stirred under argon at 23 °C for 30 min. TLC (silica, 10 % CH3OH in CH2Cl2, Rf (product) 
0.25, Rf (reactant) 0.61) was used to confirm removal of the tert-butoxycarbonyl group. 
The solvent was removed under reduced pressure and the residue re-dissolved in CH2Cl2 
(2 mL). This process was repeated 5 times to ensure removal of excess trifluoroacetic 
acid. The crude residue was purified by preparative HPLC (Table 24, tR = 14.6 min) to 
give L38 as a white solid (41 mg, 72%). TLC analysis Rf 0.25 (silica, 10% CH3OH in 
CH2Cl2); m.p. 156-158 °C;  
1H NMR (295 K, 700 MHz, CDCl3) δH 7.92 (2H, s, py-H3), 
7.63 (2H, s, py-H5), 7.38 (4H, d, 3J 8.5, H3/3’), 7.32-7.21 (10H, m, Ph-H), 6.91 (4H, d, 3J 
8.5, H2/2’), 4.59 (4H, s, CH2Ph), 3.95 (4H, s, py-CH2), 3.78 (6H, s, OCH3), 3.06 (4H, m, 
ring Hs), 2.93 (4H, m, ring Hs), 2.74 (4H, m, ring Hs); 13C NMR (295 K, 175 MHz, 
CDCl3) δC 116.0 (CONH), 162.3 (C1), 159.9 (py-C6), 151.1 (py-C2), 139.7 (Ph-Ci), 135.4 
(C4), 134.6 (C3/3’), 129.7 (Ph-C), 128.7 (Ph-C), 128.5 (Ph-C), 128.0 (py-C5), 123.8 (py-
C3), 115.4 (C2/2’), 114.7 (py-C4), 96.8 (C5), 86.0 (C6), 61.5 (py-CH2), 55.9 (OCH3), 51.6 
(ring C), 45.1 (ring C), 44.3 (CH2Ph); m/z (HRMS
+) 838.4083 [M+H]+ (C52H52N7O4 
requires 838.4081). 
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[Eu.L38](CF3SO3)3 
 
The deprotected ligand, L38, was subjected to ion exchange chromatography to remove 
any formate present (from HPLC purification). The ligand (4 mg, 0.005 mmol) was 
dissolved in CH3OH and [Eu.(CF3SO3)]3 (3 mg, 0.005 mmol) was added. The solution 
was stirred at 60 °C for 24 h. The solvent was removed under reduced pressure to give a 
white solid which was used directly without any further purification. ESI+ (MeCN no 
column) m/z 1285.4 [M+2(CF3SO3)]
+, 569.9 [M+(CF3SO3)]
2+; λexc (MeOH) = 348 nm; 
ɸem (MeOH) 0.02, ε (MeOH) 40,000 M-1cm-1, τ (H2O) = 0.26 ms, τ (D2O) = 0.43 ms, q = 
1.3.  
 
4-Iodo-3,5-dimethylanisole, 5a, CAS: 90609-47-5 
 
4-Iodo-3,5-dimethylphenol (1.00 g, 4.03 mmol) was dissolved in acetone (10 mL). K2CO3 
(0.724 g, 5.24 mmol) and iodomethane (0.75 mL, 12.1 mmol) were added and the reaction 
was heated to reflux and stirred under argon for 24 h. The mixture was filtered to remove 
the potassium salts and the solvent was removed under reduced pressure. The residue was 
dissolved in CH2Cl2 (50 mL) and washed with water (50 mL). The aqueous layer was 
extracted into CH2Cl2 (3 x 50 mL) and the organic layers were combined, dried over 
MgSO4, filtered and the solvent removed under reduced pressure. The crude solid was 
purified by flash column chromatography (silica, 2% CH2Cl2 in hexane) to yield 5a as a 
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white crystalline solid (1.01 g, 87%). TLC analysis Rf 0.23 (silica, 4% CH2Cl2 in hexane); 
m.p. 36-37 °C (lit. 33-34 °C)224; 1H NMR (295 K, 400 MHz, CDCl3) δH 6.67 (2H, s, Ar-
H), 3.77 (3H, s, OCH3), 2.45 (6H, s, CH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 159.3 
(Ar-C1), 143.0 (Ar-C), 113.0 (Ar-C), 97.2 (Ar-C), 55.4 (OCH3), 29.9 (CH3); m/z 
(HRMS+) 261.9849 (C9H11
127IO requires 261.9855). CHN% Found: C, 41.38; H, 4.17; 
N, 0.09% (C9H11
127IO requires C, 41.24; H, 4.23; N, 0.00%). 
 
((4-Methoxy-2,6-dimethylphenyl)ethynyl)trimethylsilane, 5b 
 
4-Iodo-3,5-dimethylanisole (703 g, 2.68 mmol) was dissolved in anhydrous THF (9 mL) 
and the solution was degassed (freeze-thaw cycle) three times. Ethynyl trimethylsilane 
(1.33 mL, 9.39 mmol) and triethylamine (1.87 mL, 13.4 mmol) were added and the 
solution was degassed (freeze-thaw cycle) once more. [1,1-Bis(triphenylphosphine)] 
palladium(II) dichloride (188 mg, 0.268 mmol) and CuI (102 mg, 0.536  mmol) were 
added and the resulting brown solution was stirred at 55 °C under argon for 48 h. The 
solvent was removed under reduced pressure and the resulting brown oil was purified by 
column chromatography (silica, gradient elution starting from 100% hexane to 6% 
CH2Cl2 in hexane in 0.2% increments) to give 5b as a bright yellow oil (410 mg, 66%). 
TLC analysis Rf  0.19 (silica, 10% CH2Cl2 in hexane); 
1H NMR (295 K, 400 MHz, CDCl3) 
δH 6.57 (2H, s, Ar-H), 3.77 (3H, s, OCH3), 2.41 (6H, s, CH3), 0.25 (9H, s, Si(CH3)3); 13C 
NMR (295 K, 100 MHz, CDCl3) δC 159.2 (Ar-C4), 142.6 (Ar-C), 113.1 (Ar-C), 112.5 
(Ar-C), 103.1 (alkyne C), 101.0 (alkyne C), 55.3 (OCH3), 21.4 (CH3), 0.40 (Si(CH3)3); 
m/z GC-EI tR = 4.47 min, 232.1 (M
+), 217.1 (M+ - CH3). 
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2-Ethynyl-5-methoxy-1,3-dimethylbenzene, 5c 225 
 
The protected alkyne 5b (400 mg, 1.72 mmol) was dissolved in dry THF (7 mL) and 
triethylamine trihydrofluoride (2.80 mL, 17.2 mmol) was added. The solution was stirred 
at 30 °C under argon for 72 h. The solvent was removed under reduced pressure and the 
crude residue was purified by flash column chromatography (silica, gradient elution 
starting from 100% hexane to 2% CH2Cl2 in hexane in 0.2% increments) to give the 
compound, 5c, as a yellow oil (154 mg, 56%). TLC analysis Rf 0.19 (silica, 10% CH2Cl2 
in hexane); 1H NMR (295 K, 400 MHz, CDCl3) δH 6.60 (2H, s, Ar-H), 3.79 (3H, s, OCH3), 
3.43 (1H, s, alkyne H), 2.44 (6H, s, 2CH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 159.3 
(Ar-C5), 142.8 (Ar-C), 144.4 (Ar-C), 112.5 (Ar-C), 83.9 (alkyne C), 81.4 (alkyne C), 55.3 
(OCH3), 21.4 (2CH3); m/z GC-EI tR = 3.75 min, 160.1 (M
+), 145.1 (M+ - CH3). 
 
Methyl 6-(hydroxymethyl)-4-((4-methoxy-2,6-dimethylphenyl)ethynyl)picolinate, 
5d 171 
 
Methyl 6-(hydroxymethyl)-4-iodopicolinate, 3a, (210 mg, 0.717 mmol) was dissolved in 
anhydrous THF (5 mL) and the solution was degassed (freeze-pump-thaw cycle) three 
times. The alkyne, 5c, (138 mg, 0.860 mmol) and triethylamine (0.50 mL, 3.59 mmol) 
were added and the solution was degassed (freeze-pump-thaw cycle) once more. [1,1-
Bis(diphenylphosphino)ferrocene]dichloropalladium(II) (52 mg, 0.072 mmol) and CuI 
(27 mg, 0.143 mmol) were added and the resulting brown solution was stirred at 65 °C 
under argon for 48 h. The solvent was removed under reduced pressure and the resulting 
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brown oil was purified by column chromatography (silica, gradient elution starting from 
100% hexane to 50% EtOAc in hexane in 10% increments) to give the compound 5d as 
a white solid (164 mg, 70%). TLC analysis Rf 0.31 (silica, 100% EtOAc); m.p. 177 – 179 
°C; 1H NMR (295 K, 700 MHz, CDCl3) δH 8.05 (1H, s, py-H3), 7.58 (1H, s, py-H5), 6.63 
(2H, s, H2,2’), 4.86 (2H, s, py-CH2), 4.01 (3H, s, CO2CH3), 3.80 (3H, s, OCH3), 2.49 (6H, 
s, CH3); 
13C NMR (295 K, 175 MHz, CDCl3) δC 165.5 (CO2CH3), 160.6 (C1), 160.2 (py-
C6), 147.3 (C4), 143.1 (py-C2), 134.4 (C3,3’), 125.5 (py-C3), 125.2 (py-C5), 114.0 (py-C4), 
112.8 (C2,2’), 94.0 (C5), 93.3 (C6), 64.7 (py-CH2), 55.3 (OCH3), 53.1 (CO2CH3), 21.5 
(CH3); m/z (HRMS
+) 326.1378 [M+H]+ (C19H20NO4 requires 326.1392). 
 
Methyl 4-((4-methoxy-2,6-dimethylphenyl)ethynyl)-6-
(((methylsulfonyl)oxy)methyl)picolinate, 5e 171 
 
The alcohol 5d (89 mg, 0.274 mmol) was dissolved in anhydrous THF (3 mL) and NEt3 
(0.13 mL, 0.959 mmol) was added. The mixture was stirred at 5 °C (ice / water bath), 
methanesulfonyl chloride (30 µL, 0.411 mmol) was added and the reaction was allowed 
to warm to r.t. and stirred under argon for 30 min. The solvent was removed under reduced 
pressure and the residue dissolved in EtOAc (15 mL) and washed with water (15 mL). 
The aqueous layer was re-extracted with EtOAc (3 x 15 mL) and the organic layers were 
combined, dried over MgSO4, filtered and the solvent removed under reduced pressure to 
yield the mesylate 5e, as a bright yellow oil (107 mg, 97%), which was used directly in 
the next step without further purification. TLC analysis Rf 0.63 (silica, 100% EtOAc); 
1H 
NMR (295 K, 400 MHz, CDCl3) δH 8.06 (1H, s, py-H3), 7.62 (1H, s, py-H5), 6.58 (2H, s, 
H2,2’), 5.37 (2H, s, py-CH2OSO2), 3.97 (3H, s, CO2CH3), 3.75 (3H, s, OCH3), 3.14 (3H, 
s, SO2CH3), 2.44 (6H, s, CH3); m/z (HRMS
+) 404.1170 [M+H]+ (C20H22NO6S requires 
404.1168). 
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Methyl 4-(mesitylethynyl)-6-((4-((4-((4-methoxy-2,6-dimethylphenyl)ethynyl)-6-
(methoxycarbonyl)pyridin-2-yl)methyl)-1,4,7-triazonan-1-yl)methyl)picolinate, L39 
 
1,4,7-Triazacyclononane trihydrochloride (113 mg, 0.474 mmol) and the mesylate, 5e, 
(363 mg, 0.901 mmol) were dissolved in anhydrous CH3CN (30 mL) and K2CO3 (197 
mg, 1.42 mmol) was added. The mixture was stirred under argon at 60 °C and carefully 
monitored by LC-MS. After 1 h significant formation on the bis-alkylated product was 
observed and the reaction was cooled and filtered to remove excess potassium salts. The 
solvent was removed under reduced pressure and the crude material purified by column 
chromatography (silica, gradient elution starting from 100% CH2Cl2 to 10% CH3OH in 
CH2Cl2 in 1 % increments) to give L39 as a yellow glassy solid (183 mg, 52%). TLC 
analysis Rf 0.18 (silica, 10% CH3OH in CH2Cl2); 
1H NMR (295 K, 700 MHz, CDCl3) δH 
9.48 (1H, br s, ring NH), 7.91 (2H, s, py-H3), 7.43 (2H, s, py-H5), 6.59 (4H, s, H2,2’), 4.03 
(6H, s, CO2CH3), 4.02 (4H, s, py-CH2), 3.74 (6H, s, OCH3), 3.48 (4H, br s, ring Hs), 3.06 
(4H, br s, ring Hs), 2.81 (4H, s, ring Hs), 2.42 (12H, s, CH3); 
13C NMR (295 K, 175 MHz, 
CDCl3) δC 165.2 (CO2CH3), 160.2 (C1), 159.4 (py-C6), 147.6 (C4), 134.5 (C3,3’), 126.9 
(py-C5), 125.7 (py-C3), 113.8 (py-C4), 112.8 (C2,2’), 94.2 (C5), 92.8 (C6), 60.3 (py-CH2), 
55.3 (OCH3), 53.9 (ring Cs), 53.6 (CO2CH3), 50.5 (ring Cs), 46.2 (ring Cs), 21.4 (CH3); 
m/z (HRMS+) 744.3765 [M+H]+ (C44H50N5O6 requires 744.3761). 
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[Eu.L39]Cl 
 
An aqueous solution of sodium hydroxide 0.1 M (0.5 mL) was added to a solution ligand 
L39 (10 mg, 13.4 µmol) in methanol (0.5 mL). The mixture was stirred at 65 °C for 4 h. 
The reaction was monitored by LC-MS. Upon completion, aqueous hydrochloric acid 
(0.1 M) was added until pH 6.5 was achieved. Europium chloride hexahydrate (5 mg, 15 
µmol) was added and the pH was readjusted to 6.5 by addition of aqueous sodium 
hydroxide (0.1 M). The reaction was stirred at 65 °C for 24 h. The solvent was removed 
under reduced pressure to give the complex [Eu.L39]Cl as a white solid (5 mg, 43%); m/z 
(HRMS+) 864.2371 M+ (C42H43N5O6
151Eu requires 864.2412); λexc (MeOH) = 352 nm; 
ɸem (MeOH) 0.20, ε (MeOH) 35,000 M-1cm-1, τ (H2O) = 0.27 ms, τ (D2O) = 0.38 ms, q = 
0.9. 
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Trimethyl 6,6',6''-((1,4,7-triazonane-1,4,7-triyl)tris(methylene))tris(4-((4-methoxy-
2,6-dimethylphenyl)ethynyl)picolinate), L35   171 
 
The compound L35 was obtained as a yellow solid (20%) according to the alkylation 
procedure used for L39. TLC analysis Rf 0.18(silica, 10% CH3OH in CH2Cl2); 
1H NMR 
(295 K, 400 MHz, CDCl3) δH 7.96 (3H, s, py-H3), 7.68 (3H, s, py-H5), 6.61 (6H, s, H2,2’), 
4.39 (6H, s, py-CH2), 3.90 (9H, s, CO2CH3), 3.79 (9H, s, OCH3), 3.37 (12 H, br s, ring 
Hs), 2.46 (18H, s, CH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 164.9 (CO2CH3), 160.4 
(C1), 159.5 (py-C6), 147.7 (C4), 143.2 (py-C2), 134.6 (C3,3’), 127.7 (py-C5), 125.8 (py-
C3), 113.7 (py-C4), 112.8 (C2,2’), 94.8 (C5), 92.9 (C6), 60.6 (py-CH2), 57.4 (ring Cs), 55.3 
(OCH3), 53.1 (CO2CH3), 21.6 (CH3); m/z (HRMS
+) 1051.499 [M+H]+ (C63H67N6O9 
requires 1051.497).  
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[Eu.L35] 171 
 
An aqueous solution of sodium hydroxide 0.1 M (0.5 mL) was added to a solution ligand 
L5 (11 mg, 10.5 µmol) in methanol (0.5 mL). The mixture was stirred at 65 °C for 4 h. 
The reaction was monitored by LC-MS. Upon completion, aqueous hydrochloric acid 
(0.1 M) was added until pH 6.5 was achieved. Europium chloride hexahydrate (4 mg, 
11.6 µmol) was added and the pH was readjusted to 6.5 by addition of aqueous sodium 
hydroxide (0.1 M). The reaction was stirred at 65 °C for 24 h. The solvent was removed 
under reduced pressure and the resulting solid was purified by flash column 
chromatography (silica, 100% CH2Cl2 to 15% CH3OH in CH2Cl2) to give the complex 
[Eu.L35]Cl as a white solid (8 mg, 66%); m/z (HRMS+) 1159.349 [M+H]+ 
(C60H57N6O9
151Eu requires 1159.349); λexc (MeOH) = 352 nm; ɸem (MeOH) 0.45, ε 
(MeOH) 60,000 M-1cm-1, τ (MeOH) = 0.90 ms. 
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Dimethyl 6,6'-((7-benzyl-1,4,7-triazonane-1,4-diyl)bis(methylene))bis(4-((4-
methoxy-2,6-dimethylphenyl)ethynyl)picolinate), L40 
 
The bis-alkylated ligand, L39 (25 mg, 0.034 mmol) and K2CO3 (4 mg, 0.034 mmol) were 
dissolved in anhydrous CH3CN (2 mL). Benzyl bromide (6 mg, 0.034 mmol) was added 
dropwise at room temperature over 15 minutes. The mixture was stirred under argon at 
40 °C and monitored by LC-MS. After 3 h the reaction was cooled and filtered to remove 
excess potassium salts. The solvent was removed under reduced pressure and the crude 
material purified by column chromatography (alumina, 100% CH2Cl2) to give L40 as a 
yellow glassy solid (17 mg, 60%). TLC analysis Rf 0.52 (alumina, 2% CH3OH in 
CH2Cl2); 
1H NMR (295 K, 700 MHz, MeOD) δH 7.95 (2H, s, py-H3), 7.58 – 7.43 (7H, m, 
Bn-H, py-H5),6.64 (4H, s, H2,2’), 3.99 (4H, s, py-CH2), 3.92 (6H, s, CO2CH3), 3.78 (6H, 
s, OCH3), 3.66 (4H, br s, ring Hs), 3.06 (4H, br s, ring Hs), 2.91 (2H, s, CH2Ph), 2.42 
(12H, s, CH3) ; 
13C NMR (295 K, 175 MHz, CDCl3) δC 165.7 (CO2CH3), 160.2 (C1), 
147.6 (py-C6), 143.0 (C4), 133.9 (C3/3’), 129.1 (Bn-C), 128.4 (Bn-C), 127.8 (Bn-C), 126.9 
(py-C5), 125.1 (py-C3), 114.1 (py-C4), 112.8 (C2/2’), 93.6 (2C, alkyne Cs), 64.7 (py-CH2), 
56.3 (Ph-CH2), 55.4 (OCH3), 53.1 (CO2CH3), 51.8 (ring Cs), 29.8 (ring Cs), 21.5 (CH3); 
m/z (HRMS+) 834.4246 [M+H]+ (C51H56N5O6 requires 834.4231). 
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[Eu.L40]Cl 
 
An aqueous solution of sodium hydroxide 0.1 M (0.5 mL) was added to a solution ligand 
L40 (11 mg, 13 µmol) in methanol (0.5 mL). The mixture was stirred at 65 °C for 4 h. The 
reaction was monitored by LC-MS. Upon completion, aqueous hydrochloric acid (0.1 M) 
was added until pH 6.5 was achieved. Europium chloride hexahydrate (5 mg, 15 µmol) 
was added and the pH was readjusted to 6.5 by addition of aqueous sodium hydroxide 
(0.1 M). The reaction was stirred at 65 °C for 24 h. The solvent was removed under 
reduced pressure and the solid was purified by flash column chromatography (silica, 
gradient elution starting from 5% CH3OH to 15% CH3OH in CH2Cl2 in 0.5% increments) 
to give the complex [Eu.L40]Cl as a white solid (10 mg, 80%). m/z (HRMS+) 954.2896 
M+ (C49H49N5O6
151Eu requires 954.2881); λexc (MeOH) = 352 nm; ɸem (MeOH) 0.18, ε 
(MeOH) 36,000 M-1cm-1, τ (H2O) = 0.53 ms, τ (D2O) = 0.50 ms, q = 0. 
 
3-(Bromomethyl)phenylethylene boronate CAS: 1225388 -28- 2 
 
3-(bromomethyl)phenylboronic acid (100 mg, 0.465 mmol) was dissolved in anhydrous 
pentane (2 mL) over 4 Å molecular sieves. Ethylene glycol (30 μL, 0.465 mmol) was 
added and the white suspension was allowed to stir at r.t. for 1 h under an atmosphere of 
CHAPTER FIVE –EXPERIMENTAL DETAILS 
198 
 
argon. Upon completion, CH2Cl2 was added to the reaction mixture and the solution was 
decanted from the molecular sieves. The solvent was removed under reduced pressure to 
give 3-(bromomethyl)phenylethylene boronate as a colourless oil which was used with 
no further purification (80 mg, 72%). TLC analysis Rf 0.28 (silica, 5% CH3OH in 
CH2Cl2); 
1H NMR (295 K, 400 MHz, CDCl3) δH 7.85 (1H, s, H2), 7.75 (1H, dt, 3J 7.5, 4J 
1.5, H6), 7.51 (1H, dt, 3J 7.5, 4J 1.5, H4), 7.37 (1H, t, 3J 7.5, H5), 4.50 (s, 2H, CH2Br), 
4.37 (s, 4H, BO(CH2)2O); 
13C NMR (295 K, 175 MHz, CDCl3) δC 137.4 (Ar-C), 135.5 
(Ar-C), 134.9 (Ar-C), 132.2 (Ar-C), 128.5 (Ar-C), 66.2 (BO(CH2)2O), 33.5 (CH2Br); 
11B 
NMR (295 K, 128 MHz, CDCl3) δB 31.41; m/z GC-EI tR = 4.68 min, 240.0 (M+), 161.1 
(M+ - Br). 
 
(3-((4,7-bis((4-((4-methoxy-2,6-dimethylphenyl)ethynyl)-6-
(methoxycarbonyl)pyridin-2-yl)methyl)-1,4,7-triazonan-1-
yl)methyl)phenyl)boronic acid, L41 
 
The bis-alkylated ligand, L39 (15 mg, 0.020 mmol) and K2CO3 (3 mg, 0.020 mmol) were 
dissolved in anhydrous CH3CN (2 mL) and bubbled with argon (20 minutes). 3-
(Bromomethyl)phenylethylene boronate (5 mg, 0.020 mmol) was added and the mixture 
was stirred under argon at 55 °C and monitored by LC-MS. After 24 h the reaction was 
cooled and filtered to remove excess potassium salts. The solvent was removed under 
reduced pressure and the crude material was purified by flash column chromatography 
(silica, 0 to 5% CH3OH in CH2Cl2) to give L41 as a glassy solid (20 mg, 85%). 
1H NMR 
(295 K, 600 MHz, CDCl3) δH 8.02 (2H, s, py-H3), 7.78-7.72 (3H, m, Ph-H), 7.53 (2H, s, 
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py-H5), 7.39-7.34 (1H, m, Ph-H), 6.62 (4H, s, H2,2’), 4.31 (2H, s, Ph-CH2), 4.02 (4H, s, 
py-CH2), 3.93 (6H, s, CO2CH3), 3.80 (6H, s, OCH3), 3.53-2.95 (12H, br m, ring Hs), 2.46 
(12H, s, CH3); 
13C NMR (295 K, 150 MHz, CDCl3) δC 165.2 (CO2CH3), 160.3 (C1), 157.6 
(py-C6), 148.1 (C4), 143.1 (Ph-C), 136.6 (Ph-C), 135.7 (Ph-C), 134.6 (C3/3’), 133.86 (Ph-
C), 127.8 (py-C5), 126.0 (py-C3), 113.7 (py-C4), 112.8 (C2/2’), 94.8 (C5), 92.9 (C6), 66.2 
(Ph-CH2), 61.0 (py-CH2), 55.3 (OCH3), 53.6 (ring Cs), 53.1 (CO2CH3), 51.8 (ring Cs), 
46.3 (ring Cs), 21.5 (CH3); 
11B NMR (295 K, 128 MHz, CDCl3) δB 31.3; m/z (HRMS+) 
877.4350 [M+H]+ (C51H57
10BN5O8 requires 877.4337); tR = 8.8 min (analytical HPLC, 
Table 23). 
 
[Eu.L41]Cl 
 
An aqueous solution of sodium hydroxide 0.1 M (0.5 mL) was added to a solution ligand 
L41 (5 mg, 6 µmol) in methanol (0.5 mL). The mixture was stirred at 65 °C for 4 h. The 
reaction was monitored by LC-MS. Upon completion, aqueous hydrochloric acid (0.1 M) 
was added until pH 6.5 was achieved. Europium chloride hexahydrate (3 mg, 8 µmol) 
was added and the pH was readjusted to 6.5 by addition of aqueous sodium hydroxide 
(0.1 M). The reaction was stirred at 65 °C for 24 h. The solvent was removed under 
reduced pressure to give the complex [Eu.L41]Cl as a white solid (7 mg, 80 %). m/z ESI 
(NH4HCO3/MeCN) 999.327 [M]
+, tR = 6.2 min;  λexc (MeOH) = 356 nm; ɸem (MeOH) 
0.05, ε (MeOH) 35,000 M-1cm-1, τ (H2O) = 0.38 ms, τ (D2O) = 0.48 ms, q = 0.2. 
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Methyl 3-((methylamino)carbonyl)benzoate, 6b, CAS: 23668-00-0 
 
A slurry of mono-methyl isophthalate (250 mg, 1.39 mmol) in anhydrous CH2Cl2 (5 mL) 
at room temperature, was treated with oxalyl chloride (0.23 mL, 2.78 mmol) followed by 
DMF (1 drop, catalytic). The resultant mixture was stirred under reflux for 90 min. The 
mixture was cooled to r.t., the solvent removed under reduced pressure and the residue 
azeotroped with CH2Cl2. The residue was dissolved in anhydrous THF (5 mL), cooled to 
0 °C and treated with a solution of methylamine (2 M, 1.39 mL, 2.78 mmol) in THF. The 
mixture was allowed to warm to r.t. overnight. The solvent was removed under reduced 
pressure and the resultant mixture was partitioned between EtOAc (25 mL) and H2O (25 
mL). The organic layer was washed with NaHCO3 (sat. aq., 20 mL), brine (20 mL), dried 
over MgSO4, filtered and concentrated under reduced pressure to give 6b as a white solid 
(243 mg, 91%). TLC analysis Rf  0.45 (silica, 5% CH3OH in CH2Cl2); m.p. 125–127 °C; 
1H NMR (295 K, 400 MHz, CDCl3) δH 8.36 (1H, t, 4J 1.5, H2), 8.16 (1H, dt, 3J 8, 4J 1.5, 
H6), 8.04 (1H, dt, 3J 8, 4J 1.5, H4), 7.53 (1H, t, 3J 8, H5), 6.27 (1H, br s, CONH), 3.94 
(3H, s, CO2CH3), 3.04 (3H, d, 
3J 5, CONHCH3); 
13C NMR (295 K, 100 MHz, CDCl3) δC 
167.3, 166.5, 135.1 (Ar-C), 132.4 (Ar-C), 132.0 (Ar-C), 130.6 (Ar-C), 129.1 (Ar-C), 
127.5 (Ar-C), 52.5 (CO2CH3), 27.1 (CONHCH3); m/z (HRMS
+) 194.0821 [M+H]+ 
(C10H12NO3 requires 194.0817). 
 
3-((Methylamino)methyl)phenylmethanol, 6c, CAS: 69383-73-9 
 
A stirred solution of amide 6b (243 mg, 1.26 mmol) in anhydrous THF (6 mL) was treated 
dropwise with a solution of lithium aluminium hydride (2 M, 1.25 mL, 2.52 mmol) in 
THF. The resultant slurry was stirred under reflux overnight, cooled and treated with 
water (0.1 mL), 15% NaOH (0.15 mL) and water (0.2 mL). The white solid was removed 
by filtration and washed multiple times with ethyl acetate. The filtrate was concentrated 
under reduced pressure and the oily residue was dissolved in EtOAc (50 mL). The organic 
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layer was washed with brine (50 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude oil was purified by flash column chromatography (silica, 
gradient elution starting from 5% CH3OH in CH2Cl2 to 15% CH3OH, 1% NH3 in CH2Cl2) 
to give 6c as a colourless oil (130 mg, 68%). TLC analysis Rf 0.08 (silica, 15% CH3OH 
in CH2Cl2); 
1H NMR (295 K, 400 MHz, CDCl3) δH 7.23-7.08 (4H, m, Ar-H), 4.51 (2H, 
s, CH2OH), 3.58 (2H, s, CH2NHMe), 2.28 (3H, s, NHCH3); 
13C NMR (295 K, 100 MHz, 
CDCl3) δC 142.0 (Ar-C), 139.2 (Ar-C), 128.3 (Ar-C), 127.0 (Ar-C), 126.6 (Ar-C), 125.5 
(Ar-C), 64.1 (CH2NH), 55.5 (CH2OH), 35.4 (NHCH3); m/z (HRMS
+) 152.1074 [M+H]+ 
(C9H14NO requires 152.1075). 
 
N-(3-(hydroxymethyl)benzyl)-N-methylformamide, 6d 
 
3-((Methylamino)methyl)phenylmethanol, 6c, (120 mg, 0.795 mmol) was dissolved in 
anhydrous THF (2 mL) and treated with TFEF (0.39 mL, 3.97 mmol). The resulting 
mixture was stirred at r.t. for 18 h. The solvent was removed under reduced pressure and 
the residue dissolved in ethyl acetate. The organic layer was washed with water, NaHCO3 
(sat. aq., 25 mL), brine (25 mL), dried over MgSO4, filtered and concentrated under 
reduced pressure. The crude residue was purified by flash column chromatography (silica, 
gradient elution starting from 100% CH2Cl2 to 5% CH3OH in CH2Cl2 in 0.5% increments) 
to give 6d as a colourless oil (96 mg, 67%). TLC analysis Rf 0.28 (silica, 5% CH3OH in 
CH2Cl2); 
1H NMR (295 K, 700 MHz, CDCl3) δH mixture of rotamers a and b: 8.20 (1H, 
s, NCOH, a), 8.08 (1H, s, NCOH’, b), 7.38-7.06 (4H, m, Ar-H, a and b), 4.65 (2H, s, 
CH2OH, a or b), 4.63 (2H, s, CH2OH, a or b), 4.46 (2H, s, CH2’NMe, b) 4.34 (2H, s, 
CH2NMe, a), 2.81 (NCH3’COH, b), 2.73 (3H, s, NCH3COH, a), 2.00 (1H, br s, CH2OH); 
13C NMR (295 K, 175 MHz, CDCl3) δC 163.0 (NCOH, a), 162.8 (NC’OH, b), 142.1, 
141.9, 136.2, 136.0, 129.0, 128.9, 127.2, 126.7, 126.6, 126.5, 126.3, 125.9, 64.8 (CH2OH, 
a or b), 64.6 (CH2OH, a or b), 53.6 (CH2N, a), 47.8 (C’H2N, b), 34.3 (NC’H3, b), 29.6 
(NCH3, a); m/z (HRMS
+) 202.0847 [M+H]+ (C10H13NO
23Na requires 202.0844). 
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3-((N-methylformamido)methyl)benzyl methanesulfonate, 6e 
 
 
The alcohol 6d (16 mg, 0.106 mmol) was dissolved in anhydrous THF (1 mL) and NEt3 
(52 μL, 0.371 mmol) was added. The solution was cooled to 0 °C using an ice/water bath. 
Methanesulfonyl chloride (12 µL, 0.159 mmol) was added and the reaction stirred at 0 
°C for 20 min and then warmed to r.t. over 30 minutes. The solvent was removed under 
reduced pressure and the residue dissolved in CH2Cl2 (10 mL) and washed with brine (10 
mL). The aqueous layer was re-extracted with CH2Cl2 (3 x 10 mL) and the organic layers 
were combined, dried over MgSO4, filtered and the solvent removed under reduced 
pressure to yield the mesylate 6e, as a white solid (26 mg, 95%), which was used directly 
in the next step without further purification. TLC analysis Rf 0.49 (silica, 100% EtOAc); 
1H NMR (295 K, 400 MHz, CDCl3) δH mixture of rotamers a and b: 8.26 (1H, s, NCOH, 
a), 8.14 ( H, s, NCOH’, b) 7.42-7.20 (4H, m, Ar-H, a and b), 5.20 (2H, s, CH2OS, a or 
b), 5.19 (2H, s, CH2’OS, a or b), 4.50 (2H, s, CH2’NMe, b), 4.39 (2H, s, CH2NMe, a), 
2.96 (3H, s, NCH3’COH, b), 2.93 (3H, s, NCH3COH, a),  2.84 (6H, s, SO2CH3); m/z 
(HRMS+) 258.0802  [M+H]+ (C11H16NO4S requires 258.0800). 
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Dimethyl 6,6'-((7-(3-((N-methylformamido)methyl)benzyl)-1,4,7-triazonane-1,4-
diyl)bis(methylene))bis(4-((4-methoxy-2,6-dimethylphenyl)ethynyl)picolinate), Pre-
L42 
 
The bis-alkylated ligand, L39 (23 mg, 0.031 mmol) and K2CO3 (5 mg, 0.037 mmol) were 
dissolved in anhydrous CH3CN (2.5 mL) and bubbled with argon (20 minutes). The 
mesylate 6e (8 mg, 0.031 mmol) was added and the mixture was stirred under argon at 
65 °C and monitored by LC-MS. After 24 h the reaction was cooled and filtered to remove 
excess potassium salts. The solvent was removed under reduced pressure and the crude 
material was purified by flash column chromatography (silica, gradient elution starting 
from 100% CH2Cl2 to 10% CH3OH in CH2Cl2 in 1% increments) to give pre-L42 as a 
glassy solid (13 mg, 46%). TLC analysis Rf 0.32 (silica, 10% CH3OH in CH2Cl2); 
1H 
NMR (295 K, 600 MHz, CDCl3) δH 8.25, 8.11 (1H, 2 x s, NCOH, NCOH’), 8.02 (2H, s, 
py-H3), 7.62 (2H, s, py-H5), 7.49–7.14 (4H, m, Ph-H), 6.62 (4H, s, Ar-H2/2’), 4.49 (1H, s, 
NCH2Ph), 4.39 (1H, s, NCH2’Ph), 4.12 (4H, s, py-CH2), 3.93 (6H, s, CO2CH3), 3.80 (6H, 
s, OCH3), 3.47-2.99 (12H, br m, rings Hs), 2.87, 2.74 (3H, 2 x s, NCH3, NCH3’), 2.47 
(12H, s, Ar-CH3); 
13C NMR (295 K, 150 MHz, CDCl3) δC 165.3 (CO2CH3), 162.9 
(NCOH), 160.4 (Ar-C1), 157.8 (py-C6), 148.0 (Ar-C4), 143.1 (Ar-C3/3’), 137.4 (Ph-C), 
134.6 (Ph-C), 130.3 (Ph-C), 129.6 (Ph-C), 129.5 (Ph-C), 128.8 (Ph-C), 128.0 (py-C5), 
125.9 (py-C3), 113.8 (py-C4), 112.9 (Ar-C2/2’), 94.8 (alkyne C5), 93.0 (alkyne C6), 61.9 
(ring Cs), 59.7 (ring Cs), 55.4 (OCH3), 53.6 (CO2CH3), 53.1 (py-CH2), 51.7 (ring Cs), 
47.7 (NCH2Ph), 34.6, 29.7 (NCH3), 21.5 (Ar-CH3); m/z (HRMS
+) 905.4599 [M+H]+ 
(C54H61N6O7 requires 905.4602). 
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 [Eu.L42]Cl2 
 
An aqueous solution of sodium hydroxide 0.3 M (0.5 mL) was added to a solution of 
ligand pre-L42 (13 mg, 14 µmol) in methanol (0.5 mL). The mixture was stirred at 70 °C 
for 48 h. The reaction was cooled to r.t. and aqueous hydrochloric acid (0.1 M) was added 
until pH 7 was achieved. The crude solid was purified by preparative HPLC (Table 25) 
tR = 16.5 min. The solid was passed down an ion exchange column to remove the presence 
of formate. Europium chloride hexahydrate (3 mg, 8 µmol) was added and the pH was 
readjusted to 6.5 by addition of aqueous sodium hydroxide (0.1 M). The reaction was 
stirred at 65 °C for 24 h. The solvent was removed under reduced pressure to give the 
complex [Eu.L42]Cl2 as a white solid (5 mg, 68%). m/z ESI (MeOH no column) 1044 
[M+H]+;  λexc (MeOH) = 352 nm; ɸem (MeOH) = 0.18;  ε (MeOH) 36,000 M-1cm-1; τ 
(MeOH) = 0.77 ms. 
 
N-Acetyl-α-neuraminic acid methyl ester, CAS: 20298-35-5 
 
 
N-Acetylneuraminic acid (50 mg, 0.162 mmol) was dissolved in anhydrous MeOH, dry 
Dowex® 50Wx4 (H+) resin (100 mg) was added and the mixture was stirred at r.t. for 6 
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h under an argon atmosphere. After completion (reaction monitored by LC-MS), the resin 
was removed by filtration and the solvent was removed under reduced pressure to give 
N-acetyl-α-neuraminic acid methyl ester as a white solid (51 mg, 97%). 1H NMR (295 K, 
400 MHz, CD3OD) δH 4.08-3.99 (2H, m, H3, H5), 3.85-3.79 (2H, m, H4, Hγ), 3.78 (3H, s, 
CO2CH3), 3.71 (1H, ddd, 
3JHα 9, 
3JHγ’ 5.5, 
3JHγ 3, H
β), 3.62 (1H, dd, 2JHγ 11, 
3JHβ 5.5, H
γ’), 
3.49 (1H, dd, 3JHβ 9, 
3JH5 1.5, H
α), 2.22 (1H, dd, 2J2ax 13, 
3JH3 5, 2Heq), 2.02 (3H, s, 
NHCOCH3), 1.90 (1H, dd, 
2J2eq 13, 
3JH3 11, 2Hax); 
13C NMR (295 K, 100 MHz, CD3OD) 
δC 175.1, 171.8, 96.7, 72.1, 71.6, 70.2, 67.9, 64.8, 54.3, 53.1, 40.7, 22.7; m/z (HRMS+) 
324.1291 [M+H]+ (C12H22NO9 requires 324.1295). 
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Appendix One – Crystal Data 
 
 
 Identification code CCDC 
S-Δ-(λλλ)-[Eu.L30] 12srv245 965909 
R-Λ-(δδδ)-[Eu.L30] 13srv002 965910 
S-Δ-(λλλ)-[Yb.L30] 13srv030 965911 
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Appendix Two – List of Complexes 
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